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Abstract
ABSTRACT
Calcium oxalate (COM) crystals are the commonest component of kidney stones. 
These arise mainly in the distal tubules and collecting ducts. To gain further insight 
for the cellular damage in terms of oxidative stress caused by COM deposition, in 
vitro and in vivo model studies were performed.
In vitro
In renal distal tubule cells, COM and free oxalate treatment caused a 3- and 2- fold 
increase respectively in superoxide (0 2 *") formation, originating from mitochondria. 
This was measured by lucigenin chemiluminescence in digitonin permeabilised cells. 
However, hydroxyapatite produced a much lower but significant enhancement of 02*", 
whilst other micro-particles, uric acid crystals, brushite, zymosan, and latex beads had 
no effect. When EDTA was omitted during O2*’ monitoring, COM induced 
mitochondrial O2*" was ablated indicating a requirement for the release of free oxalate.
Mitochondrial oxalate uptake was studied by employing different oxalate transport 
inhibitors. Omitting phosphate from the media or using mersalyl both of which block 
dicarboxylate transport, caused a significant decrease in the O2*’ formation evoked by 
COM treatments.
Using the membrane potential sensitive-probe tetramethylrhodamine methyl ester 
(TMRM) together with confocal microscopy, evidence is presented that in cells where 
COM binding had occurred a marked change in the mitochondrial membrane 
potential (Aij/m) occurred.
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COM also modulated intracellular Ca signalling as demonstrated using the Ca - 
sensitive dye Fura-2 AM, and this was via a non-mitochondrial mechanism.
In Vivo
Using a rat model of crystalluria and renal stones initiated by treatment with ethylene 
glycol (EG) and 1, 25-dihydroxycholecalciferol (DHC), nephrolithiasis arose in 
kidneys and this was linked to oxidative stress. In the EG + DHC treated animals 
where crystalluria was evident, this oxidative insult was manifest by a decrease in 
total and mitochondrial glutathione concentration, as well as an increased activity of 
glucose-6-phosphate dehydrogenase.
Severe kidney damage at the mitochondria level was a further observation, indicated
by the diminished O2  consumption resulting in a lowered O2 " production. In
addition, histopathological analysis revealed increased renal tubular pathology 
characterised by obstruction, distension and interstitial inflammation. The above 
findings were not observed in hyperoxaluria (EG) or calciuria (DHC) and are 
therefore a direct effect of crystal formation in kidney distal tubules that have 
implications in kidney stone disease which are discussed.
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1.1 UROLITHIASIS
Urolithiasis is the medical term for kidney stone disease and is one of the most painful 
urological disorders. Renal stone disease is an ancient and common affliction, whose 
clinical occurrence and presentation was first described in the Aphorisms o f  
Hippocrates. Scientists have also found evidence of kidney stones in a 7,000-year old 
Egyptian mummy [http://kidney.niddk.nih.gov/kudiseases/pubs/stonesadults/]. 
Recently, reports have shown that renal stones occur once in a lifetime in 15 % of 
white men and 6 % of all women [Goodman, HO., et al., 1995]. Patients that have 
been diagnosed with kidney stone disease face a considerable risk of becoming 
recurrent stone formers, and for this reason it is desirable to provide an efficient stone 
preventive treatment [Tiselius, HG., & Hojgaard, I., 1999]. Most kidney stones pass 
out of the body without any intervention by a physician. Stones that cause lasting 
symptoms or other complications may be treated by various techniques most of which 
do not involve major surgery. However, in order to understand the patho - 
physiological mechanisms of stone disease, allowing more effective diagnosis and 
treatment, stone composition should be analysed and mechanisms of crystallisation 
and crystal-cell interaction need to be understood.
1.2 KIDNEY STONE COMPOSITION
The major crystalline substances that have been identified in urinary calculi are shown 
in Table 1.1. Studies conducted using x-ray power diffraction have identified six 
major groups of kidney stones constituents: calcium oxalate (monohydrate, and 
dihydrate), calcium phosphate (hydroxyapatite and brushite), bacterial induced 
(struvite), purines and their salts (uric acid), and cystine.
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Table 1. 1 Crystalline substances that occur most frequently in urinary calculi.
Calcium Oxalate Monohydrate CaC2 0 4  • H2O
Calcium Oxalate Dihydrate CaC20 4 • (2 + x) H20
Basic calcium Hydrogen 
(hydroxyapatite)
Phosphate Ca5 (P04)3 (OH)
Calcium Hydrogen Phophate (brushite) CaHP04 • 2H20
Magnesium Ammonium 
(struvite)
Phosphate Mg(NH4)(P04) • 6H20
Uric Acid c 5h 4n 4o 3
1.2.1 CALCIUM OXALATE STONES
Urine is usually supersaturated with calcium and oxalate ions that nucleate to form 
calcium oxalate crystals [Coe, FL., & Parks, JH., 1988]. Previous studies of renal 
stones or fragments of stones recovered after shock wave lithotripsy have shown that 
the most common constituent of kidney stones is the calcium oxalate monohydrate 
(COM) [Figure 1.1 A]. In addition, calcium oxalate dihydrate (COD) crystals [Figure
1.1 B] are the most common crystals found in the urine [Tiselius, HG., & Hojgaard, I.,
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1999; Lieske, JC., & Deganello, S., 1999]. COD crystals are metastable and once 
formed tend to undergo a phase transition to COM, which is the thermodynamically 
stable hydrate and most abundant crystal found in kidney stones [Coe, FL., & Parks, 
JH., 1988]. In this way the association of COD crystals with renal cells could result in 
the formation of COM stones. Recent studies have demonstrated that COM crystals 
can bind rapidly to the surface of renal epithelial cells [Lieske, JC., et al., 1995; Riese, 
RJ., et al., 1988] and be internalised [Lieske, JC., et al., 1992; Lieske, JC., & Toback, 
FG., 1993]. The attachment mechanism and internalisation of COM crystals will be 
discussed in detail in the following sections.
Figure 1. 1 Calcium oxalate stones. Scanning electron micrographs of (A) calcium 
oxalate monohydrate and (B) calcium oxalate dihydrate crystals as adapted from 
http://www.herringlab.com/photos/Urinarv/Oxalates/Com
(A) (B)
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1.2.2 URIC ACID STONES
Uric acid stones [Figure 1.2 A] are smooth, round, yellow-orange and nearly 
radiographically transparent. High purine diet, containing organ meats and fish, result 
in hyperuricosuria, and in combination with low urine volume and low urinary pH 
(resulting from impaired renal ammonia production), can lead to uric acid formation 
[Colussi, G., et al, 2000]. Even in the absence of elevated serum or urinary uric acid 
concentrations, uric acid can precipitate out in acid urine. Furthermore, 
hyperuricaemic disorders including gout, myeloproliferative disorders, tumor lysis 
syndrome, and inborn errors of metabolism result in an increased filtered load of uric 
acid and thus, hyperuricosuria [Rumsby, G., 2000]. As with all stones, certain drugs 
may enhance stone formation, and in the case of uric acid stones, hyperuricosuric 
agents include low dose salicytates, probenecid, and thiazides.
1.2.3 STRUVITE STONES
Radiographs show struvite stones as large, gnarled, and laminated. They are 
associated with substantial morbididty including bleeding, obstruction, and urinary 
tract infection. Signs of struvite stones [Figure 1.2 B] include urinary pH greater than 
7 and urease that grows bacteria on culture. Struvite stones which develop if urine is 
alkaline, have a raised concentration of ammonium, contain trivalent phosphate, and 
contain urease produced by bacteria [Cohen, TD., & Preminger, GM., 1996].
1.2.4 CYSTINE STONES
Cystine stones [Figure 1.2 C], caused by an inborn, heritable renal defect. The tubular 
reabsorption of the amino acids cystine, arginine, lysine, and ornithine is reduced, 
even though only cystine is poorly soluble [Shekarriz, B., & Stoller, ML., 2002; 
Knoll, T., et a l, 2003]. Cystine stone formation might occur only in infancy, although
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the first manifestation mostly occurs in the second decade [Singh, A., et al, 1998; 
Slavkovic, et al., 2002]. They are greenish-yellow, flecked with shiny crystallites, and 
are moderate radio opaque with a rounded appearance. Calcium stones are more dense 
than vertebral bodies, whereas cystine stones are less dense. People who are 
homozygous for cystinuria (an autosomal recessive disorder) excrete more than 600 
mg per day of insoluble cystine. Low urinary dilution and a high intake of animal 
protein, as well as sodium chloride, increase the urinary excretion of cystine. More 
than half the stones in cystinuria are of mixed composition, and many patients have 
associated physiological problems, such as hypercalciuria, hyperuricosuria, and 
hypercitraturia [Sakhee, K., et al., 1989].
1.2.5 CALCIUM PHOSPHATE STONES
Hydroxyapatite crystals [Figure 1.2 D] are often present in the urine. Randall's 
plaques, which are submucosal calcifications on the human renal papillary surface, 
have been proposed as early sites of stone formation that seem to arise from a calcium 
phosphate nucleus [Prien, EL., 1975]. Hydroxyapatite crystals appear to bind to the 
anions anchored on the apical surface of the kidney epithelial cells in culture. 
Hydroxyapatite crystals also interact with microvilli on the apical renal cell surface, 
undergo internalisation, and subsequently appear within membrane-lined vesicles 
[Lieske, JC., et al., 1999]. These results suggest that the interactions of hydroxyapatite 
with renal cells are regulated by the structure or function of soluble anions in tubular 
fluid and those anions anchored to the cell surface could be critical determinants of 
hydroxyapatite crystal retention in the nephron.
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Figure 1. 2 Different types of kidney stones. Scanning electron micrographs of (A) 
uric acid dihydrate, (B) cystine stones, (C) magnesium ammonium phosphate 
(struvite), and (D) calcium phosphate (hydroxyapatite) kidney stone as adapted from 
http://www.herringlab.com/photos/Urinarv/Oxalates/Com.
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Information about the composition of the specific types of kidney stones allows 
improvements in medical treatment to prevent that particular type of stone to form, 
and thereby to prevent recurrent kidney stone attacks. In addition, such information 
could shed light on the mechanism of kidney stone formation, another important 
factor to be investigated in order to eliminate the risks of kidney stone development.
1.3 MECHANISMS OF STONE FORMATION
The formation of stones within the urinary tract is a multifaceted and complex 
process. Supersaturation of the urine with respect to calcium oxalate is a prerequisite 
for calcium oxalate urinary stone formation. Urine supersaturation though is not the 
only determinant factor for urinary stone formation. Both stone-forming patients and 
healthy subjects share the common phenomenon of supersaturated urine and 
crystalluria [Robertson, WG., 1969; Elliot, JS., & Rabinowitz, IN., 1976]. This 
finding led to the concept that the precipitation of COM crystals by itself poses no 
problem as long as the particles formed are allowed to pass freely through the urinary 
tract. Problems occur only when the particles are retained and allowed to form the 
nidus of a stone. The movement through the urinary tract at a speed lower than that of 
the urinary flow is defined as retention. Retention can occur because the particles 
become too big to pass freely through the renal tubules, by adhesion to the tubular 
cells, and by trapping of particles at sites of disturbed urinary flow. When the size of 
the particle is the decisive factor for the mechanism of stone formation, the process is 
defined as the free particle mechanism. This is in contrast to the fixed particle 
mechanism, where adhesion plays a dominant role.
The chances of forming stone through a free particle mechanism were calculated by 
Finlayson and Reid [Finlayson, B., & Reid, S., 1978]. These studies were based on
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average normal values for oxalate excretion, kidney structure and nephron 
dimensions, and they claimed that the "free-particle" model was unlikely to occur. 
They also claimed that there was not sufficient time to allow crystals to grow large 
enough and become trapped before they were extruded. Instead, they suggested that 
the nuclei of CaOx, resulting from supersaturation of the tubular fluid, are attached to 
epithelial cells lining the tubule due to the damage that has occurred, either as a result 
of the abrasive action of the crystals or as a consequence of an infection.
This "fixed-particle" model was reassessed more recently by Kok and Khan [Kok, 
DJ., & Khan, SR., 1994], taking into account new evidence on tubule dimensions and 
the flow rates of tubular fluid. These authors formed a compromise between the "free" 
and "fixed"-particle models. They proposed that the "free-particle" model could be 
possible in the case where crystal agglomeration occurred, since the latter constitutes 
the fastest means by which particles may become large within a short space of time.
More recently, Robertson [Robertson, WG., 2004] examined the probability that 
crystals can indeed become large enough at some point in the nephron by introducing 
three new hydrodynamic factors that may lead to the delay of crystal passage. This 
latest model takes into account that crystals may move at different speeds in relation 
to the fluid flow rate at the central axis of the tubule, and crystals moving adjacent to 
the tubule walls move more slowly than crystals at tubule axis. In addition, it was 
suggested that crystal transit may be delayed more in tubules with long loops of 
Henle, and crystals may stop moving or even fall backwards in the upward-draining 
sections of the tubule. Finally, Robertson proposed that if these hydrodynamic factors 
are operative in the human kidney, it is possible that the "free-particle" model might 
still be a mechanism by which CaOx stones are initiated.
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1.3.1 CALCIUM OXALATE CRYSTAL ADHERE TO RENAL 
EPITHELIAL CELLS
Studies using diverse cultured renal epithelial cells have demonstrated that calcium 
oxalate monohydrate (COM) crystals, the most common crystal in human stones, 
rapidly adhere to molecules on the apical surface [Lieske, JC., et al., 1995; Lieske, 
JC., et al., 1996; Riese, RJ., et al., 1988; Riese, RJ., et al., 1992; Verkoelen, CF., et 
al., 1996] and are internalised [Lieske, JC., et al., 1992; Lieske, JC., et al., 1993]. The 
COM crystal surface behaves as if it were positively charged [Lieske, JC., et al.,
1995] and the apical kidney tubular cell surface functions as if it were negatively 
charged [Lieske, JC., et al., 1996]. It has been proposed that anionic molecules on the 
cell surface, by acting as receptors for COM crystals [Lieske, JC., et al., 1996; 
Bigelow, MW., et al., 1997], and specific anions in tubular fluid by binding to the 
crystal surface and blocking its adhesion to the cell [Verkoelen, CF, et al., 1996], 
have each emerged as potentially critical determinants of stone formation.
Lieske and Deganello [Lieske, JC., & Deganello, S., 1999], in their attempt to 
understand how renal cells respond to crystals and how these processes might result in 
stone formation, have proposed a potential mechanism of cell-crystal interaction in 
the nephron [Figure 1.3]. Calcium oxalate or calcium phosphate crystals can either 
nucleate in luminal fluid or potentially form on the surface of renal cells. In the case 
where crystals nucleate in tubular fluid can be coated by soluble ions 
(glycosaminoglycans, citrate, proteins), or adhere to anchored anions on the cell 
surface. These in turn bind to candidate receptors such as glycoproteins, 
phospholipids, or glycolipids. Once attached to their surface, crystals can be 
internalised by cells and eventually appear in membrane lined vacuoles. Crystals may
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then be dissolved within the cells or possibly become situated in the interstitium. The 
outcome of this series of events could determine whether a crystal is flushed out of 
the nephron or is retained in the kidney with the potential to initiate stone formation.
While studies were performed on interaction between crystals and renal tubular cells 
[Lieske, JC., et al., 1992; Weissner, JH., et al, 1987], other studies were based on the 
cell-surface substances responsible for crystal attachment.
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Figure 1. 3 Proposed mechanism of nucleation, growth and adhesion of calicium 
oxalate crystals in the renal tubule, adapted from Lieske, JC., et al., 2000.
Calcium oxalate or calcium phosphate crystals nucleate in tubular fluid or on the 
tubular cell surface. Crystals that are nucleated in tubular fluid can either be coated by 
soluble ions (proteins, GAGs) or adhere to ions of the tubular cell surface. These can 
then be flushed out of the nephron or be retained in the kidney and develop a kidney 
stone. Oxalate crystals that anchor on the tubular surface, can be internalised by the 
cells. These crystals may then be dissolved within the tubular cells or possibly 
become translocated in the interstitium.
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1.4 CRYSTAL BINDING MOLECULES
Observations made in kidneys derived from hyperoxaluric rats and stone-forming 
patients suggested that under pathological conditions, renal tubular cells express cell- 
surface molecules that have an affinity for crystals. These surface molecules were 
described as crystal-binding molecules and fall into four main groups: 
phosphatidylserine, sialic acid, extra-cellular matrix molecules, and hyaluronan.
1.4.1 PHOSPHATIDYLSERINE
The possible role of plasma-membrane phospholipids in the attachment of COM 
crystals to primary cultures of inner medullary collecting duct (IMCD) was first 
investigated by Mandel's group [Weissner, JH., et al., 2001; Bigelow, MW., et al., 
1997]. Specifically, these authors, by exogenously adding phospholipid liposome 
suspensions or by exposing IMCD cells to a calcium ionophore (A23187), were able 
to induce alteration in the membrane lipid composition of the cells. Both of these 
approaches have revealed that the expression of phosphatidylserine at the cell surface
greatly enhanced crystal binding. Further experiments on treating phosphatidylserine-
2+
expressing cells with the apoptotic marker annexin V, a Ca -dependent binding 
protein with a high affinity for phosphatidylserine, have revealed similar results, 
indicating low levels of crystal binding. Based on these observations, Bigelow and his 
group [Bigelow, MW., et al., 1997] proposed that crystal retention might be caused 
under pathological conditions by the appearance of phosphatidylserine at the surfaces 
of epithelial cells lining the collecting ducts. The same effect of phosphatidylserine 
exposure and crystal binding was also shown by the group of Scheid [Cao, LC., et al., 
2001] when they treated Madin-Darby canine kidney (MDCK) cells with toxic 
oxalate concentrations.
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1.4.2 SIALIC ACID
In 1996, Lieske et al. [Lieske, JC., et al, 1996] described the adherence of COM 
crystals to wild type MDCK cells. When these cells were incubated with positively 
charged compounds, crystal binding was reduced. This suggested that crystals adhere 
to negatively charged cell surface components [Lieske, JC., et al., 1996]. Pre­
treatment of the crystals with these cationic compounds did not influence crystal 
binding, indicating that they affected the cell surface rather than the crystal surface. 
Since most of the cell surface of the negative charge is attributable to terminal sialic 
acid residues, these investigators subsequently studied the effect of sialidase on 
crystal binding. This treatment significantly reduced the binding of the crystals. In 
addition, pre-treatment of the MDCK cells with sialic acid-specific lectins could also 
reduce crystal binding. Therefore, it has been suggested that crystals can bind to sialic 
acid.
As it has been described earlier in section 1.3.1, Lieske et al. have proposed a possible 
interaction mechanism where one population of anions anchor to the apical plasma 
membrane and the other free in tubular fluid. Both of these populations are deemed as 
competitors for the crystal surface. To determine whether or not crystals bind to the 
renal tubular surface, further investigation is required on the alterations in the quality 
and quantity of either population of ions.
1.4.3 EXTRACELLULAR MATRIX MOLECULES
Other potential crystal binding molecules are those of the extra-cellular matrix. Kohri 
et al. [Kohri, et al., 1991] observed that calcium oxalate crystals adhere to collagen 
type IV-positive cell clumps in primary cultures of IMCD cells. This observation led 
to the speculation that renal tubular basement membrane collagen IV is a potential
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crystal-binding molecule. Further investigations [Yamate, T., et al., 1992] have shown 
that when wild-type MDCK cells were exposed to osteopontin resulted in increased 
crystal deposition on the cell surfaces. The fluorescence intensity of osteopontin at the 
cell surface could be reduced by osteopontin antibodies and therefore reducing crystal 
binding. From these observations, it was proposed that osteopontin might serve as a 
crystal binding molecule.
1.4.4 HYALURONAN
Besides sialic acid, glycosaminoglycans (GAGs) also make a substantial contribution 
to the overall negative charge of the cell surface. These molecules have therefore 
frequently been postulated as potential crystal-binding molecules. Hyaluronan is a 
principal component of stone matrix GAG content, and it participates in one or more 
stages of renal stone formation. The multiple roles attributable to hyaluronan in renal 
stone formation may be a consequence of its various size-related functions. The high 
molecular mass (100 kDa) forms that stabilise matrix architectures [Laurent, TC., & 
Fraser, JRE., 1992; Knudson, W., et al, 1993; Scott, JE., et al., 1991] can coat 
crystals and thus block crystal-crystal or crystal-cell interaction. However, the lower 
molecular mass forms can mediate crystal-cell adhesion and crystal nucleation 
[McKee, CM., et al., 1996; McKee, CM., et al., 1997; Oertli, B., et al., 1998].
Although hyaluronan is usually found in the medullary and papillary interstitium of 
the normal kidney [Wells, AF., et al., 1990; MacPhee, PJ., 1998], it has also been 
demonstrated [Wessler, E., 1971; Hansen, C., et al., 1997; Lokeshwar, VB., et al., 
1997] that a minor component may be found in normal urine. The urinary hyaluronan 
is predominantly in the range of 10 kDa [Lipkin, GW., et al, 1993]. Studies 
[Gustafson, S., et al., 1997] have shown that renal and extra-renal high molecular
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mass hyaluronan is rarely excreted in the urine. However, in the case of injury or 
inflammation of renal tissues, degradation of high molecular mass hyaluronan to 
lower molecular fragments occurs [Saari, H., 1991; Kreil, G., 1995]. The latter may 
become signal molecules that upregulate expression of adhesion molecules in renal 
tubular epithelial cells [Oertli, B., et al., 1998]. In addition, these low molecular 
fragments of hyaluronan, produced as a secondary product of injury or inflammation, 
may become involved in the crystallisation of urinary calcium oxalate as a prelude to 
cell-crystal adhesion and crystal-crystal aggregation, leading to renal stone formation.
Having described various candidate crystal-binding molecules that determine the 
susceptibility of the renal tubular cell surface to crystal binding, other investigations 
have focused on the effects of stone matrix proteins responsible for inhibiting or 
promoting kidney stone formation.
1.5 KIDNEY STONE PROTEINS
Urolithiasis researchers have been searching for synthetic or natural occurring 
substances that can inhibit crystallisation of calcium salts. A number of urinary 
components have been identified as inhibitors and those can be divided into low- and 
high-molecular weight substances [Ryall, RL., 1997]. It has been suggested that high- 
molecular weight substances and especially proteins may have an important role in 
the prevention of stone disease [Ryall, RL., 1995]. Studying proteins that have been 
identified in human calculi have suggested that the presence of these proteins in stone 
matrices play a role (as either inhibitors or promoters) in stone pathogenesis. 
Therefore, analysis of stone matrix proteins to assess their roles in kidney stone 
formation is of great value. As it has been discussed in earlier sections healthy human 
urine does not under physiological conditions contain proteins. The presence of
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proteins in the urine can arise as a result of tissue trauma. Therefore, studying proteins 
included in calcium oxalate crystals precipitated from fresh healthy human urine in 
vitro might yield important information of the role of these proteins in stone 
formation. In the following paragraphs a few of these proteins will be discussed 
according to their potential role in kidney stone formation.
1.5.1 TAMM-HORSFALL PROTEIN
Tamm-Horsfall protein (THP) is a glycoprotein present abundantly in human urine. 
Urinary excretion occurs by proteolytic cleavage of the large ectodomain of the 
glycosyl phosphatidylinositol-anchored counterpart exposed at the luminal cell 
surface of the thick ascending limb of Henle's loop [Chakraborty, J., et al., 2003; 
Serafini-Cessi, F., et al., 2003]. THP of normal subjects inhibits the aggregation, but 
has little effect on nucleation and growth of CaOx crystals [Worcester, EM., et al,
1988]. However, THP activity is influenced by its own concentration, urinary pH and 
ionic strength, playing a role in crystal formation depending on the environmental 
conditions [Hess, B., 1994]. Moreover, THP isolated from the urine of recurrent stone 
formers sometimes becomes a promoter of CaOx aggregation due to a tendency to 
self-aggregation, which removes it from effective interaction with CaOx monohydrate 
crystals [Hess, B., et al, 1991]. THP is a macromolecule and has been extensively 
studied, sometimes with paradoxical results concerning CaOx crystallization, 
depending on the conditions and methods employed. Most authors agree that THP is a 
weak inhibitor of nucleation and growth, but in solutions with high pH, low ionic 
strength, and low concentrations of divalent ions, the glycoprotein acts as a powerful 
inhibitor of CaOx crystal aggregation [Dussol, B., & Berland, Y., 1996].
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1.5.2 OSTEOPONTIN
It has been proposed that osteopontin (OPN) is involved in stone formation as a 
component of the stone matrix [Yamate, T., et al., 1999]. Initially these authors 
performed sequencing of the cDNA of proteins in the stone matrix of calcium oxalate 
calculi and they found that OPN was present [Kohri, K., et al, 1992; Umekawa, T., et 
al., 1995]. In addition they observed that the OPN expression in renal distal tubular 
cells was increased in renal stone-forming rats [Kohri, K., et al., 1993]. According to 
these observations they suggested a dual action of OPN. Firstly, OPN playing a role in 
binding with calcium and secondly OPN may be contributing to the cell adhesion. 
Furthermore, the same authors [Yamate, T., et al., 1999] have reported that calcium 
oxalate crystal adhesion on the surface of MDCK cells increased when OPN was 
added to MDCK cells [Yamate, T., et al., 1996]. To further evaluate the effect of 
OPN on the adhesion of calcium oxalate crystals to MDCK cells, they suppressed the 
urolithic activity of OPN. When they pre-treated MDCK cells with OPN, and 
thrombin, which is an OPN inhibitor, scanning electron micrographs revealed that the 
degree of CaOx crystal deposition was suppressed between 40 % to 80 %. These 
Findings led to the conclusion that OPN is essential for crystal deposition on MDCK 
cells, and plays an important role as a component of extracellular matrices.
1.5.3 PROTHROMBIN FRAGMENT 1
Prothrombin fragment 1 (PTF1) has been identified as a crystal matrix protein 
[Stapleton, AMF., & Ryall, RL., 1995; Nishio, T., et al., 1998] that exhibits strong 
inhibitory effects on calcium oxalate crystallisation. PTF1 is localised to lithogenic 
regions of renal tubules [Stapleton, AMF., et al. 1993] and has a potent inhibitory 
activity against calcium oxalate crystal growth and crystal aggregation, under
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inorganic aqueous conditions [Grover, PK, et al., 1998] and in undiluted human urine 
in vitro [Ryall, RL., et al., 1995]. Evidence to support a direct role for the protein in 
stone pathogenesis requires demonstration that synthesis of the protein is influenced 
by the formation of crystals or stones within the urinary tract. Recently, PTF1 was 
found in calcium phosphate crystals generated in urine and in the stone matrix of 
CaOx [Stapleton, AMF., et al., 1996]. Urinary PTF1 strongly inhibits CaOx crystal 
aggregation; therefore its abundance in urine is believed to prevent urinary stone 
formation [Suzuki, K., et al., 1994; Doyle, IR., 1995]. Reports have also showed that 
PTF1 strongly inhibited the crystal growth of CaOx at a physiological concentration 
in urine [Bezeaud, A., & Guillin, MC., 1984].
1.5.4 BIKUNIN
A factor that may explain the difference between stone and non-stone forming 
patients is that normal human urine is more efficient in inhibiting the formation and 
aggregation of calcium oxalate crystals. Numerous studies have shown that normal 
urine contains macromolecular substances capable of preventing and reducing 
calcium oxalate crystal formation and aggregation [Ryall, RL., & Stapleton, AMF., 
1995; Atmani, F., et al., 1998; Khan, SR., 1997]. One substance that has attracted 
attention is inter-a-inhibitor (Ial) and its various components, particularly the light 
chain called bikunin. Ia l is composed of three distinct polypeptide chains: two heavy 
chains HI and H2, and bikunin. The bikunin chain originates from a common a l -  
microglobulin/bikunin precursor, which is separated into two polypeptides by post- 
translational cleavage. Free bikunin is found in plasma as well as in urine. Urinary 
bikunin, obtained from human or rat urine, was shown to be a potent inhibitor of 
calcium oxalate growth [Atmani, F., et al., 1996]. When the same inhibitor was
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isolated from the urine of stone formers it showed less inhibitory activity towards 
calcium oxalate growth [Atmani, F., et al., 1996]. In addition, further studies have 
shown that during calcium oxalate nephrolithiasis increased levels of bikunin were 
synthesized [Atmani, F., et al, 1996]. Furthermore, bikunin is thought to be a 
calcium-binding protein [Kobayashi, H., et al., 1998] and is likely that the inhibitory 
action against crystal adhesion may depend on the binding of bikunin to the crystal 
surface.
1.5.5 ANNEXIN II
A critical step for the development of kidney stones is the attachment of newly 
formed crystals to renal epithelial cells. Annexin II has been shown to be the most 
prominent crystal-binding protein [Kleinamnn, JG, & Soronika, EA., 1999]. It is 
present on the apical cell surface and is an intrinsic membrane bound protein. It has 
been demonstrated that when IMCD cells are exposed to oxalate there is enhanced 
(14)C - oxalate crystal binding and increased exposure of phosphotidylserine (PS) on 
the cell membrane [Cao, LC., et al., 2001; Weissner, JH., et al., 1999]. Further studies 
have also shown that treatment of IMCD cells with PS-containing liposomes 
enhanced (14)C - oxalate crystal binding. Annexin-II binds to anionic phospholipids, 
and to COM crystals. According to these observations it is therefore, possible that 
enhanced COM crystal binding to cells under conditions where PS is exposed could 
be related to increased Annexin-II present on the cell surface [Kumar, V., et al., 
2003]. These authors have also suggested that Annexin-II not only mediates adhesion 
of COM crystals to renal cells, but it could also play a role in their subsequent 
internalisation.
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It has been proposed that deposition of crystals in the renal tubules is associated with 
injury to the tubular epithelium. In order to evaluate the mechanisms involved in 
crystal retention within the kidneys, it is necessary to understand how epithelial injury 
and the subsequent process of wound healing could lead to increased crystal binding.
1.6 IMPACT OF EPITHELIAL INJURY ON CRYSTAL- CELL 
INTERACTION
The idea that renal tubular cell injury might play a role in urolithiasis is supported by 
several lines of evidence: (1) it was observed that in clinical idiopathic calcium 
oxalate stone formers increased levels of brush border and lysosomal enzymes of 
renal epithelial origin were excreted in their urine [Baggio, BG., et al., 1983], (2) 
increased urinary enzyme levels and renal tubular apical membranes were also found 
in experimental models of stone disease [Hackett, RLP., et al., 1994; Khan SR., et al.,
1989], and (3) calcium oxalate crystals are able to adhere to injured urothelium of the 
rat bladder [Gill, WB., et al., 1981; Khan, SR., et al., 1984].
Further studies of crystal deposition in association with renal epithelial injury have 
also showed that epithelial cells lining the crystal-containing tubules suffered damage 
[Khan, SR., 1991; Khan, SR., & Hackett, RL., 1985; Khan, SR., et al., 1979; Khan, 
SR., et al., 1982]. The first observed phenomena occurred in the proximal tubules 
where the brush border was distorted by clubbing of the microvilli, blebs were formed 
and focal loss of the brush border. Progressive changes in the cells resulted in their 
ultimate death and detachment from the basement membrane. Furthermore, a number 
of dividing cells were found in the epithelial lining of the tubules. Many of them were 
seen in close proximity to the cell surface and in association with the microvilli. Some 
were found attached to the injured cells. At later stages, many crystals were found in
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the intracellular spaces and also attached to the denuded basement membrane. Renal 
cellular injury is indicated by an increase of urinary excretion enzymes such as, y- 
glutamyl transpeptidase, alkaline phosphatase, and A-acetyl-p-glucosaminidase 
[Khan, SR., et a l, 1989; Khan, SR., et al, 1992].
Similar studies were performed by Hackett et al. [Hackett, RL., et al, 1994], showing 
that when MDCK cells were exposed to calcium oxalate crystals, this resulted in 
detachment and shedding of the cells from their substrates. This was indicated by 
elevated levels of y-glutamyl transpeptidase, leucine aminopeptidase, and A-acetyl-P- 
glucosaminidase found in the culture media indicative of cellular injury. The cells 
remaining attached appeared injured, showing blebbing and swelling of the microvilli, 
with their eventual loss. In addition, cell-to-cell contacts appeared stretched with 
widened intracellular space. As a result of these phenomena, crystals became attached 
to the cells and microvilli and some of them were internalised whilst others were 
found in the intracellular spaces. Other studies included the effect of calcium oxalate 
crystals in a proximal origin cell line (LLCPK). The effect of crystal deposition was 
the same, exhibiting morphological changes including vacuolisation [Menson, M, et 
al., 1993].
Hyperoxaluria in the absence of calcium oxalate crystal deposition in the kidneys also 
appears to be injurious to renal epithelial cells. Thus, it is important to understand 
how free oxalate is associated with urolithiasis.
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1.6.1 OXALATE IS ASSOCIATED WITH INJURY OF RENAL 
EPITHELIAL CELLS
COO'
Oxalate is a small dicarboxylic ion || (C2O42') that is freely filtered at the
COO'
glomerulus. Dietary oxalate is a major contributor to urinary oxalate excretion in most 
individuals. Studies have indicated that dietary oxalate can contribute up to 50 % to 
the daily urinary oxalate excretion [Holmes, RP., et al., 1995; Assimos, et al., 1997]. 
Calcium oxalate crystals have an increased propensity to form in the presence of 
hyperoxaluria, even in the absence of elevated calcium [Seftel, A., & Resnick, MI.,
1990], suggesting a prominent role for oxalate. Oxalobacter forminogenes is a 
bacterium colonising the gastrointestinal tracts of vertebrates, including humans 
[Allison, MJ., et al., 1985]. This bacterium has an important symbiotic relationship 
with its hosts in regulating oxalic acid absorption through the intestine, as well as 
oxalic acid levels in the plasma [Doane, LA., et al., 1989; Hatch, M., & Freel, RW.,
1996]. Further studies [Han, JZ, et al., 1995 Kwak, C., et al., 2003] have indicated 
that the absence of O. forminogenes can lead to a significant increase in the 
absorption of oxalate from the gut, thereby increasing the levels of urinary oxalate 
excretion, especially when the diet is rich in oxalate. The absence of O. forminogenes 
from the gut appears to be a risk factor for absorptive hyperoxaluria and its 
subsequent complications, including nephrolithiasis.
The amount of oxalate that is excreted in the urine not only depends on the intestinal 
absorption, but on the dietary intake, endogenous production, and renal transport 
[Larsson, L., & Tiselius, HG., 1987; Menon, M., & Mahle, CJ., 1982; Menon, M., & 
Koul, H., 1992; Wandzilak, TR., & Williams, HE., 1990; Williams, AW., & Wilson, 
DM., 1990; Williams, HE., & Wandzilak, 1989; Senekjian, HO., & Weinman, EJ.,
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1982]. The endogenous production of oxalate predominantly derives from the 
metabolism of glyoxylate and ascorbate and contributes importantly to the amount of 
oxalate that is excreted in the urine [Menon, M., & Mahle, CJ., 1982; Menon, M., & 
Koul, H., 1992; Senekjian, HO., & Weinman, EJ., 1982].
The mechanism by which oxalate promotes stone formation is not yet clear. The 
majority of the patients with calcium oxalate stone disease show a small, but a 
definite, increase in urinary oxalate excretion, but few have been diagnosed with 
hyperoxaluria [Tiselius, HG., 1980]. However, the probability of stone formation and 
the severity of stone disease are directly proportional to urinary oxalate levels [Elliot, 
JS., et al, 1976]. Elevated urinary oxalate levels can lead to calcium oxalate 
crystallisation, but not necessarily to stone formation. Therefore, the mechanism 
through which oxalate promotes stone formation is clearly more complex than a 
simple increase in crystal formation. Moreover, presence of crystals in the urine does 
not appear to be a distinguishable difference between stone formers and healthy 
subjects. Crystal formation is not an indication of symptomatic stone disease, since 
most of the solid particles crystallising within the urinary tract will be excreted freely. 
Studies by Robertson [Robertson, WG., 1969] have concluded that crystalluria does 
not indicate kidney stone disease. Therefore, the mechanism by which oxalate 
promotes crystal retention has been the focus of studies for several years.
Previous reports [Barker, G., & Simmons, NL., 1981] have suggested that oxalate 
transport may be altered by morphological or functional changes of renal epithelial 
cells. Oxalate transport across cellular membranes is mediated by anion-exchange 
transport proteins. A defect in the structure of these transport proteins could explain 
augmented transcellular oxalate transport. Aronson [Aronson, PS., Kuo SM., 1994]
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demonstrated that difference in the structure of band-3-related transport protein would 
alter the affinity of a transport system for oxalate in such a way that oxalate 
absorption in the intestine and secretion in the kidney is increased.
Two proposed mechanisms were developed to explain crystal retention. The first one 
includes the direct entry of oxalate into the renal tubular cells to promote crystal 
formation within the tubular cells. Alternatively, an increased oxalate flux would 
result in cellular proliferation and or damage that could promote crystal retention 
[Khan, SR., & Hackett, RL., 1993; Khan, SR., et al, 1990]. Specifically, during cell 
proliferation cell-cell contacts are minimised, mitosis then reduces cell adhesion to the 
extra-cellular matrix and exposes previously masked basolateral membrane domains 
to tubular fluid, thereby favouring crystal retention.
As previously mentioned, oxalate is a dicarboxylate that is freely filtered at the 
glomerulus and undergoes both reabsorption and secretion in the proximal tubule, 
with secretion dominating under normal conditions [Aronson, PS., 1989]. In vitro 
studies [Koul, HK., et a l, 1999; Scheid, C., et al, 1996; Khan, SR., et al, 1999] have 
demonstrated that exposure of elevated levels of oxalate led to progressive changes in 
the morphology and cell viability. Furthermore, it has been shown [Koul, HK., et al., 
1999] that proximal tubular cells are more susceptible to oxalate challenges than the 
cells of the collecting duct epithelium. An injury to cells of the proximal tubular 
epithelium may provide substrate for heterogeneous nucleation of crystals in the 
collecting ducts where urine is concentrated and calcium oxalate is metastable. Scheid 
[Scheid, C., et al, 1996] has provided evidence that oxalate is toxic to proximal 
tubule cells. These authors treated LLCPK cells, an epithelial cell line with 
characteristics of proximal tubular cells, to high concentrations (> 350 pM) of oxalate
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and have showed changes in morphology and viability of these cells. This is at a 
concentration of oxalate that is likely to be higher than might occur in the normal 
kidney, but within the range that might be found in hyperoxaluria or in end-stage 
renal disease. The same group also suggested that a possible mechanism by which 
hyperoxaluria may promote crystal retention relies on the increase of turnover of renal 
epithelial cells that provides cellular debris for nucleation and retention of calcium 
oxalate crystals.
Having discussed the injurious effect of oxalate on LLCPK cells, it is worthwhile 
mentioning whether cellular death may be necrotic or apoptotic. There are specific 
differences when a cell undergoes necrosis or apoptosis. During apoptosis cells 
shrink, cell membrane remains intact, phosphatidylserine of the plasma membrane 
flips from inside to the cell surface, chromatin in the nucleus condenses, and DNA 
fragments. During necrosis, cells swell, vacuoles enlarge, mitochondria become 
swollen, plasma membranes are compromised, and blebbing may occur on cell 
surfaces. However, cells undergoing necrosis, do not exhibit either an increase in 
phosphatidylserine on the cell surface or condensation of chromatin and DNA 
fragmentation. Cells undergoing apoptosis detach from the basement membrane and 
break into smaller bodies that are phagocytosed by the neighbouring cells, whereas 
necrotic cells rupture and release their contents into the surrounding area. 
Consequently, cell necrosis can provoke an inflammatory response, whereas cell 
death by apoptosis shows a reduced incidence.
Renal epithelial cells of proximal tubular origin exposed to oxalate have been reported 
to follow both mechanisms of cell death [Lieberthal, W., et al, 1996]. When LLCPK 
cells were exposed to oxalate for 24 h and 48 h, apoptotic cells start accumulating and
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being phagocytosed by the neighbouring healthy cells, while the plasma membrane is 
still intact. However, the clearance of apoptotic cells was interrupted and cells went 
through a process of secondary necrosis [Lieberthal, W., & Hughes, H., 1993; 
Lieberthal, W., et al, 1996; Schwartzman, RA., & Cidlowski, JA., 1993]. Apoptosis 
of renal epithelial cells in response to oxalate may play a significant role in 
nephrolithiasis. Exposure of annexin binding phosphatidylserine to the cell surface, a 
mechanism described as an apoptotic marker, results in attracting calcium and acting 
as a site for attachment of calcium oxalate crystals to the cell surfaces [Bigelow, 
MW., et al., 1996].
In addition, oxalate has been reported to induce lipid peroxidation. Lipid peroxidation 
refers to the oxidative damage of unsaturated fatty acid molecules by free radicals. 
This injury to a cell alters membrane permeability, impairs the transport of ions, and 
results in the inability of the cells to maintain a normal ionic environment [Scheid, 
CR, et al, 1996 (a); Scheid, CR., et al., 1996 (b)]. There has long been an association 
between urolithiasis and free radicals, and the study of the latter is important to 
understand their role in the mechanism of action and their implication in the 
pathogenesis of kidney stone disease.
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1.7 REACTIVE OXYGEN SPECIES (ROS)
Many natural occurring molecules require metabolic activation to form reactive 
intermediates in order to exert their toxicity. It is known that many of these 
intermediates are free radicals, with at least one unpaired electron in the outermost 
shell, and are capable of independent existence. The free radicals formed may be 
carbon, nitrogen or oxygen centred and have been implicated in the action of a wide 
range of structurally and pharmacologically diverse compounds with an equally broad 
range of toxicities including carcinogenesis, mutagenesis, cell necrosis and lipid 
peroxidation [Mason, 1982; Mason & Chignell, 1982; Trush et al., 1982]. Other 
intermediates derived from free radicals in which electrons are paired can also be 
cytotoxic. Both classes are referred to as Reactive Oxygen Species (ROS). These 
species because of their high reactivity can undergo a number of reactions including: 
(i) electron transfer to molecular oxygen generating superoxide anion radical and 
other active oxygen species, (ii) hydrogen atom abstraction leading to autoxidation of 
polyunsaturated fatty acids and (iii) covalent binding to tissue macromolecules by 
radical addition to carbon-carbon double bonds or by radical combination [Smith., et 
al., 1984]. ROS include a number of chemically reactive molecules derived from 
oxygen. Some are extremely reactive, such as the hydroxyl radical and singlet oxygen 
whilst others are less reactive such as superoxide and hydrogen peroxide.
Free radicals and ROS can readily react with many biomolecules, starting a chain 
reaction of free radical formation. In order to stop this chain reaction, a newly formed 
radical must either react with another free radical scavenger or antioxidant.
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Table 1. 2 ROS molecules and their sources
ROS Molecule Main cellular sources
Superoxide (O2*’) Leakage of electrons form the electron transport chain
Activated Phagocytes
Xanthine Oxidase
Flavoenzymes
Hydrogen peroxide (H2O2) From O2*’ via superoxide dismutase 
(SOD)
NADPH-oxidase 
Glucose oxidase 
Xanthine oxidase
Hydroxyl Radical (’OH) From O2*" and H2O2 via transition metals 
(Fe2+ or Cu+)
Nitric oxide (NO) 
Peroxynitrite (OONO )
Nitric oxide synthases 
NO and 0 2#'
Singlet Oxygen ( ^ 2) Photochemical reactions between light, oxygen, and photosensitizers eosinophils
The most familiar intracellular and extra-cellular forms of ROS are listed in Table 1.2, 
along with their main sources of production. The main reaction steps in the single 
electron reduction of molecular oxygen are shown below [ 1 ]:
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e e e e
* •OH + OH' L * 2H20  [1]
2 t i
In the following sections the main ROS molecules will be discussed in terms of 
pathways of formation and their cellular effects.
The superoxide anion produced from molecular oxygen by the addition of an electron 
is, in spite of being a free radical, not highly reactive. It is not able to penetrate 
through the lipid membranes and therefore it is normally enclosed in the compartment 
in which it is produced. Superoxide can be produced enzymatically by flavoenzymes 
such as xanthine oxidase or by enzymes such as lipoxygenase and cyclooxygenase 
[Kuppusamy, P., & Zweier, JL., 1989; McIntyre, et al, 1999]. However, the majority 
of superoxide that is produced in most eukaryotic cells originates from the 
mitochondrial respiratory chain and is produced by a nonenzymatic mechanism. 
Ubisemiquinone (UQio) species generated during electron transfer in the respiratory 
chain donate electron to oxygen and provide a constant source of superoxide [2]:
Under normal circumstances, the rate of generation of superoxide from mitochondria 
is rather low and does little damage. However, there are circumstances, such as 
ingested chemicals that act as radical amplifiers, medically applied high 
concentrations of oxygen, or during periods of perfusion of tissues with oxygen
1.7.1 SUPEROXIDE (0 2# )
UQio + 02 — 02 + UQio [2]
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following ischemia, where high rates of superoxide do occur. O2*" formation is also 
affected by the NADH/NAD+ ratio. Disturbances in the ratio of NAD+ to NADH have 
significant implications in the regulation of electron flow. As the flow of electrons 
during state 4 respiration is coupled to ATP function, A\|/m (membrane potential across 
the inner mitochondrial membrane) and the NADH/NAD+ ratio determine the rate of 
electron leakage to O2*' at complex III.
Under normal rates of superoxide production, superoxide dismutase (SOD) acts as a 
defence mechanism to successfully and efficiently remove the superoxide. Superoxide 
dismutases were the first ROS-metabolising enzymes discovered [McCord, JM., & 
Fridovich, I., 1969]. In eukaryotic cells O2*' can be metabolised to hydrogen peroxide 
by two metal containing SOD isoenzymes, an 80 - kDa tetrameric Mn - SOD present 
in mitochondria, and the cytosolic 32 - kDa dimeric Cu / Zn - SOD. Both of SOD 
catalyse the same reaction [3]:
SOD
2H+ + O2 + O2 ------- ► H2O2 + O2 [3]
However, the presence of increased Cu / Zn -  SOD, at the same time as catalysing 
efficient removal of superoxide, it leads to rapid synthesis of hydrogen peroxide, 
which itself can be damaging. Increased production of hydrogen peroxide in the 
cytosolic compartments or subsequent production of ’OH radical by the Fenton 
reactions has been suggested as responsible for making the Cu / Zn -  SOD 
overexpressing mice more susceptible to radiation, infection and other stresses 
[Golenser, J., et al., 1998; Gahtan, E., et al., 1998]. Therefore, overexpression of 
superoxide dismutases can be as problematic as underexpression.
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1.7.2 HYDROGEN PEROXIDE (H20 2)
H2O2 is not a free radical, but is nonetheless highly important mostly because of its 
ability to penetrate biological membranes, and is mainly formed by dismutation of 
superoxide. It plays a radical forming role as an intermediate in the production of 
more reactive ROS molecules, including hyperchlorous acid (HOC1) in inflammatory 
cells [4]:
H4- + Cl' + H20 2 —*• HOC l + H20  [4]
H2O2 once produced by the above mechanism is removed by at least three antioxidant 
enzyme systems, namely catalases, glutathione peroxidases, and peroxiredoxins 
[Chae, E., et al., 1999; Mates, et al., 1999]. Catalase, present in the peroxisomes of 
nearly all aerobic cells, serves to protect the cell from the toxic effects of hydrogen 
peroxide by catalysing its decomposition into molecular oxygen and water without the 
production of free radicals. However the most important is glutathione peroxidase by 
oxidising glutathione (GSH) and therefore reducing cytosolic H2O2 to H2O (reaction
5).
H20 2 + 2 GSH -> GSSG + 2 H20  [5]
1.7.3 HYDROXYL RADICAL (#OH)
Due to its strong reactivity with biomolecules, *OH is believed by some to be capable 
of causing more damage to biological systems than any other ROS [Betteridge, DJ., 
2000; Halliwell, B., 1987]. The radical is formed from hydrogen peroxide in a
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reaction catalysed by metal ions (Fe2+ or Cu+), often bound in complex with different 
proteins or other molecules. This is known as the Fenton reaction [6 ]:
H2O2 + Cu+/Fe2+---------- ► *OH + OH' + Cu2+/Fe3+ 161
Superoxide also plays an important role in connection with Reaction 5 by recycling 
the metal ions. Transition metals may be released from proteins such as ferritin and 
the [4Fe - 4S] centre of different dehydrases by reactions with O2*’ [Harris, LR., et al,
1994] [7]:
Cu2+/Fe3+ + 0 2" --------► Cu+/Fe2+ + 0 2 I71
1.7.4 NITRIC OXIDE (NO*)
Nitric oxide represents an odd member of the free radical family and is similar to O2*' 
in several aspects in that it does not readily react with most biomolecules despite its 
unpaired electron. On the other hand it easily reacts with other free radicals, 
generating mainly less reactive molecules, thus in fact functioning as a free radical 
scavenger. NO* for example, has been shown to inhibit lipid peroxidation in cell 
membranes [Rubbo, H., et al., 2000; Hogg, N., & Kalyanaraman, B., 1998]. However, 
if O2*' is produced in large amounts and parallel with NO, the two react with each 
other very rapidly (1.6 x 10' 10 Mol' 1 s '1) to yield peroxynitrite (OONO'), which is 
highly cytotoxic [Meckman, JS., & Koppenol, WH., 1996]. In physiologic 
concentrations NO* functions mainly as an intracellular messenger stimulating 
guanylate cyclase and protein kinases, thereby relaxing smooth muscle in blood
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vessels, among other effects. NO* has the ability to cross cell membranes and can 
thereby also transmit signals to other cells [Ignarro, LJ., 1990]. When produced in 
larger amounts it becomes an important factor in redox control of cellular function 
[Wink, DA., & Mitchell, JB., 1998]. The total effect of NO* on the redox status of 
cells is multifaceted, though, in conclusion, in many respects it seems to function as 
an antioxidant and not as an oxidant [Halliwell, B., 1996].
1.7.5 SINGLET OXYGEN (10 2)
Singlet oxygen ( '0 2 ) is a highly reactive form of molecular oxygen that may harm 
living systems by oxidising critical organic molecules. It originates as a consequence 
of photochemical reactions between light, oxygen, and light-reactive substances 
called photosensitizers [Foote, CS., 1968]. Biological !0 2 , however, may also arise 
from non-photochemical sources such as the neutrophil respiratory burst and 
membrane lipid peroxidative chain reactions [Cadenas, E., 1989]. The macrophage 
myeloperoxidase catalyse the halide driven reduction of hydrogen peroxide, to form 
the oxidant hyperchlorus acid (HOC1). HOC1 then reacts with H2O2 to form ’Ch [8 ]:
H20 2 + BrCT ► HOC1 +OH'
18]
H2O2 + HOCl ______ ►1o 2 + c r  + Hf
In vitro studies have shown that O2 oxidises macromolecules such as lipids, nucleic 
acids, and protein, depending on its intracellular site of formation, and promotes 
detrimental processes such as lipid peroxidation, membrane damage, and cell death.
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1.7.6 LIPID PEROXIDATION
Biological macromolecules, such as lipids, proteins, and DNA are all targets for free 
radical injury [Shewfelt, & Purvis, 1995]. Polyunsaturated fatty acids (PUFA), the 
main components of membrane lipids, are susceptible to peroxidation. Lipid 
peroxidation is one of the most investigated consequences of the free radical action on 
the membrane structure and function. The idea of lipid peroxidation as a solely 
destructive process has changed during the last decade. It has been shown that lipid 
hydroperoxides and oxygenated products of lipid degeneration as well as lipid 
peroxidation initiators (free radicals) can participate in the signal transduction cascade 
[Tarchevskii, 1992].
Hydroxyl radicals and singlet oxygen can react with the methylene groups of PUFA 
forming conjugated dienes, lipid peroxyl radicals and hydroperoxides [Smirnoff,
1995], [9 and 10]:
PUFA H + X*  ► PUFA * + X-H [9]
PUFA* + 0 2  ► PUFA- 0 0 # [10]
The peroxyl radical formed is highly reactive and is able to propagate the chain
reaction [1 1 ]:
PUFA- 0 0 # + PUFA- H ____________ ^ PUFA-OOH + PUFA# [11]
The formation of conjugated dienes occurs when free radicals attack the hydrogens of 
methylene groups that separates double bonds and leads to rearrangement of the 
bonds [Recknagel, 1984]. The lipid hydroperoxides produced (PUFA- OOH) can
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2 " h  •undergo reductive cleavage by reduced metals, such as Fe , according to the 
following equation [1 2 ]:
Fe2+complex + PUFA- OOH _______ ^ Fe3+ complex + OH' + PUFA-O* [12]
The lipid alkoxyl radical produced, PUFA- O*, can initiate additional chain reactions 
[Buettner, 1993] [13]:
PUFA- O’ + PUFA- H ____________ ^ PUFA- OH + PUFA# [13]
1.8 SITES OF FREE RADICALS PRODUCTION
The superoxide anion radical and hydrogen peroxide, respectively, the products of the 
univalent and bivalent reduction of oxygen, are produced during normal aerobic 
metabolism and constitute physiological intracellular metabolites. Several reactions in 
biological systems contribute to the steady state concentrations of O2” and H2O2 , 
although mitochondria seem to be quantitatively the most important cellular source.
Mitochondria, which are present in virtually all-eukaryotic cells, are membrane-bound 
organelles that convert energy to forms that can be used to drive cellular reactions. It 
is estimated that 1 - 2  % of oxygen reacting with the respiratory chain leads to the 
formation of O2*'.
In eukaryotic mitochondria, electrons are fed into the electron transport chain from 
reduced substrates such as glycerol phosphate, fatty acids, NADH or succinate. Large 
membrane bound enzymes, such as glycerol phosphate dehydrogenase, NADH-Q 
oxidoreductase (Complex I) or succinate-Q oxidoreductase (Complex II) pass 
electrons down the gradient of redox potential to the mobile lipid-soluble carrier, 
ubiquinone (UQ). From UQ, the electrons pass down through UQ-cytochrome c
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oxidoreductase (Complex III) to the final acceptor, oxygen. Coupling of this series of 
energy-releasing oxidation reactions to the energy-demanding reactions of ATP 
synthesis is accomplished by a chemiosmotic mechanism. As electrons flow down 
their chemical gradient, Complex I, Complex III and complex IV pump protons from 
the mitochondrial matrix to the intermembrane space, against their electrochemical 
gradient. This active proton pumping sets up a proton-motive force which, consists 
mostly of an electrical gradient (membrane potential), accompanied by a small 
chemical gradient (pH difference). The proton-motive force that drives protons back 
into the matrix through the mitochondrial ATP synthase, results in ATP synthesis. 
The resulting chemiosmotic proton circuit is the mechanism of oxidative 
phosphorylation.
Therefore, oxidative phosphorylation in the mitochondria is carried out by four 
electron-transporting complexes (I-IV) and one H+- translocating ATP synthetic 
complex (complex V). Two of these complexes have been shown to be responsible for 
much of the superoxide generated by mitochondria: complex I, the NADH- 
ubiquinone oxidoreductase, and complex III, the ubiquinonol-cytochrome c 
oxidoreductase [Beyer, R., 1991; Takeshiga, K., & Minakami, S., 1979]. A series of 
electron carriers, that are conserved from prokaryotes through to higher mammals, 
conduct electrons derived from the oxidation of NADH through a series of iron - 
sulphur centres to finally reduce ubiquinone during which protons are pumped from 
the matrix space to the outside of the mitochondrial membrane. Semiquinones 
generated within complex I have been identified as the likely donors for transforming 
O2 to 0 2 * .
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Complex III of the mitochondrial respiratory chain is another site of O2*’ production. 
Complex III (ubiquinol-cytochrome c oxidoreductase) is responsible for receiving 
reducing equivalents, which are generated in complexes I and II and contained in 
ubiquinol, and transferring them through reactions with cytochrome b, the Rieske 
iron-sulphur protein, and then cytochrome ci to the final electron acceptor cytochrome 
c. The Rieske iron-sulphur protein accepts one electron from ubiquinone (Q), forming 
a semiquinone. The latter reduces the first cytochrome b haem (Tl), which donates 
one electron to the second cytochrome b haem (6 h) to reduce ubiquinone and 
eventually form ubisemiquinone (UQH*), which is the source of O2*’.
The concentration of QH* in the electron transport chain is an important determinant 
of ROS production. Agents that increase respiration rate, such as uncouplers or ADP 
have long been known to decrease ROS production by isolated mitochondria 
[Boveris, A., & Chance, B., 1973]. However, inhibitors of electron transport can 
either increase or decrease ROS production depending on their site of action, so ROS 
production is not linearly related to the rate of electron transport. However, it shows a 
steep dependence on the magnitude of the proton-motive force in isolated 
mitochondria [Liu, SS., 1997; Korshunof, SS., et al., 1997]. Uncouplers and ATP 
synthesis lower proton-motive force by increasing its consumption. The proton- 
motive force would affect ROS production by altering the redox state of UQ; at high 
proton-motive force respiration slows, so electrons would accumulate at Q instead of 
passing down the electron transport chain to oxygen. This would increase the steady- 
state concentration o f QH* and so increase the rate of mitochondrial ROS production. 
Inhibitors of electron transport lower proton-motive force, but they also affect the 
redox state of the UQ pool: those that are expected to increase the oxidation of the UQ
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pool decrease ROS production and those that are expected to increase the reduction of 
the UQ pool increase ROS production.
1.8.1 COMPLEX I AND SUPEROXIDE PRODUCTION
Mammalian complex I is a large macromolecular assembly of proteins comprising 
thirty four subunits encoded by the nuclear DNA and seven subunits encoded by 
mitochondrial DNA [Shoffner, JM., & Wallace, DC., 1995]. Semiquinones generated 
within complex I have been identified as potential donors for transforming O2 to O2*", 
although the exact mechanism of how and where these semiquinones are generated by 
the complex I components is yet to be fully elucidated [Boveris, A., & Chance, B., 
1977; Du, G., et al., 1998]. The sites within complex I where semiquinones are 
generated are thought to be in proximity to inhibition sites within the complex for the 
quinone analogue inhibitors such as rotenone [Boveris, A., & Chance, B., 1977; Du, 
G., et al., 1998] [Figure 1.4]. The detailed mechanisms of how complex I functions to 
transport electrons linked to vectorial proton transport are not yet clear. It is likely that 
rotenone and other complex I inhibitors increase O2* and H2O2 production from 
mitochondria at complex I, possibly by blocking a site where semiquinone donates an 
electron to an acceptor [Pitkanen, S., et al., 1996; Pitkanen, S., & Robinson, BH.,
1996]. In addition, it has been shown that diphenyleneiodonium (DPI) a 
mitochondrial inhibitor of complex I, resulted in decreased oxidative phosphorylation 
[Holland, PC., et al., 1973; Ragan, CL, & Bloxham, DP., 1977]. Majander et al. 
[Majander, A., et al., 1994] further demonstrated that DPI inhibits the reduction of 
iron-sulfur clusters of the complex I possibly through irreversibly reacting with 
flavoenzymes.
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Deficiency or inhibition of mitochondrial complex I has been associated with clinical 
studies. Tomomi et al. [Tomomi, I., et al, 1999] provided evidence for the increased 
production of O2*’ at the complex I site in the mitochondria isolated from failing 
cardiac myocytes. It has also been reported that excessive superoxide production in a 
family with cataracts is linked to complex I deficiency on the mitochondrial 
respiratory chain [Pitkanen, SF., et al., 1995]. It has also been demonstrated that 
NADH / NADPH oxidase is the predominant O2** source in both endothelial and 
smooth muscle cells [Griendling, KK., et al., 1994; Mohazzab-H, KM., et al., 1994].
INTERMEMBRANE COMPARTMENT
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Figure 1. 4 Mitochondrial sites of superoxide formation as adapted from 
http://www.ruf.rice.edu/~bioslabs/studies/mitochondria/mitets.html. Inhibition of 
electron flow upstream of ubiquinone decreases O2 " whilst downstream inhibition 
enhances O2 ’ formation. In the presence of succinate (Complex II substrate), thenoyl 
trifluoracetone which inhibits succinate dehydrogenase prevents O2*’ formation.
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1.8.2 COMPLEX III AND SUPEROXIDE PRODUCTION
The Q-cycle describes the general mechanism of electron and proton transfers within 
the cytochrome bcl complex. Quinol is oxidised and quinone reduced at two separate 
sites, the Q0 and Qj sites, respectively [Mitchel, P., 1976]. The oxidation of quinol at 
the Q0 site entails an obligatory bifurcation of the two electrons. The first electron 
from the quinol is transferred to the iron - sulfur center and then to cytochrome c\. 
The electron on the semiquinone product is transferred to heme bi and from there 
proceeds to the Qj site via heme bn. Even though, antimycin and myxathiazol are two 
of complex III inhibitors they have different effects on 0 2 *' production [Slater, EC., 
1973] [Figure 1.4]. Blocking electron passage out of cytochrome bn prevents the 
semiquinone at the Q0 site from donating its electron and therefore inhibition with 
antimycin produces a tenfold increase in O2*' from complex III. Inhibition by 
myxathiozol produces little or no increase in O2*’ formation, because it prevents 
ubisemiquinone formation at the cytosolic side of the inner mitochondrial membrane 
[Li, Y., et al., 1999; Raha, S., et al, 2000].
Studies [Matsuno-Yagi, A., & Hatefi, Y., 1996] have revealed features of the electron 
transfer system of bovine mitochondrial ubiquinol-cytochrome c oxidoreductase 
(complex III, bc\ complex) that are incompatible with the Q cycle hypothesis. Firstly, 
it was shown that in bovine-heart submitochondrial particles, the inhibition of 
complex III by either antimycin or myxathiozol was incomplete. In addition, 
cytochrome b of complex III was partially reduced via cytochrome c\ and the Reiske 
iron sulfur protein by ascorbate, and this reaction was inhibited more strongly by 
antimycin than by myxothiazol [Miki, T., et al., 1994],
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The results of carefully examining the efficacy of various complex III inhibitors on 
O2*’ production in isolated whole mitochondria, compared with Mn - SOD - depleted 
submitochondrial particles also suggests that there is a sidedness to O2*" production 
[Raha, S., et a l, 2000]. That much of 0 2 *’ produced by the respiratory chain under 
physiological conditions is generated at the matrix side of the membrane is likewise 
suggested by the presence of Mn - SOD in the mitochondrial matrix and the 
comparatively low levels of O2** production by whole mitochondria containing Mn - 
SOD [Raha, S., et a l, 2000]. When this enzyme is physically removed, the rates of 
O2*’ produced by mitochondria are significantly increased [Raha, S et al., 2000].
1.9 OXIDATIVE STRESS AND MITOCHONDRIA
Mitochondria, is the most prominent cellular site of 0 2 *’production in mammalian 
cells, and the steady state concentration of O2*' in the mitochondrial matrix is about 5 
- to 10 - fold higher than that in the cytosolic and nuclear spaces [Richter, C., et al., 
1988; Richter, C., et al., 1995]. Mitochondria are sensitive to changes in the redox 
state of the cell. Several studies have demonstrated that when there is mitochondria 
dysfunction under conditions of oxidative stress this can lead to apoptosis [Zamzami, 
N., et al., 1995; Zamzami, N., et al., 1996; Green, DR., & Reed, JC., 1988; Susin, 
SA., et al., 1998; Morel, Y., et al, 1999]. Under severe oxidative stress, the 
mitochondrial permeability transition (PT) opens. PT involves a sudden increase of 
the inner mitochondrial membrane permeability to solutes greater than 1500 Da. 
When the PT pore is defective and it opens to larger molecules, it also causes 
uncoupling of the respiratory chain resulting in overproduction of ROS, cessation of 
ATP synthesis, matrix Ca2+ outflow and depletion of reduced glutathione and other 
reductants. After matrix solutes are released from the inner membrane, a colloidal
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osmotic pressure arises in the mitochondrial matrix due to the high concentrations of 
proteins, that are slow to equilibrate [Igbavboa, U., et al., 1989; Gunter, TE., & 
Pfeiffer, DR., 1990; Richter, C., et al., 1995]. To compensate for this osmotic 
imbalance, the diffusion of H2O results in a massive swelling of the mitochondria 
[Gunter, TE., & Pfeiffer, DR., 1990]. This change in membrane potential predisposes 
these cells to oxidative damage by impairment of endogenous antioxidant defence 
mechanisms [Petit, PX., et al., 1996; Zamzami, N., et al., 1997; Marzo, I., et al., 
1998; Yang, JC., & Cortopassi, GA., 1998]. Alteration of the Av|/m is another factor 
changed during mitochondrial impaired function [Zamzami, N., et al., 1995; 
Zamzami, N., et al., 1996; Green, DR., & Reed, JC., 1988; Susin, SA., et al., 1998; 
Morel, Y., et al., 1999]. An increase in Av|/m can induce oxidative stress and cell death 
[Ling, YH., et al., 2003]. It has been reported [Li, P., et al., 1999] that p53 -  induced 
apoptosis occurs via an increase in the generation of ROS and the disruption of 
mitochondrial membrane potential. These events indicate that ROS generation and an 
increase in Av|/m are the early and necessary events for the initiation of apoptotic 
signalling.
Calcium is another important mediator of apoptosis [Soabo, L., & Zoratti, M., 1992; 
Petrollini, V., et al., 1993] and its status is closely linked with oxidative stress in 
many isolated cell systems with the best example being isolated rat hepatocytes 
[Gutirrez, PL., & Bachur, NR., 1983]. When cells are deprived of calcium, 
mitochondria become sensitive to this calcium-deficient state and their calcium 
regulatory mechanism is disturbed. Calcium omission results in a marked decline of 
mitochondrial A\|/m, leading to oxidative stress and induction of programmed cell 
death. Therefore, calcium homeostasis via mitochondria and endoplasmic reticulum is 
vital to the function and survival of the cell [Thomas, D., & Hanley, MR., 1994].
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1.10 EFFECTS OF REACTIVE OXYGEN SPECIES
Reactive oxygen species generated by mitochondria, or from other sites within or 
outside the cell, can cause damage to mitochondrial and other intracellular 
components and initiate degradation and apoptotic mechanisms. Although mild 
oxidative damage such as that experienced during exercise training may actually be 
the stimulus for physiological mitochondrial biogenesis via superoxide production 
from ubisemiquinone. More severe or more prolonged oxidative shock is clearly 
damaging and such toxic events contribute significantly to the aging process. The 
relation between free radicals and process of ageing is now well established [Jame, 
AM., et al., 2005]. Studies in a variety of different animal species have shown that 
animals with more rapid rates of basal metabolism have faster rates of ROS 
production and shorter life span [Barja, G., & Herrero, A., 2000; Lass, A., & Sohal, 
RS., 1999]. There is strong evidence that damage to proteins and DNA is cumulative 
with age, and that mutations and deletions, especially in mitochondrial DNA, are 
much more frequent in the aged compared with the young of most species [Barja, G., 
& Herrero, A., 2000], These data have been interpreted as indicating that life span is 
influenced by mitochondrial DNA deletions and mutations accumulated through 
exposure to oxygen free radical damage, and that this is a function of the endogenous 
rate of electron transport mediated by the fixed electron-transport intermediary 
ubiquinone [Lass, A., & Sohal, RS., 1999]. The faster the rate of metabolism, the 
faster is the rate of electron transport and the rate of generation of superoxide, thus 
leading to free radical damage to proteins, lipids and DNA by superoxide and its 
downstream reactive metabolites.
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In order to prevent excessive oxidative stress and tissue injury, organisms specifically 
synthesise molecules that fight against active oxygen species by developing a balance 
between the generation of reactive oxygen species and the tissue antioxidant defence 
mechanism. Glutathione is one of the most important molecules that protect cells 
against oxidative stress.
Glutathione (GSH) [Figure 1.5] is a tripeptide of glutamate, cysteine and glycine that 
contains a ^-peptide bond between glutamate and cysteine [Griffith, OW., & Meister,
A., 1985], which prevents GSH from being hydrolysed by most peptidases.
GSH is the most abundant intracellular thiol that is found in mammalian and 
prokaryotic cells. GSH has several important cellular functions, including its 
participation as a coenzyme responsible for amino acid transport and its involvement 
in metabolism and the maintenance of the thiol moieties of proteins. Probably its most 
important function relies on the protection mechanism that provides against oxidative 
damage caused by ROS formed normally during cell metabolism.
1.11 GLUTATHIONE
H2
CH2
CH -----    NH   CH2
O
H C  NH3
Figure 1. 5 Chemical structure of glutathione (GSH).
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Figure 1. 6 Summary of GSH synthesis and redox.
GSH reacts rapidly and non-enzymatically with hydroxyl radical, the cytotoxic 
Fenton reaction product, and with N2O3 and peroxynitrite, cytotoxic products formed 
by the reaction o f nitric oxide with O2 and superoxide, respectively [Kalyanaraman,
B., et al., 1996; Luperchio, S., et al., 1996; Brivida, K., et al., 1999]. In reactions 
catalysed by glutathione peroxidase, GSH also participates in the reductive 
detoxification o f hydrogen peroxide and lipid peroxides [Ursini, F., et a l, 1995]. Each 
of these reactions leads directly or indirectly to the formation of glutathione disulfide 
(GSSG) that is reduced intracellularly to GSH by glutathione reductase in a NADPH - 
dependent reaction [Kehrer, JP., et al., 1994]. At normal levels of oxidative stress,
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glutathione reductase activity and NADPH availability are sufficient to maintain 
[GSH] / [GSSG] in a ratio of approximately 100 : 1 [Akerboom, TP., et al., 1982] and 
under these conditions there is no net loss of GSH through oxidation. However, if 
stress levels increase or GSSG reductase is limited, GSSG accumulates. This has two 
important consequences: (i) the thiol redox status of the cell will shift, activating 
certain oxidant response transcriptional elements [Sen, CK., & Packer, L., 1996; 
Muller, JM., et a l, 1997], (ii) GSSG will be secreted from the cell, and (iii) protein 
mixed disulfides will form [Akerboom, T., & Sies, H., 1990]. As GSSG is not taken 
up by cells, but rather is actively transported out of cells and degraded extracellularly, 
loss of GSSG from cells under conditions of oxidative stress increases cellular 
requirements for de novo GSH synthesis [Figure 1.6].
1.11.1 GLUTATHIONE BIOSYNTHESIS
GSH is synthesised intracellularly by the consecutive actions of /-glutamylcysteine 
synthase (GCS) and GSH synthases:
L-Glu + L- Cys + ATP 4 GCS  ^ l-/-G1u —  L-Cys + ADP + Pi
L-/-G lu—  L-Cys + Gly + ATP GSH synthase GSH + ADP+Pi
Cysteine is usually the limiting substrate and GCS the rate limiting enzyme in the 
synthesis of GSH. Intracellular GSH is exported from some cells, but it is not 
significantly taken up by cells under normal conditions [Meister, A., 1991]. Once 
outside of the cell, the /-glutamyl bond of GSH is cleaved by the membrane bound /- 
glutamyl transpeptidase. The product of this reaction is a /-glutamyl enzyme, which 
accepts an amino acid to form /-glutamyl amino acid. This amino acid is cleaved by 
/-glutamyl cyclotransferase to yield free amino acid and 5-oxoproline. One of the best
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acceptor amino acids for transpeptidases is cysteine, thus its product is y- 
glutamylcysteine [Thompson, GA., 1976].
GSH, is synthesised from its constituent amino acids by the sequential action of 
cytosolic enzymes ^glutamylcysteine synthase (^-GCS) and glutathione synthase 
[Griffith, OW., & Mulcahy, RT., 1999; Meister, A., 1994]. Mammalian ^-GCS is a 
heterodimer comprised of a catalytically active heavy subunit (MW 73000 Da) that 
includes all substrate binding sites and a light subunit (MW 31000 Da) that modulates 
the affinity of the heavy subunit for substrates and inhibitors [Yan, N., & Meister, A., 
1990; Gipp, JJ., et a l, 1992; Huang, CS., et al., 1993]. ^-GCS is involved in the 
chemical mechanism in which, L-glutamate and ATP first react to form tightly bound 
^-glutamylphosphate, and that intermediate then reacts with L-cysteine to form the 
final products. In addition, mammalian gluathione synthase is a homodimer with each 
subunit (MW 52 000 Da) containing about 2 % carbohydrate [Oppenheimer, L., et al., 
1979; Huang, CS., et al., 1995] and catalyses the ATP - dependent formation of GSH 
from ^-glutamylcysteine and glycine.
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1.11.2 THE IMPORTANCE OF MITOCHONDRIAL 
GLUTATHIONE
It has been reported that glutathione deficiency produced in guinea pigs and newborn 
rats leads to death within a few days; adult mice and rats exhibit morbidity associated 
with damage to various tissues, including lung and certain organs of the 
gastrointestinal tract [Meister, A., 1991]. L-buthionine-sulfoximine (BSO), a synthetic 
amino acid that depletes glutathione by irreversibly inhibiting y-glutamylcysteine, 
when administered to newborn rats leads to cataracts [Calvin, HL., et al., 1986] and 
long term treatment with BSO produces severe GSH deficiency. The cellular damage 
found after administration of BSO mostly involves the mitochondria. The 
considerable cellular damage found in glutathione deficiency reflects the extensive 
formation of ROS, which occurs normally in the mitochondrial compartment. In 
addition, it was found that mitochondrial glutathione decreases much more slowly 
than total cell glutathione after giving BSO [Griffith, OW., & Meister, A., 1985], 
suggesting that there is a separate mitochondrial pool of glutathione. Furthermore, it 
was reported that mitochondria do not synthesize GSH, but they obtain their GSH 
from other intracellular GSH [Griffith, OW., & Meister, A., 1985]. Reversible 
conversion of GSH to GSSG occurs in the cytosol and in the mitochondria, however, 
GSH synthesis occurs only in the cytosol, which is transported in the mitochondria 
[Figure 1.7].
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Figure 1. 7 Glutathione transport from the cytosol into mitochondria. Glutathione 
is formed by glutamate and cysteine through the action of two sequential ATP -  
dependent enzymatic reactions catalysed by y-glutamylcysteine synthase. 
Mitochondria do not synthesise GSH, because it does not contain y-glutamylcysteine 
synthase [Griffith, OW., & Meister, A., 1985]. Therefore, the mitochondrial pool is 
derived from the activity of a mitochondrial transporter that translocates GSH from 
the cytosol into the mitochondrial matrix.
Transport of GSH from the cytosol across the inner mitochondrial membrane must 
occur to supply the mitochondria with its pool of GSH. Studies have shown that GSH 
does not diffuse passively across the inner mitochondrial membrane. Rather, because 
mitochondria possess a membrane potential with the matrix space being negative 
relative to the cytoplasm and because GSH is a negatively charged molecule at
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physiological pH, GSH must be transported actively or in exchange with another 
anion [Smith, CV., et a l, 1996]. Examples of these carriers include the dicarboxylate 
carrier (DCC) and the oxoglutarate carrier (OGC), which are responsible for at least 
80 % of the total uptake of cytoplasmic GSH into renal cortical mitochondria 
[McKeman, TM., et a l, 1991; Chen, Z., & Lash, LH., 1998; Chen, Z .,et a l, 2000].
The electron transport system is a source of O2*’. Since mitochondria do not contain 
catalase, they depend upon GSH peroxidase and non-enzymatic reaction with GSH to 
protect against peroxide toxicity. In cases where GSH levels are severely depleted, 
mitochondria swell and cells contain vacuoles, indicating endogenous oxidative stress 
[Martensson, J., & Meister, A., 1989; Martensson, A., et a l, 1991]. This oxidative 
stress can be reversed by administering ascorbate or other GSH esters. The use of 
BSO to produce a model of GSH deficiency has led to interesting data that elucidate 
some of the functions of GSH and provides a model to test therapies designed to 
increase cellular GSH levels. One such disease that is associated with GSH deficiency 
is thought to be nephrolithiasis.
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1.12 Hypothesis and Aims
COM crystals in the renal tubule form the basis of most kidney stones. It is now 
established that exposure of renal cells to CaOx results in a free-radical mediated 
oxidative stress. In view of the ability of COM crystals to elicit O2 ’ production in 
renal epithelial cell mitochondria, the aim of this study is to further investigate 
whether this phenomenon is common to other crystals or micro-particles.
In addition, oxalate transport into the mitochondria may also prove important for the 
development and thus treatment of stone disease. Therefore, this study aims to 
examine mitochondrial transport systems for oxalate and its role in the mitochondrial 
membrane potential and superoxide production.
Finally, mitochondrial dysfunction caused by crystal formation may contribute to 
pathological events during clinical conditions where tubular crystal-cell interactions 
are uncontrolled. To further develop these studies an in vivo animal model is 
employed to investigate how specific agents that can induce kidney stone formation 
may trigger free radical production by altering cell homeostasis and function.
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2.1 Materials
All materials were purchased from Sigma-Aldrich Chemical Company Ltd unless 
otherwise stated. All tissue culture plastic was acquired from Greiner Laboratories or 
Fisher Scientific.
2.2 Cell culture
Madin-Darby canine kidney type -I (MDCK) distal-collecting duct cells, and Lewis 
Lung Carcinoma Pig kidney (LLC-PK1) proximal tubule renal epithelial cells, were 
maintained and grown in Dulbecco’s modified Eagle’s minimal essential medium 
(DMEM). Human kidney (HK2) cells were maintained and grown in keratinocyte 
serum free medium (SFM). All of the cell lines were supplemented with 8  % foetal 
calf serum (FCS), 2 mM glutamine, and penicillin streptomycin (100 U/ml/100 
pg/ml), and maintained in T80 flask, at 37 °C under 5 % CO2 / 95 % air. When cells 
were 80 % confluent, they were washed in 1 x phosphate buffer saline (PBS) and 
harvested using 500 pi of trypsin / versin. T80 flasks were then kept in the incubator 
for 10 min for the cells to become detached from the surface of the flask. After this 
time, 10 ml of 8  % FCS medium was added and resuspension of the mix was 
achieved, using a 1 0  ml sterile syringe and a quill, to disperse and produce a single 
cell suspension. After counting the cells 1 ml of the resuspended cells were then 
transferred (at a density of 2.5 x 106 cells/dish) to 35 mm dishes and an additional 
volume of 1 ml of 8  % FCS medium was added to ensure an even distribution on the 
surface of the 35mm dishes. This resulted after cell adhesion in confluent monolayers 
of cells.
Cells were also grown and maintained on polycarbonate cell culture inserts (Becton 
Dickinson, Belgium) [Figure 2.1]. After cell counting, 1ml of pre-warmed medium
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was added to each well of a six-well plate and the insert was gently placed into the 
well. Cells at density 2.5 x 106 were added into the insert and cells were cultured 
under the conditions described above.
Transwell insert
Upper compartment
Microporous membrane 
Lower compartment
Figure 2. 1 Polycarbonate membrane supports. MDCK cells were seeded on the 
microporous membrane to form polarised monolayers that separate the cell culture 
medium into a basolateral and luminal side.
2.3 Cell treatment
After 48 h incubation of cultured cells on 35 mm dishes, cells were treated with 
calcium oxalate monohydrate (COM) (Merck Eurolab Supplies, UK) crystals or 
sodium oxalate (NaOx). Before treatment, cells cultured in 35 mm dishes were 
washed with PBS to remove any unattached or dead cells. Treatment of the cells with 
COM or NaOx followed. Sterile COM (25 mg/ml) was suspended in water and stored 
at 4 °C, and sterile sodium oxalate (150 mM) was prepared in water and adjusted to 
pH 6 .8 . Before treatment of cells COM was diluted to the final required concentration 
(250 pg/ml) in DMEM containing 2 % FCS which was continually stirred during the 
addition procedure. COM at 250 pg/ml is equivalent to 28.4 pg/cm in a 35 mm dish.
Cell growth area 
o.i43 cm2
82
Chapter 2 -  Methods and Materials
Similarly, NaOx was prepared and used at a final concentration of 750 pM to 1.5 mM 
in 2 % FCS containing DMEM. COM treated cells were incubated for 4 h at 37 °C to 
allow crystals to attach to the cells, and cells treated with NaOx were pre-incubated 
for 15 min. Finally, control (untreated) cells were also kept in 2 % FCS containing 
DMEM.
Uric acid crystals were prepared by dissolving 100 mg of uric acid in 250 ml H2O at 
60 °C and then adding 250 ml ethanol and stirring overnight at 25 °C. The resulting 
crystal suspension was filtered and washed twice with ethanol, once with acetone and 
then air-dried. Crystals formed were 1- 8  pm in size. Crystals and hydroxyapatite 
particles (Merck Eurolab Supplies, UK) were suspended in water and adjusted to pH 
6 .8 .
Unless otherwise stated COM and other particulates were used at 250 pg/ml, 
equivalent to 28.4 pg/cm2 in a 35-mm dish. Finally, crystals and particulates were 
added for 4 - 6  h and free oxalate 15 min before O2*' measurement. Additional 
treatment with specific inhibitors, or Ca2+ chelators, were carried out in the manner 
described above, either added prior to O j' measurement, or pre-incubated for the 
stated period of time. Table 2.1, lists details of these agents, including the 
concentration used.
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Table 2. 1 Details of the reagent used
Reagent Final
Concentration
Superoxide Dismutase (SOD) 300mU/ml
Mn(III) tetrakis(l-methyl-4-pyridyl) porphyrin 
(MnTMPyP)
200pM
Rotenone 20pM
Antimycin A 30pM
Carbonylcyanide chlorophenylhydrazone (CCCP) lOOpM
Thenoyl trifluoracetone (TTFA) lOpM
4-hydroxyccinamic acid 500pM
Pyruvate 300pM
Nordihydroguaiaretic acid (NDGA) 250pM
Oligomycin lOpM
Indomethacin lOpM
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N ,N ’ dicyclohexylcarbodiimide (DCCD) 50pM
Nigericin lOpM
Uric acid 250pg/ml
Zymosan 250pg/ml
Hydroxyapatate 250pg/ml
Latex Beads 250pg/ml
Ethylenediminetraacetic acid (EDTA) ImM
Ethylene glycol-bis(P-aminoethyl ether-N,N’,N’- ImM
tetraacetic acid (EGTA)
Citrate ImM
Ascorbate 1 mM
Desferall ImM
(N-2[Hydroxyethl)]piperazine-N’-[2-ethanesulfonic 3mM
acid]) (HEPES)
(3-[N-Morppholino]propanesulfonic acid) (MOPS) 5mM
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2.4 Chemiluminescence technique used for monitoring ROS 
production
Detection and measurement of the flux of reactive oxygen species within cells is of 
critical importance for investigating the patho - physiological consequences resulting 
from altered cellular reactive oxygen homeostasis. Therefore, the chemiluminescence 
technique, along with a selection of probes, has been used extensively in the 
measurement of ROS production. Chemiluminescence (CL) occurs whenever a 
molecule emits a photon of light as a result of an exergonic chemical reaction that 
generates an intermediate or end - product in an electronically excited state. The 
relaxation of the excited state molecule to ground state results in the emission of a 
photon [Allen, RC., 1986; Trush, MA., 1987].
As discussed earlier, there are many potential cellular sources of ROS production, 
however, mitochondrial respiration consuming approximately 90 % of the O2 utilised 
by cells is generally considered to be the major source of cellular ROS. As such, 
mitochondria -derived ROS have frequently been implicated in a number of diseases 
and disorders most prominent being cancers, ischemia / perfusion injury. Thus, the 
need for detection and measurement of mitochondria-generated ROS has led to the 
development of different probes and techniques that can specifically monitor 
mitochondrial ROS generation. Lucigenin, pholasin and luminol are 
chemiluminescence probes that have been widely used for the detection of ROS 
production in various cellular systems [Faulkner, K., &. Fridovich, I., 1993; Roberts, 
PA., et al., 1987].
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2.4.1 Lucigenin-Derived Chemiluminescence (LDCL)
Lucigenin (bis-N-methylacridinium) - derived chemiluminescence is widely used as a 
specific assay for superoxide formation in mitochondria. The mechanism of LDCL 
depends on the fact that superoxide is capable of reducing lucigenin to its 
semiquinone in the following reaction [1 ]:
0 2*' +  L uc2+ ■*------ ► 0 2 + Luc*+ [1]
The ability of lucigenin to function as a probe of mitochondrial superoxide generation 
should be dependent on its relative proximity to the mitochondrial electron transport 
activity. Therefore, lucigenin must first enter the cell and cross the plasma membrane. 
Once inside the cell it has been shown that lucigenin accumulates in the mitochondria, 
due to an ionic attraction between the positively charged lucigenin molecule and the 
negatively charged mitochondria. Once inside the mitochondria, lucigenin can 
undergo a one - electron reduction catalysed by components of the mitochondria 
electron transport chain, yielding the lucigenin cation radical [Figure 2.2]. The latter 
then reacts with the 0 2 *’, to yield an unstable dioxetane intermediate. The lucigenin 
dioxetane decomposes to produce two molecules of TV-methylacridone, one of which 
is in an electronically excited state, which upon relaxation to the ground state emits a 
photon [Figure 2.3].
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Figure 2. 2 Diagram illustrating how lucigenin -  derived CL detects 
mitochondrial ROS production.
Lucigenin
1 electron 
reduction
Lucigenin Radical
Lucigenin Dioxetane 
/
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Photon (hv)
Figure 2. 3 Schematic illustration of the chemical reaction pathways leading to 
lucigenin - derived CL.
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2.4.2 S u p e ro x id e  M e a s u re m e n t
Cells cultured in 35 mm dishes were used for lucigenin-chemiluminescence 
measurement in a photon counting device comprising a gallium arsenate photo 
multiplier tube (Hamamatsu R943), thermoelectrically cooled to -20  °C. CL emission 
from samples in dishes maintained at 37 °C in a thermostatic light sealed chamber and 
was reflected and focused onto the photo multiplier tube [Figure 2.4]. After treatment 
with COM and NaOx, media from the cells was removed. Control and treated cells 
were washed in PBS to remove unattached crystals, and 1 ml of respiration buffer 
(RB), pH 7.4, was added [Table 2.2].
1500 volt
Thermostatic light-sealed 
chamber (37 °C)
Chamber where 35mm dish is 
positioned over the photomultiplier 
tube (PM tube)
Gallium arsenate PM housed in 
thermoelectric cooler (-20 °C)
Signal out to amplifier 
discriminator and computer 
counting
Figure 2. 4 Schematic illustration of the chemiluminescence photon counting 
device.
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Table 2. 2 Respiration Buffer at pH 7.4
REAGENTS CONCENTRATION
Sucrose 70mM
Mannitol 220mM
EDTA ImM
KH2P 0 4 2.5mM
HEPES 2mM
MgCl2 ImM
As previously discussed, in order to measure superoxide a chemiluminescence probe 
was used. Lucigenin at sub - recycling concentrations (20 pM) was added to the cells 
to obtain light derived from the Oi ~. In addition, specific inhibitors and quenchers of 
ROS were added prior to chemiluminescence counting. Finally, digitonin (100 pg/ml) 
diluted in 50 % (v / v) DMSO was added to permeabilize the cells and to initiate 
lucigenin chemiluminescence signal. Instrument readings (100 x 0.1 secs) were taken 
every 2 min.
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2.5 MTT assay
Cell viability and functionality were tested using the MTT (3-(4, 5-dimethylthiazole- 
2yl)-2, 5-diphenyl tetrazolium bromide) reduction assay according to the method of 
Hansen et al [Hansen., et al., 1989]. The MTT cell proliferation assay is a 
colorimetric assay system that measures the reduction of a tetrazolium component 
(MTT) into an insoluble formazan product by reductive enzymes in the mitochondria 
of viable cells. After incubation of the cells with the MTT reagent for approximately 2 
to 4 h, DMSO was added to lyse the cells and solubilise the coloured crystals. The 
samples were read using a plate reader at a wavelength of 540 nm.
MTT was dissolved in RPMI (Roswell Park Memorial Institute) medium at a 
concentration of 0.5 mg/ml. MDCK cells were transferred in a density of 105 cells / 
well into 96 well - plate and were incubated for one day before the experimental 
treatment. Once cells adhered on to the wells, they were treated with 250 pg/ml COM 
or with 1.5 mM NaOx for 24 h. Three hours before the incubation, treatment was 
removed and 100 pi / well of MTT in RPMI were added. Cells were then incubated 
for three hours at 37 °C. After three-hour incubation, MTT-containing medium was 
removed, cells washed once in PBS and 100 pi / well of DMSO was added. The plate 
was shaken and incubated for a further 30 min, and absorbance values determined at 
540 nm using a Victor2, Wallac 1420 Multilabel counter.
2.6 Scanning Electron Microscopy
MDCK cells were grown on Thermenox coverslips and treated with COM for 10 to 
240 min. The coverslips were then washed 3 times in PBS to remove unattached 
COM and cells were fixed in half-strength Kamowsky's fixative (1 % (v /v)
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paraformaldehyde and 1.5 % (v/v) glutareldeyhde). After cells were washed they were 
dehydrated through a graded series of ethanol starting at 30 % and progressing 
through 50, 70, and 90 % up to 3 x 100 % (v / v). The cells were then transferred to 
amyl acetate and then placed into a critical point dryer (CPD7501; Polaron LTD). 
Drying was carried out using carbon dioxide as the drying fluid. Fragments of 
coverslips were then mounted onto stubs using colloidal silver dag. The cells were 
then coated with gold using a sputter coater (Polaron Ltd.) and finally observed in a 
Jeol JSM6310 scanning electron microscope.
2.7 Preparation of Radioactive COM crystal suspension
Radioactive sodium oxalate was prepared by adding 1 ml of 0.37 MBq/ml [14C] oxalic 
acid (Amersham Pharmacia Biotech, UK) to 0.5 ml of 200 mM sodium oxalate. A 
calcium chloride solution was prepared by adding 0.5 ml 200 mM calcium chloride to 
8 ml distilled water. After mixing the two solutions at room temperature (final 
concentration of 10 mM for both calcium and oxalate), radio labelled COM crystals 
were formed immediately. The crystal suspension was allowed to equilibrate for 3 
days, and finally washed 3 times with calcium oxalate saturated distilled water and 
finally resuspended in 5 ml of this solution.
2.8 COM Dissociation
The release of free oxalate from COM was determined in RB in the absence and 
presence of different chelators using [14C] - COM (Amersham Bioscience, UK) 
prepared from [14C] -sodium oxalate. The dissociation of [14C]-COM (250 pg/ml, 
specific activity 74 KBq/mg) was determined after equilibration in RB containing 
EDTA, EGTA, desferrioxamine (Desferal) (CIBA Laboratories, UK), citrate, and
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ascorbate (1 mM) for 10 min at 37 °C by centrifugation of un-dissociated COM at 1000 
x g for 10 min. The supernatant (free dissociated oxalate) and pellet (un-dissociated 
COM) were counted in a Beckman LS 6500 scintillation counter. The concentration of 
free oxalate was calculated from the supernatant counts relative to the un-dissociated 
[l4C] -COM standard (no chelators with 100 pM CaCb).
2.9 Con focal Microscopy
Confocal images were produced using the Zeiss LSM 510 laser scanning microscope. 
This is based around a Zeiss Axiovert 100 M inverted epifluorescence microscope 
equipped with x 40 and x 63 oil immersion lenses (NA 1.3 and 1.4, respectively) as 
well a x 63 water immersion lens (NA 1.2). The water immersion lens was corrected 
for chromatic aberration. Fluorescence was excited using one or more of three laser 
types -  a UV argon (lines at 351 and 364 nm), an argon (lines at 458, 488 and 514 
nm) and two helium-neon lasers (lines at 543 and 633 nm).
The confocal principle is based around the use of a point source of excitation 
illumination in combination with an adjustable aperture (the ‘pinhole diaphragm’) 
placed in the emission light pathway [Figure 2.5]. The laser light source is focused on 
the specimen so that only a small fraction is illuminated at any one time and a 
scanning module (a silvered mirror) rapidly scans this point back and forth across the 
area being imaged. The emission signal is scanned concurrently by the same module 
and the pinhole placed in the emission pathway limits the light falling on the PMT to 
a similar single point. Thus, light from out of focus layers is rejected, resulting in 
images that are less blurred, and allowing optical sections of the preparation to be 
obtained non-invasively (in practice, optical sections of around 1 pm thickness were
93
Chapter 2 -  Methods and Materials
imaged). In addition, the fact that the LSM 510 is equipped with four lasers and four 
PMTs allows truly simultaneous imaging using up to seven excitation wavelengths 
and up to four emission wavelengths. The presence of an acousto-optic tuneable filter 
meant that the intensity of each laser line could be independently controlled.
z/k
Analogue signal from P M T *  
displayed as digital image I  
on computer V D U  •  '
Laser
p |  PM T 2
Imaging aperture
_  PM T 1
f|E D
Scanning module Dichroic mirror Bandpass filter
Figure 2. 5 Schematic diagram of confocal setup. For clarity, only one laser and 
two PMTs are shown. The Zeiss LSM 510 has four of each allowing truly 
simultaneous imaging of several fluorescent probes.
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2.9.1 Measurement of mitochondrial membrane potential (Avj/m)
Cells were loaded with the membrane potential-sensitive dye tetramethylrhodamine 
methyl ester (Molecular probes, Netherlands) (TMRM; 20 nM in HEPES-buffered 
salt solution). Digital imaging of TMRM-loaded cells was performed using either a 
cooled CCD camera (Hamamatsu 4880) or a Zeiss 510 CLSM confocal microscope 
equipped with x 40 and x 63 oil immersion, quartz objectives lenses. For the cooled 
CCD system, coverslips were placed in a custom-made chamber and mounted on the 
microscope stage and fluorescence was excited using a monochromator emitting light 
of 490 nm which then passed through a 510 nm dichroic mirror. Light of wavelength 
longer than 590 nm was collected and focused on the camera. Confocal measurement 
of Aij/m was obtained at 488 nm argon laser line excitation. TMRM fluorescence was 
measured using a 505 to 550 nm bandpass filter. Illumination intensity was kept to a 
minimum (at 0.1 % of total laser output) to avoid phototoxicity and the pinhole was 
set to give an optical slice of approximately 2 pm.
Distribution of lucigenin within the cells was monitored by confocal imaging of cells 
illuminated by the 364 nm line of a HeNe laser and imaged between 475 and 525 nm. 
Cells were immersed in a solution of HEPES-buffered salt (100 pM lucigenin) and 
distribution of the dye followed for up to 30 min.
2.9.2 Cytosolic calcium [Ca2+]c measurements
Fluorescence cytosolic calcium concentration ([Ca2+]c) measurements were obtained 
using a Nikon Diaphot (Tokyo, Japan) epifluorescence inverted microscope with a x 
20 fluorite objective. Excitation light from a xenon arc lamp was selected using 10 nm 
bandpass filters centred at 340 and 380 nm housed in a computer-controlled filter 
wheel (Cairn Research, Faversham, UK). Emitted light passed through a long-pass
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filter to a cooled charge-coupled device (CCD) camera (Orca ER; Hamamatsu, 
Welwyn Garden City, UK). All imaging data were collected at intervals of 15 s, 
digitised, and analysed using Kinetic Imaging (Wirral, UK) software. Cells were 
protected from phototoxicity and photobleeching by interposing a shutter in the light 
path to limit exposure between the acquisitions of successive images.
Cells were loaded for 30 min at room temperature with 5 pM Fura-2 AM (Molecular 
Probes, Netherlands) and 0.005 % Pluronic F-127 in a HEPES-buffered salt solution 
composed of 156 mM NaCl, 3 mM KC1, 2 mM MgSOzj, 1.25 mM KH2PO4 , 2 mM 
CaCh, 10 mM glucose, and 10 mM HEPES, adjusted to pH 7.4. Cells were then 
washed and imaged in 0.5 ml of this solution at room temperature. Traces, obtained 
using the cooled CCD imaging system are presented as ratios of excitation at 340 and 
389 nm, both with emission beyond 515 nm. Cells were imaged for several minutes 
before the addition of either COM (250 pg/ml) as 2 pi aliquots. All imaging data 
presented here were from at least 3 coverslips and 2 or 3 different cell preparations.
2.10 Animals and tissue sampling
All animals were handled according to UK Home Office approved guidelines. This rat 
model of calcium oxalate nephrolithiasis employed ethylene glycol (EG) to induce 
hyperoxaluria and l, 25-dihydroxycholecalciferol (DHC) to initiate hyper-calciuria 
[Okada, Y., et al., 1985].
Male Sprague-Dawley rats (36 x 200 g) were maintained under constant conditions 
and were divided into 4 groups (control, EG, DHC and EG + DHC) of 9 animals each. 
Each group was then subdivided into 3 sub - groups, of 3 animals each, with the 
above treatments for 1, 2 and 3 weeks.
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Controls animals received water, whereas in EG and EG+ DHC experimental groups 
0.5 % (v / v) of EG was administered in drinking water. Fluid intake was monitored 
in all groups. DHC (1, 25-dihydroxycholecalciferol 50 ng / 100 g of body weight) was 
administered intraperitonial every other day to the EG + DHC (starting 24 h after first 
exposure to EG) and DHC groups. After 7, 14 and 21 days of treatment animals were 
anaesthetised with halothane and urine was taken directly by a needle from the 
bladder. The anaesthetised animals were sacrificed by cervical dislocation and the 
kidneys removed. The right kidney and urine sample were immediately frozen in 
liquid nitrogen and the left kidney was washed in saline solution at 4 °C, trimmed of 
adipose and connective tissue, weighed and homogenised 1 : 9 (w/v) in buffer 
containing 0.25 M sucrose, 5 mM HEPES, ImM EDTA and 0.1 % (w /v) BSA pH 7.2 
with protease inhibitor cocktail in a Teflon-glass Potter/Elvehjem homogeniser [Table 
2.3].
The whole homogenate was centrifuged at 500 x g for 10 min at 4 °C to remove the 
nuclear fraction and cell debris. 1 ml of the resulted homogenate (supernatant) was 
kept to process for total cytosolic and mitochondrial glutathione. The remaining 
supernatant was then fractionated by centrifugation at 10,000 x g for 15 min to isolate 
the cytosolic and mitochondrial components. Mitochondria were resuspended 1:1 (12 
- 15 mg protein / ml) in original homogenisation media.
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Table 2. 3 Table showing the individual components of the protease inhibitor 
cocktail with their concentrations and inhibitory properties.
Inhibitors Concentration Inhibitory properties
AEBSF 104 mM Serine proteases, such as 
trypsin and chymotrypsin
Aprotinin 80 pM Trypsin, chymotrypsin, 
plasmin trypsinogen, 
urokinase and kallikrein
Leupeptin 2.1 mM Serine and cysteine 
proteases, such as calpain, 
trypsin, appain, and 
cathepsin
2.11 Urinary oxalate and calcium
The oxalate concentration of urine was measured in supernatants prepared from 
samples centrifuged at 10,000 x g for 1 min by ion chromatography with suppressed 
conductivity detection on an IonPac AS4A anion chromatographic column using a 
Dionex high-performance pump. Urinary calcium was measured in the same sample 
using an ion-selective electrode. Oxalic acid and calcium chloride were used as 
standards.
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2.12 Bicinchoninic acid (BCA) protein assay
The principle of the BCA assay is similar to the Lowry procedure [Lowry OH et at,
s y i
1951], in that both rely on the formation of a Cu -protein complex under alkaline
^  I j ^
conditions, followed by the reduction of Cu to Cu . The amount of reduction is 
proportional to the protein present. BCA forms a purple-blue complex with Cu+ in 
alkaline environments, thus providing a basis to monitor the reduction of alkaline 
Cu2+ by proteins.
The BCA Working Reagent was first prepared by mixing 50 parts of Reagent A 
(bichinconinic acid, sodium carbonate, sodium tartrate, and sodium bicarbonate in 0.1 
N NaOH) with 1 part of Reagent B (4 % w/v copper (II) sulphate pentahydrate). 25 pi 
of sample and 175 pi of BCA Working Reagent were added in to its well of a 96-well 
plate. The microplate was then shaken and incubated at 37 °C for 30 min. After 
incubation the plate was allowed to cool at room temperature. Absorbance was the 
measured at 562 nm on a Wallac Victor plate reader.
2.13 Tissue section preparation
Longitudinal kidney sections (5 pm ) were taken using a cryostat (Bright, UK) and 
thaw mount onto Vectabond coated slides. The slides were then air-dried for 15 - 20 
min and then baked at 56 °C for 30 min in order for the sections to be affixed well.
2.14 Haematoxylin and Eosin staining
Changes of renal histopathology were visualised using haematoxylin and eosin (H & 
E) staining. After placing the slides with sections in a rack, the tissues were re­
hydrated in deionised water for 3 min. Excess water was blotted from the slide and the 
sections were placed in Harris haematoxylin (Lemer Laboratories, UK) for 5 min
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followed by rinsing with deionised water and a 5 min wash in running tap water in 
order to allow the satin to develop. This was followed by dipping the slides 12 times 
in 1 % acid alcohol and again washing with running water for 2 min and then with 
deionised water for a further 2 min. Excess water was blotted and the slides were 
incubated in 1 % - filtered eosin (Sigma, UK) for 5 min. Sections were then washed in 
running tap water until the water became clear. Sections were then dehydrated 
through a series of ascending alcohol solutions; 3 min in 70 % (v / v) ethanol, 3 min 
in 95 % (v / v) ethanol, and 3 min in absolute ethanol. Finally, the slides were cleared 
by incubation in histoclear for 2 min. Sections were left to air - dry thoroughly 
followed by mounting with Permount (Fisher, UK). The location of the birefringent 
crystals was examined under plain and polarised light microscopy.
2.15 Preparation of mitochondrial and cytoplasmic fractions 
for glutathione assay
Whole homogenates of fresh kidney were prepared, as described in section 2.10, and 
immediately processed for mitochondrial and cytoplasmic total glutathione (GSH + 
GSSG) measurements. 1 ml of whole homogenate was incubated with 20 pi of 
digitonin (10 mg/ml) for 20 s with vortexing, and was then centrifuged at 14,000 x g 
for 20 s. To the resultant cytosolic fraction (supernatant) 50 pi of 5 % (v / v) 
metaphosphoric acid (MPA) was added. The unsuspended pellet was then washed 
with 200 pi MOPS buffer pH 7.4 [Table 2.4], followed by 5 s centrifugation at 14, 
000 x g. The supernatant was discarded and the resultant pellet was finally 
resuspended in 250 pi of MOPS buffer. Cytosolic and mitochondrial fractions were 
then processed for total glutathione measurements.
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Table 2. 4 MOPS buffer at pH 7.4.
Reagents Concentration
EDTA 19.8 mM
Mannitol 250 mM
MOPS 19.8 mM
EGTA 19.8 mM
2.16 Total Glutathione assay
This GSH assay is a carefully optimised enzymatic recycling method using 
glutathione reductase for the quantification of GSH [Figure 2.6] [Tietze, F., 1969; 
Eyer, P., & Podhrasky, D., 1986; Baker, MA., et a l, 1990]. The sulfhydryl group of 
GSH reacts with DTNB (5,5'-dithiobis-2-nitrobenzoic acid, Ellman's reagent) and
produces a yellow coloured 5-thiol-2-nitrobenzoic acid (TNB). The mixed disulfide, 
GSTNB (between GSH and TNB), that is concomitantly produced is reduced by 
glutathione reductase to recycle the GSH and produce more TNB. The rate o f TNB 
production is directly proportional to this recycling reaction, which is in turn directly 
proportional to the concentration of GSH in the sample. Measurement of the 
absorbance of TNB at 414 nm provides an accurate estimation in the sample.
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Glutathione Reductase
GSSG > 2GSH
Glutathione V Reductase
GSTNB
DTNB
Figure 2. 6 GSH Recycling.
GSH is oxidised to the disulfide dimer GSSG. GSSG is produced during the reduction 
of hydroperoxides by glutathione peroxidase. GSSG is reduced to GSH by glutathione 
reductase and it is the reduced form that exists mainly in biological systems. Because 
of the use of glutathione reductase in this assay, both GSH and GSSG are measured 
and the assay reflects total glutathione.
Total glutathione was measured based on the above described principle. 20 pi of 
homogenate, cytosolic and mitochondrial fractions (were prepared as described in 
section 2.10) were added to 180 pi of glutathione assay solution [Table 2.5]. The rate 
of 5, 5'-dithiobis-(2-nitrobenzoic acid) DNTB reduction was measured over 5 min at 
412 nm in a Wallac Victor reader plate. The rate of reaction using standards of 
oxidised glutathione in 0.5 % MPA was used to calculate total glutathione (reduced + 
oxidised) expressed as pmoles per mg of tissue.
102
Chapter 2 -  Methods and Materials
Table 2. § Glutathione assay solution.
Reagents Concentration
K P04 pH 7.0 0.1 M
NADPH 240 pM
DNTB 76 pM
Glutathione Reductase 1.0 mU/ml
2.17 Antioxidant enzyme activities in the kidney fractionates
The activity of antioxidant enzymes was monitored in the kidney by measuring the 
glutathione peroxidase, glutathione reductase and glucose-6-phosphate dehydrogenase 
(G6PDH). Glutathione peroxidase assay (GPx) catalyses the reduction of 
hydroperoxides, including hydrogen peroxides, by reduced glutathione and functions 
to protect the cell from oxidative damage. This assay measures GPx activity indirectly 
by a coupled reaction with glutathione reductase (GR). Oxidised glutathione (GSSG), 
produced upon reduction of an organic hydroperoxide by GPx, and is recycled to its 
reduced state by GR and NADPH. The oxidation of NADPH to NAD+ is 
accompanied by a decrease in absorbance at 340 nM. The rate of decrease in the A340 
is directly proportional to the GPx activity in the sample [Paglia, DE., & Valentine, 
WN., 1967].
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To measure glutathione peroxidase, 10 pi of the mitochondrial fraction were added to 
1.25 ml of glutathione peroxidase assay solution [Table 2.6], followed by 5 min 
incubation at 25 °C. After incubation, 10 mM cumene-hydroperoxide was added and 
the change in absorbance at 340 nm was monitored.
Table 2. 6 Glutathione Peroxidase assay solution.
Reagents Concentration
K P04 pH 7.0 0.1 M
EDTA 100 mM
KCN 100 mM
NADPH 2 mg/ml
GR 5 pi
Cumene-peroxide 10 mM
In addition, glutathione reductase activity was monitored in the kidney mitochondrial 
fraction. Glutathione reductase is a flavoprotein that catalyses the NADPH-dependent 
reduction of oxidised glutathione (GSSG) to glutathione (GSH) [Carlberg, I., & 
Mannervik, B., 1985]. This enzyme is essential for the GSH redox cycle, which 
maintains adequate levels of reduced cellular GSH. A high GSH/GSSG ratio is 
essential for protection against oxidative stress. This assay measures GR activity by
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measuring the rate of NADPH oxidation. To measure the oxidation of NADPH to 
NAD+, 5 pi of mitochondrial fraction was added to 1.25 ml of glutathione reductase 
assay solution [Table 2.7]. Since GR is present at rate limiting concentrations, the rate 
of decrease in the Absorbance 340 is directly proportional to the GR activity in the 
sample.
Table 2. 7 Glutathione Reductase assay solution.
Reagents Concentration
Tris/HCl pH 8 1 M
EDTA 100 mM
FAD 1 mM
GSSG 30 mM
NADPH 2 mg/ml
Finally, glucose 6 phosphate dehydrogenase (G6PDH) activity was determined by 
measuring the rate of NADP+ reduction to NADPH in the presence of glucose 6 
phosphate. 50 pi of kidney cytosolic fraction was added to 1.25 ml of G6PDH assay 
solution [Table 2.8]. In all of the above assays the change in absorbance at 340 nm 
was continuously monitored in a Cary 1 double beam spectrophotometer.
105
Chapter 2 -  Methods and Materials
Table 2. 8 G6PDH assay solution.
Reagents Concentration
Glycyl-Glycyl/MgCl 0.25 M
NADP+ 2 mg/ml
Glucose-6-phosphate 50 mM
2.18 Mitochondria oxygen consumption rates
Much of our knowledge of electron transport in mitochondria and chloroplasts comes 
from oxygen electrode recordings. The oxygen concentration in a sealed incubation 
chamber is continuously monitored, and the effects of making various additions to the 
chamber can be observed. A cross section through a typical apparatus is shown below 
[Figure 2.7]:
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Figure 2. 7 Schematic diagram of a Clark electron device. The upper section 
containing a transparent, thermostated sample chamber is secured to the lower 
electrode assembly with a screwed ring. A thin Teflon membrane is trapped between 
the two sections and separates the isotonic incubation medium from the strong KC1 
electrolyte in the electrode compartment. The adjustable stopper is used to seal the 
incubation chamber and prevent room air dissolving during the experiments. The 
small hole in the centre of the stopper permits the expulsion of air bubbles and allows 
small volumes of reagents to be added with a microlitre syringe. The contents of the 
chamber are stirred continuously with a magnetic flea. Image adapted from 
http://www.bmb.leeds.ac.uk/illingworth/oxphos/oxygraph.htm
A small polarising voltage (ca. 0.6 volt) is applied between the silver anode (+) and 
the platinum cathode (-). Oxygen diffuses through the Teflon membrane and is 
reduced to water at the platinum cathode:
0 2 + 4H+ + 4 e ‘ = 2H20
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The circuit is completed at the silver anode, which is slowly corroded by the KC1 
electrolyte:
Ag + Cl' = Ag Cl + e '
The resulting current is proportional to the oxygen concentration in the sample 
chamber. This signal can be amplified and recorded. The whole process is totally 
dependent on the supply of oxygen. The rate of oxygen diffusion to the cathode (and 
hence the current) depends on the oxygen concentration in the main incubation 
chamber. It also depends on several other factors: temperature, membrane thickness 
and permeability, sample viscosity and stirring speed. In contrast to pH electrodes 
which measure an equilibrium position, oxygen electrodes measure the velocity of a 
physico-chemical process that is far from equilibrium. pH electrodes have an intrinsic 
thermodynamic response which is relatively insensitive to temperature and sample 
composition, but there is no intrinsic calibration to an oxygen electrode - at regular 
intervals, or if the instrument is dis-assembled, it must be re-calibrated against a 
known standard, usually air. It is particularly important to control the temperature.
If mitochondria are incubated in an oxygen electrode in an isotonic medium 
containing substrate and phosphate, then addition of ADP causes a sudden burst of 
oxygen uptake as the ADP is converted into ATP [Figure 2.8]:
The actively respiring state is sometimes referred to as "state 3" respiration, while the 
slower rate after all the ADP has been phosphorylated to form ATP is referred to as 
"state 4".
State 4 respiration is usually faster than the original rate before the first addition of 
ADP because some ATP is broken down by ATPase activities contaminating the
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preparation, and the resulting ADP is then re-phosphorylated by the intact 
mitochondria.
- [O2 ] mM substrate: 5mM succinate 
*—ADP added
state 3 (active)
ADP exhausted
state 4 respiration 
Oo exhausted
i
2 3
time (minutes)
Figure 2. 8 Representative graph of Oxygen Electron recordings as adapted from 
http://www.bmb.leeds.ac.uk/illingworth/oxphos/oxygraph.htm.
The ratio [state 3 rate] : [state 4 rate] is called the respiratory control index and 
indicates the tightness of the coupling between respiration and phosphorylation. With 
isolated mitochondria the coupling is not perfect, probably as a result of mechanical 
damage during the isolation procedure.
It is possible to calculate a P :0  ratio (the relationship between ATP synthesis and 
oxygen consumption) by measuring the decrease in oxygen concentration during the 
rapid burst of state 3 respiration after adding a known amount of ADP. It is necessary 
to subtract the basal respiration due to imperfect coupling and the recycling of ATP, 
as shown in the graph above. The change in concentration must then be multiplied by 
the chamber volume, so that the answer (in micro-atoms of oxygen) can be related to 
the quantity of ADP added. The quantity of oxygen in the chamber is calculated from 
published oxygen solubility data at the appropriate temperature.
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Oxygen consumption in freshly isolated mitochondria (1-1.5mg protein/ml) in 1.5ml 
of respiration buffer [Table 2.2] was assayed using a Clark electrode device (Rank 
Brothers, UK). Malate plus pyruvate at 5 and 2mM respectively (complex I), or 
succinate at 5mM (complex II) were used as reducing substrates and ADP (lOOpM) 
were used to measure state 3 and state 4 respiration.
2.19 Statistics
All values shown are means ± standard deviation (SD). Student's t-test was used to 
determine whether there was a significant difference between two groups (p < 0.05). 
When multiple means were compared, significance (p < 0.05) was determined by one­
way ANOVA followed by t-test and p values corrected for multiple comparisons 
using the method of Bonferroni.
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CHAPTER 3
Method development and optimisation for monitoring 0 2 " 
production in calcium oxalate monohydrate (COM) and 
sodium oxalate (NaOx) treated MDCK cells
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The interaction between crystals and urothelial cell membrane is considered an 
essential and critical event in the development of the renal calculi [Weissner, JH., et 
al., 2001]. The use of renal epithelial cells in tissue culture is widely accepted as a 
powerful tool in physiological and cell biological studies. In recent years, it has been 
established that renal tubular cells can provide insight into the conditions under which 
stones can develop. Since it is difficult to study these mechanisms in vivo, cultured 
renal tubular cells have become increasingly popular for the study of physiological 
and cell biological processes that are linked to stone disease. It has been known that 
CaOx crystals and free oxalate are injurious to renal epithelial cells and can induce 
lipid peroxidation [Huang, HS., et al., 2003]. However, in order to understand the 
mechanisms involved in crystal retention within the kidneys, it is necessary to identify 
the initial site and causes of crystal deposition within the kidneys. So far many 
investigators have used a number of renal epithelial cells to identify the initial site and 
the detailed mechanism involved in crystal deposition within the tubules. The most 
widely used cell type to conduct these experiments is Madin Darby Canine Kidney 
(MDCK) cells.
To identify mechanisms by which crystal deposition and its subsequent pathology, 
can contribute to the reported cellular transformation during the development of renal 
calculi, it was necessary to develop a method that would answer the questions arising 
from the current work.
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3.2 The effect of digitonin on lucigenin-derived 
chemiluminescence
It has been previously shown [Li, Y., et al., 1999] that superoxide formation can be 
measured directly by employing the lucigenin-derived chemiluminescence technique. 
Specifically, Li Y et al., 1999 suggested that intact MDCK cells can take up lucigenin 
and therefore give rise to a chemiluminescence (CL) signal. On the contrary, a more 
recent study has shown [Khand, FD., et al., 2002] that intact MDCK cells either in the 
presence or absence of COM were unable to take up lucigenin. However, the same 
authors demonstrated that when the cells were permeabilised with digitonin, lucigenin 
uptake was facilitated and superoxide production was observed.
To investigate the effect of digitonin on lucigenin -  derived chemiluminescence 
(LDCL), MDCK cells were incubated with 20 pM lucigenin for 20 min at 37 °C in 
order to allow time for lucigenin to enter the intracellular compartments. Media was 
then removed and respiration buffer was added to the lucigenin pre-incubated cells. A 
lack of detectable CL signal was observed, implying either the inability o f MDCK 
cells to uptake this specific chemiluminescence probe or the requirement of prolonged 
incubation.
To investigate the latter, a time course of lucigenin treatment was performed. MDCK 
cells incubated with lucigenin, in the same manner as described above, for 20, 30, 40, 
and 60 min (data not shown). Once again the absence of CL signal further supported 
the initial findings. Thus, having confirmed that in MDCK cells lucigenin is incapable 
of penetrating the intracellular compartments, further experiments were performed to 
investigate the means of lucigenin uptake.
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Digitonin is a solubilisation agent that interacts with membrane cholesterol causing 
permeabilisation by creating pores and allowing the release of diffusible molecules 
outside the cell. Therefore digitonin was employed to permeabilise MDCK cells. 
When 100 pg/ml of digitonin was added in COM treated MDCK cells, supplemented 
with respiration buffer, a clear lucigenin CL signal was detected [Figure 3.1], which 
lasted for approximately 10 min, after which time lucigenin CL signal was decreased. 
Hence, the non-ionic detergent digitonin was able to permeabilise the cells, and 
therefore facilitate lucigenin entry into the cells. In contrast to this observation, when 
MDCK cells were treated with COM and in the absence of digitonin, the CL signal 
was monitored at basal levels.
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Figure 3. 1 Lucigenin CL mediated by digitonin. Lucigenin-enhanced
chemiluminescence counts of COM treated cells in the presence (+) and absence (-) of 
100 pg/ml digitonin.
Having shown the permeabilisation of cells by using 100 pg/ml of digitonin, further 
experiments were performed to investigate how different concentrations of digitonin 
might influence the lucigenin CL signal. As illustrated in Figure 3.2, when COM 
treated cells were permeabilised by using lower concentrations of digitonin, a greater 
lucigenin CL signal was observed than that seen at 100 pg/ml digitonin. A peak at 40 
pg/ml of digitonin was observed. This suggests that concentrations of digitonin higher 
than that of 40 pg/ml may cause changes in the membrane potential across the inner 
mitochondrial membrane, and therefore reducing the total proton motive force that 
determines the rate of electron leakage to O2'". This in turn results in the observed
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decrease of the chemiluminescence signal. In addition, it was observed that the lower 
the concentration used the later the peak of CL signal appeared.
Nevertheless, the lucigenin CL signal derived from COM treated cells in the presence 
of 10 pg/ml of digitonin was significantly lower when compared with untreated cells 
in the presence of 100 pg/ml of digitonin. Moreover, levels of superoxide counts 
resulting from the addition of 10 pg/ml of digitonin were similar to those of non 
permeablised cells. This indicates that at this concentration of digitonin, cells were not 
sufficiently permeabilised to monitor superoxide production [Figure 3.3]. Therefore, 
the bell-shaped pattern of Figure 3.3 indicates the threshold between the excess and 
minimal permeabilisation of the membrane, to achieve sufficient monitoring of 0 2 *' 
production.
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Figure 3. 2 Effect of digitonin concentration on COM mediated lucigenin CL 
signal. MDCK cells were treated with 250 pg/ml COM for 4 h. Lucigenin-enhanced 
chemiluminescence counts were taken in the presence of different concentration of 
digitonin (100 -  10 pg/ml) in the respiration buffer. Values are compared with 
untreated cells in the presence of 100 pg/ml digitonin (control).
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control
Figure 3. 3 Dose effect of digitonin on lucigenin CL. Percentage of lucigenin CL 
counts monitored by using different concentrations (100 -  10 pg/ml) of digitonin on 
COM treated cells. Control is untreated cells in the presence of 100 pg/ml of 
digitonin. Data are mean ± SD for n=20; ** ;? < 0.01 * p < 0.05 and f p < 0.01 vs 
control.
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3.3 Dose-dependent effect of COM on MDCK cells
Having optimised the conditions by which lucigenin chemiluminescence signal is 
observed and therefore able to measure superoxide production, it is of critical 
importance to identify the dose dependent effect of COM on MDCK cells.
Cells of distal tubular origin (MDCK) were treated for 4 h with increasing amounts of 
COM (50 pg/ml - 250 pg/ml equivalent to 5.7 pg/cm2 - 28.4 pg/cm2) to investigate 
whether COM activated cell superoxide production in a crystal density dependent 
manner. Figure 3.4 demonstrates that 250 pg/ml of COM induced a large and 
significant O2*’ production. However, even low amounts of COM (50 pg/ml) were 
sufficient to trigger O2*’ formation. This could be of great importance since this low 
level could represent the amount of crystals found in patient tubular fluid.
Having shown the dose dependent response of lucigenin CL signal deriving from 
various concentration of COM, it was important to investigate the effects of COM 
treatment time, to elucidate the time of exposure sufficient to cause O2*’ formation. 
Therefore experiments were performed where cells were incubated for 10 min and 4 h 
with COM. In addition, experiments were included where COM was added just after 
cells were permeabilised. The data in Figure 3.5, shows a 3 - fold increase in O2** after 
4 h COM treatment, whereas no rise in lucigenin chemiluminescence signal was 
shown when cells were only incubated for a short period of time (10 min). This may 
be due to the fact that prior to chemiluminescence assay, cells were washed with PBS 
and thus non - attached COM was removed. However, when COM was added to 
digitonin permeabilised cells (no incubation) high levels of O2*' were observed. This 
finding indicates that the presence of crystals is essential for the O2*’ formation and 10 
min is not adequate to achieve COM binding to cells.
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Figure 3. 4 Effect of different COM concentration on lucigenin CL. MDCK cells 
treated with 50 pg/ml - 250 pg/ml of COM and incubated for 4 h. Lucigenin- 
enhanced chemiluminescence counts were monitored per minute. Data are mean ± SD 
for n=20; * p  < 0.05 and ** p < 0.01 vs untreated MDCK cells (control).
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Figure 3. 5 Effect of COM incubation times on lucigenin CL. Percentage of 
lucigenin chemiluminescence counts when MDCK cells were treated with 250 pg/ml 
COM without incubation (zero time), 10 min and 4 h incubation. Lucigenin-enhanced 
chemiluminescence counts were monitored per minute. Data are mean ± SD for n=20; 
* p  < 0.05, and ** p  < 0.01 vs control.
121
Chapter 3 -  Results
3.4 Lucigenin CL response from sodium oxaiate (NaOx) 
treated MDCK cells
Following studies of superoxide production derived from COM treated MDCK cells, 
further experimental investigation was carried out to examine the effect of free 
oxalate treated cells in terms of oxidative stress.
MDCK cells were treated with increasing concentrations of sodium oxalate for 15 
min, and superoxide production was monitored. As indicated in Figure 3.6, 750 pM of 
free oxalate mediated a significant 1.5 fold increase of superoxide production when 
compared to controls. Sodium oxalate treatment also showed a dose dependent 
response in lucigenin CL signal. It is interesting to note that 1.5 mM ofNaOx resulted 
in equal levels of oxidative stress in terms of superoxide production compared to that 
of 250 pg/ml COM treatment. Furthermore, 750 pM is the concentration of free 
oxalate that is released from 250 pg/ml calcium oxalate monohydrate dissociation 
(see section 4.4).
Additional, experiments were performed to examine whether time of NaOx 
incubation had any significant effect on the lucigenin chemiluminescence signal. As 
shown in Figure 3.7, incubation of MDCK cells with 750 pM NaOx for 15 min 
caused the cells to respond similarly in terms of superoxide production compared with 
those treated for 4 h. This absence of difference with treatment time was expected, 
since NaOx represents the free form of oxalate that is transported into the cells. Thus, 
there is no requirement for crystal-cell interactions to occur as in the case with COM 
treatment.
122
Chapter 3 -  Results
30 0 0 **
** **
2 5 0 0
2000
2c
3  Oo
-IO
c
'E
.5 > 1000 o
3
1500
500
control 250 pg/ml 
COM
750 pM 
NaOx
**
900 pM 
NaOx
1.25 mM 
NaOx
1.5 mM 
NaOx
Figure 3. 6 Dose-dependent effect of NaOx on lucigenin CL. MDCK cells were 
treated with 250 jig/ml COM for 4 h. MDCK cells were also treated with increasing 
amounts (750 pM -  1.5 mM) of NaOx for 15 min. Lucigenin-enhanced 
chemiluminescence counts were monitored per minute. Data are mean ± SD for n=20; 
** p  < 0.01 and * p <  0.05 vs control.
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Figure 3. 7 Effect of NaOx incubation time on lucigenin CL. MDCK cells were 
treated with 750 pM NaOx for 15 min and 4 h. Lucigenin-enhanced 
chemiluminescence counts were monitored per minute. Data are mean ± SD for n=20; 
* p  < 0.05 vs control.
3.5 Cytotoxicity of COM or NaOx in MDCK cells
The optimal concentration and the incubation times of COM or NaOx treatment for 
cells to initiate a significant superoxide production monitored by lucigenin 
chemiluminescence have been optimised. The next question to be addressed, in order 
to further investigate this phenomenon was to examine the cytotoxic effects of the 
proposed doses and treatment time of COM and NaOx.
The MTT assays, a functional and survival method were carried out on cells receiving
1.5 mM NaOx or 250 pg/ml COM treatment for 24 h. As shown in Figure 3.8, no 
significant change was observed.
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Figure 3. 8 Cell toxicity after COM and NaOx treatment. MDCK cells were 
treated with 250 pg/ml COM or 1.5 mM NaOx for 24 h and MTT assay was 
performed. Values presented as a percentage of cell viability. Data are Mean ± SD for 
n=5.
Therefore, no cell death occurred when cells were treated with the aforementioned 
doses and treatment times. This outcome indicates that in the cell -  crystal model the 
superoxide production monitored is a result of the crystal-cell interaction effect of 
COM or the effect of free oxalate, and not due to overall cell cytotoxicity.
250 |jg/ml COM 1.5 mM NaOx
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3.6 DISCUSSION
It is now well established that cell injury is central to the process of urolithiasis 
[Wiessner, JH., et al., 2001]. An injury to the epithelial cells results in membrane 
damage and shedding, which play a critical role in crystal formation as well as crystal 
retention. Oxidative stress is a recognised source of cell injury and results from 
increased production of ROS. Although there is evidence that free oxalate ions can 
mediate oxidative insult, the origin of the ROS in oxalate crystal interactions with 
renal epithelial cells, is still unknown. This study was conducted to optimise cell 
culture conditions and to develop a method for allowing monitoring of superoxide 
production after exposure of kidney epithelial cells with the most common 
constituents of kidney stones.
It is now established that exposure of renal epithelial cells to COM crystals results in 
a free radical mediated oxidative stress [Muthukumar, A., & Selvam, R., 1998; 
Muthukumar, A., & Selvam, R., 1997]. Muthukumar and Selvam have reported 
oxalate-mediated oxidative stress by showing that during the development of calcium 
oxalate stones in ethyl glycol fed rats, GSH was depleted leading to mitochondrial 
dysfunction with observed lipid peroxidation and oxidation of protein thiols. In order 
to monitor oxidative stress, in this study the lucigenin-derived chemiluminescence 
method was employed. Lucigenin is a well validated chemiluminegenic probe for 
detecting superoxide formation [Li, Y., et al, 1998; Rembish, AJ., & Trush, M., 
1994; Faulkner, K., & Fridovich, I.,; 1993], This was based on the observation that in 
several in vitro enzymatic systems such as xanthine oxidase or glucose oxidase that 
produce little 0 2 *’, lucigenin may itself act as a source of 0 2 *" via autoxidation of the 
lucigenin cation radical. The lucigenin cation radical produced by these systems can
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reduce O2 to O2 ' and therefore give artifictual positive results. However, other studies 
by Li, Y., et al., [1999] have shown that lucigenin participates in redox-cycling is 
dependent on the concentrations of lucigenin used. To investigate this, the authors 
measured KCN-resistant O2 consumption rates for increasing amounts of lucigenin (5 
pM-100 pM) and the results were compared with 5 pM benzo(a)pyrene-l,6-quinone 
(BPQ), as a positive control. BPQ is a chemical known to undergo redox cycling in 
the mitochondria and the authors have shown that using 5pM BPQ, there was a 
dramatic increase in KCN-resistant O2 consumption rates. This observation was 
compared with 50 pM -  100 pM lucigenin which showed a similar response in the 
KCN-resistant O2 consumption rates. However, at a concentration of 20 pM and 
lower the levels of O2 consumption rates were non-detectable, indicating that at these 
concentrations, lucigenin does not undergo redox cycling. The same authors have also 
suggested that lucigenin redox cycling also depends on the charge of lucigenin and 
the intermediates. Because of the opposite charges of the lucigenin cation radical and 
O2*' and the unstable dioxetane intermediate produced from the reaction of lucigenin 
cation radical with O2’" , both the molecular binding affinity and the rate constant of 
the reaction between the lucigenin cation radical and O2 ’ may be much higher than 
those between the lucigenin cation radical and O2 . This may explain the inability of 
luginenin below certain concentrations to undergo redox cycling in the ( V  generating 
systems.
Furthermore, in this work it was shown that when intact treated or untreated MDCK 
cells were incubated with 20 pM lucigenin, a chemiluminescence signal was not 
detected. This indicates the inability of lucigenin to penetrate into the intracellular 
compartments. This contrasts with the findings of Li, Y., et al, [Li, Y., et al., 1998], 
who observed uptake of lucigenin by intact cell lines. To further support the finding
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that intact cells do not uptake luginenin, MDCK cells were incubated with 20 pM 
lucigenin for several time points. Even after 1 h incubation a chemiluminescence 
signal was absent. However, when MDCK cells were permeabilised with 100 pg/ml 
of digitonin a clear lucigenin - derived chemiluminescence signal was detected. 
Digitonin is a detergent which replaces cholesterol in the membrane and creates 
pores. In order to determine the optimum digitonin concentration and to avoid 
perturbations of mitochondrial membrane, different concentrations of digitonin were 
used and superoxide was monitored. When increasing amounts of digitonin were 
tested it was shown that digitonin at concentrations of 40 - 50 pg/ml, resulted in the 
highest recorded levels of superoxide production, whereas below this, 10 pg/ml of 
digitonin did not induce a chemiluminescence signal. This indicates that cell 
permeabilisation by digitonin at concentrations of 40 - 50 pg/ml did not seem to 
disturb the mitochondrial membrane potential, therefore increased levels of 
superoxide were observed. In contrast, 100 pg/ml of digitonin has resulted in lower 
but significant levels of superoxide formation, which indicates disturbance in the 
balance between cell permeability and damage of the inner mitochondrial membrane. 
However, it has been reported that by measuring O2 consumption in a Clark oxygen 
electrode, digitonin at a concentration of 100 pg/ml did not cause mitochondrial 
uncoupling [Khand, FD., et al., 2002]. In addition other studies have also reported the 
use of digitonin to study pathological processes that influence mitochondrial 
functions. Specifically, Floryk, D., & Houstek, J., [1999] have described a method 
suitable for sensitive measurement of mitochondrial membrane potential in different 
types of cultured cells by using digitonin [Floryk, D., & Houstek, J., 1999]. The same 
authors have also reported that digitonin influence on mitochondrial enzymatic
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activities at concentrations lower than 100 pg/ml did not significantly disturb the 
mitochondrial membrane potential.
Even though, 40 - 50 pg/ml digitonin appeared to be the optimal digitonin 
concentration, experiments performed prior to this study were carried out at using 100 
pg/ml of digitonin. This however, did not interfere with the interpretation of the 
results. Therefore, due to time limitation to repeat most of the earlier experiments and 
in order to keep consistency between the results obtained from this thesis, 100 pg/ml 
of digitonin was used throughout the whole study.
Furthermore, when MDCK cells were treated with 50 - 250 pg/ml COM, cell 
superoxide production was activated in a dose dependent manner. Even at a low COM 
concentration of 50 pg/ml superoxide levels were significantly increased compared to 
untreated cells. This could be of clinical importance, since 50 pg/ml COM is more 
likely to represent the amount of COM crystals found in stone patients tubular fluid 
than that of 250 pg/ml COM. In addition, other reports from this laboratory have 
shown that even concentrations as low as 25 pg/ml resulted in a significant increase 
of superoxide formation [Khand, FD., et al, 2002]. For this activation to occur in this 
model, MDCK cells had to be treated with COM crystals for up to 4 h, a time period 
at which COM crystal adherence to the cells is fully achieved. Prior to superoxide 
measurements, MDCK cells were washed with PBS and non - attached crystals were 
removed. When COM crystals were added to MDCK cells just 10 min prior to 
superoxide assay, no chemiluminescence signal was detected, since un-attached COM 
crystals were removed by washing before the superoxide assay. However, increased 
superoxide levels were observed when COM crystals were added without subsequent 
washing and immediately prior to digitonin permeabilisation. This indicates that the
129
Chapter 3 -  Results
physical presence of COM crystals is an absolute requirement to initiate oxidative 
stress and for this manifestation to occur.
In addition, different concentrations of sodium oxalate were used to investigate 
whether free oxalate elicited the same response. MDCK cells were treated with 1.5 
mM - 750 pM NaOx and also showed a dose dependent response with respect to 
superoxide formation. NaOx concentration of 750 pM, represents the free oxalate 
released from COM dissociation as reported in the oxalate dissociation studies 
(Chapter 4). In contrast to 4 hr COM treatment, NaOx incubation time was 
independent with respect to lucigenin chemiluminescence. Even when NaOx was 
added 10 min to MDCK cells prior to the superoxide assay, the resulting superoxide 
formation was at similar levels with those observed with 4 h NaOx treatment. This 
finding was predicted as NaOx is the free form of oxalate and there is no requirement 
for crystal-cell interaction to occur. In addition oxalate is known to be rapidly 
transported into renal epithelial cells [Cao, LC., et al., 2004].
Furthermore, to assess the cytotoxicity of COM and NaOx treatments at 
concentrations of 250 pg/ml and 1.5 mM respectively, an MTT assay was performed. 
MDCK cells were treated at the above concentration for up to 24 h and it was 
observed that there was no difference in the viability of cells when compared to 
untreated MDCK cells. This validates the use of this model system since it indicates 
that superoxide production did not arise as a result of cell death and apoptosis at these 
treatment times and concentration. In addition, since the MTT assay is a functional 
mitochondrial assay, the indications are that at the above concentration of COM and 
NaOx used no uncoupling of the mitochondria occurs and the intra-mitochondrial 
redox remains much as it is in control cells. Furthermore, SEM data also showed (see
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Chapter 5) that cells survive and divide in culture despite the presence of internalised 
COM crystal, thus providing evidence that the crystals are not toxic for these renal 
cells. Similar results were also observed in previous studies [Verkoelen, CF., et al, 
1996] where they showed that 32 pg/cm2 of COM treated MDCK cells, did not result 
in increased levels of brush border and cellular enzymes. Therefore there was no 
evidence of cellular damage or mitochondrial metabolism alteration. This observation 
is still in line with the theory that for crystal adherence to occur, renal cells must 
undergo injury and oxidative damage [Muthukumar, A., & Selvam, R., 1998; Scheid, 
C., et al, 1996]. Evidence that oxidative stress and cell damage is initiated by COM 
binding or free oxalate exposure to MDCK cells arose from studies that showed 
elevated total glutathione levels [Muthukumar, A., & Selvam, R., 1998; Lash, LH., et 
al, 1998].
At this part of the study it has been shown that COM and NaOx and different 
concentrations and time course treatments elicit oxidative stress by means of 
superoxide production. It is therefore, of critical importance to address the question of 
whether the above response is specific to COM and NaOx or whether other particles 
can mediate the same response. Further studies of how crystal internalisation and/or 
availability of oxalate can mediate oxidative stress, were subsequently performed.
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CHAPTER 4
Superoxide formation mediated by crystal and 
microparticles adherence on MDCK cells
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4.1 INTRODUCTION
A kidney stone is a hard mineral and crystalline material formed within the kidney or 
urinary tract. The chemical composition of stones depends on the chemical imbalance 
in the urine. Although the majority of renal stones contain calcium oxalate, other 
crystalline components can also contribute to renal stone formation. These include 
calcium phosphate, uric acid, and cystine stones [Herring, LC., 1962]. The 
mechanism by which stones develop in the kidney is still poorly understood. 
However, there is strong evidence that tubular dysfunction or damage is involved in 
COM binding and subsequent pathology [Selvam, R., & Devaraj, S., 1991]. As it has 
been shown in Chapter 3, COM crystals mediate oxidative stress in the form of 02*' 
production. It is therefore, important to examine whether crystal internalisation occurs 
at the time points where oxidative stress is observed and the consequences of such an 
action. In addition, this part of the study examines whether other micro-particles can 
elicit the same response.
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4.2 COM binding and internalisation
Having shown in the previous section that COM treated cells undergo oxidative stress 
in terms of O2*’ production, further experiments were performed to investigate whether 
COM binding and internalisation occurs during this process. To examine COM binding 
to MDCK cells, SEM was used. Electron micrographs obtained, showed a COM 
attachment to MDCK cell monolayers after 15 min [Figure 4.1 B] and this attachment 
process appeared to cause proliferation of cell microvilli. After 60 min a region of the 
plasma membrane invaginates and forms a membrane vesicle to endocytose COM 
crystals [Figure 4.2 A]. By 120 min COM crystals were internalised [Figure 4.2 B]. 
After 4 h of COM incubation, crystals were completely enclosed within the cell 
membrane [Figure 4.3 A]. Finally, after cell permeabilisation with digitonin in COM 
treated cells, crystals remained within the intra-cellular milieu [Figure 4.3 B].
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Figure 4. 1 Scanning electron microscopy of MDCK cells. (A) Untreated MDCK 
cells were grown on Thermenox coverslips and examined under scanning electron 
microscopy (B) MDCK cells were grown on Thermenox coverslips and incubated 
with 250 pg/ml of COM for 15 min showing microvilli being projected towards the 
crystal surface.
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Figure 4. 2 Scanning electron microscopy of MDCK cells. MDCK cells were 
grown on Thermenox coverslips and incubated with 250 pg/ml of COM for (A) 60 
min, crystal endocytosis and (B) for 120 min, crystal phagocytosis.
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Figure 4. 3 Scanning electron microscopy of MDCK cells. COM treated MDCK 
cells for 240 min where crystals were fully engulfed (A) and crystals remain within 
intracellular structures after membrane permeabilisation with digitonin (B).
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The above results indicate that up to 4 h of COM exposure, crystals were internalised 
resulting in oxidative stress as indicated by superoxide production measurements at 
the same time point.
As these measurements were carried out in permeabilised cells, respiration buffer 
containing EDTA (1 mM) was used to conserve mitochondrial integrity. EDTA is a 
strong calcium chelator, indicating that internalised COM crystals, calcium 
dissociates and free oxalate is transported into the mitochondria. To confirm this 
hypothesis, further experiments were performed by omitting EDTA from the 
respiration buffer.
4.3 Effect of Calcium Chelators on superoxide formation
COM crystal attachment and internalisation in renal epithelial cells, may result in 
dissociation to Ca2+ and free oxalate and therefore in free oxalate entry into 
mitochondria. To investigate this hypothesis and whether release of free oxalate from 
COM, due to a shift in the dissociation equilibrium resulting from calcium chelation 
was contributing to CL, identical measurements were made in the presence and 
absence of EDTA.
As illustrated in Figure 4.4, omitting EDTA from the respiration buffer caused a small 
but significant decrease in superoxide production (« 15 %) in untreated cells. By 
contrast, the absence of EDTA caused an abrogation of COM-mediated superoxide 
production. However, there remained a small but significant increase in 
chemiluminescence signal, above that of the control minus EDTA. This outcome 
strongly suggests that Ca chelation was essential for the observed COM effect.
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Figure 4. 4 Effect of EDTA on COM mediated lucigenin-CL. Lucigenin-enhanced 
chemiluminescence counts measured in the presence and absence of EDTA in 
untreated and COM treated cells. Data are mean ± SD for n=20; * p  < 0.05 vs control 
with EDTA, ** p < 0.01 vs control with EDTA, t  p < 0.01 vs COM with EDTA.
Further experiments were also performed to restore the abrogated superoxide signal 
by employing other chelators such as EGTA, desferal, citrate and ascorbate. When re- 
introduction of different chelators into the system was employed, it was observed that 
only EGTA proved to be effective in restoring superoxide formation, probably a 
reflection on its calcium chelation properties. On the other hand, neither citrate nor 
ascorbate, both weaker calcium chelators, nor desferal, an iron chelator were able to 
significantly restore any component of the COM mediated superoxide increase 
[Figure 4.5].
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Figure 4. 5 Effect of calcium chelators on COM mediated lucigenin - CL. MDCK 
cells treated with COM and a superoxide assay was performed in the presence of 
EDTA, EGTA, desferal, citrate, ascorbate, in the RB, and in COM treated MDCK 
cells. Values expressed as a percentage of lucigenin CL counts. Data are mean ± SD 
for n=20; * p<  0.05 vs control with EDTA.
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4.4 COM dissociation
To establish that free oxalate indeed is released from COM, [14C] - COM (250 pg/ml) 
was incubated with respiration buffer in the presence and absence of 1 mM EDTA. 
This was then centrifuged and the radioactive content of the soluble and crystalline 
components analysed by liquid scintillation counting.
When MDCK cells were treated with COM, 50 % of [14C] - oxalate was released in 
the presence of EDTA [Figure 4.6]. The amount of oxalate released was estimated as 
« 750 pM. This value was calculated from the specific activity of COM and 
represents the amount of oxalate released from 250 pg/ml of COM. This agrees with 
the calculated (MAXCHELATOR, WinMAxC v 2.40) buffering capacity of ImM 
EDTA at 37 °C pH 7.4 and ionic equivalent 0.142.
In addition to EDTA, EGTA is also a potential chelator resulting in COM dissociation 
and » 37 % of the oxalate from COM was released, whereas, other chelators such as 
ascorbate, desferal or citrate, did not initiate oxalate dissociation from the calcium 
crystal form.
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Figure 4. 6 Percentage of [,4C] - oxalate release from [14C ]-C O M  in the presence 
of different chelators. [14C] - oxalate dissociation from [14C]-COM in respiration 
buffer containing different chelators. Data are mean ± SD for n=5; ** p  < 0.01 vs RB 
without EDTA.
4.5 Superoxide activation by other crystal forming agents
Having established patho-physiological levels of COM that induce superoxide 
production, further experiments were performed to investigate whether other crystals 
or free oxalate in renal stones produced similar amounts of O2*". Sodium oxalate 
(NaOx), uric acid (UA) crystals, brushite, zymosan, latex beads (LB) and 
hydroxyapatite (HA) were employed to investigate this.
This was accomplished by treating MDCK cells with the above particulates at 
concentrations equal to those of COM (250 pg/ml) and a pre-incubation time of 4 h. 
Nevertheless, NaOx treatment occurred as previously described, at 1.5 mM
142
Chapter 4 -  Results
concentration and for 15 min incubation. In addition, superoxide production was 
measured in digitonin permeabilised cells by lucigenin chemiluminescence. Results 
demonstrated that at the same density as COM crystals (28.4 pg/cm2), hydroxypatite 
produced a much lower but significant enhancement of superoxide production, whilst 
neither uric acid nor brushite had an effect [Figure 4.7]. Free oxalate, as previously 
observed, produced a smaller but significant increase in CL. However, when O2*" 
production, resulting from either NaOx and HA treatment, was compared with the 
effects of COM it is clear that the latter is a more potent mediator of oxidative stress. 
Phagocytic particles such as opsinised zymosan and latex beads were also without 
effect on lucigenin CL.
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Figure 4. 7 Superoxide activation by other crystal forming agents. Lucigenin- 
enhanced chemiluminescence counts were taken after 4 h treatment with crystals and 
microparticles. NaOx was added 15 min prior to superoxide assay. HA, 
hydroxy apatite; UA uric acid; LB latex beads. Values expressed as percentage of 
activation. Data are mean ± SD for n=20; **/?<0.01, *p< 0.05.
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4.5 DISCUSSION
To evaluate the rate of COM attachment and internalisation in this model, electron 
microscopy was employed. The scanning micrographs showed that after 15 min of 
COM incubation, crystal cell microvilli changes were observed. This resulted in an 
increase of the cell surface, and therefore in an increase in the affinity of crystal 
binding. The subsequent cell internalisation occurred over a period of 30 to 240 min, 
where crystals were entrapped by the microvilli and then moved into the cells. 
Specifically at 60 min, many of the microvilli of the cells had already been elongated 
towards the crystals and microvillar projections covered the crystal surface. At later 
times when microvilli appeared to contribute to phagocytosis, crystals were engulfed 
beneath the plasma membrane. Interestingly, as it has previously been reported 
[Lieske, JC., et al., 1994], microvilli appear to play an important role in the adhesion 
and endocytosis of COM crystals. The same authors have suggested that microvilli 
may provide the initial binding site and appear to participate in a process that results 
in the internalisation of the crystal into a membrane vesicle. In addition, previous 
studies in BSC-1 cells (renal epithelial cells of non-transformed African green 
monkey lines) [Lieske, JC., & Toback, FG., 1993] and in primary cultures of rat inner 
medullary collecting duct cells [Riese, RJ., et al, 1998] suggested that COM binds to 
specific receptors. The number of these receptors may be influenced by the 
distribution of apical and basolateral proteins found in the plasma membrane. Under 
normal circumstances these receptors may be small in number but could increase 
upon injury.
It is now established that crystal formation and retention are critical events for the 
formation of kidney stones. As discussed before, COM crystals are injurious to renal
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epithelium, and membranes of injured cells promote crystal adherence and retention. 
In addition, COM adherence results in oxidative stress and manifest via superoxide 
production. However, data that links superoxide formation with other forms of 
crystals and micro-particles is currently unavailable. A part of this work investigated 
the effect of other constituents found in tubular fluid that are known to be involved in 
the kidney stones, on superoxide production. Calcium phosphate crystals, the second 
most common crystal present in urine and kidney stones [Smith, LH., & Wemess, 
PG., 1982] were employed to investigate their injurious effect on renal epithelial cells. 
When MDCK cells were treated with brushite and hydroxyapatite crystals at the same 
density as COM (28.4 pg/cm2), only the hydroxyapatite produced a significant 
enhancement of superoxide production. However, this increase of superoxide 
production was lower than that observed with COM treatment. The absence of 
chemiluminescence signal with brushite treatment may be due to the fact that calcium 
phosphate crystals form in different locations in the kidney. Supersaturation for 
calcium phosphate crystals is reached more likely where urine is alkaline and 
therefore in early segments of the nephron, whereas calcium oxalate crystals reach 
supersaturation where urine is acidic, therefore distal tubules and collecting ducts 
[Fasano, JM., & Khan, SR., 2001; Asplin, JR., et al., 1996]. In addition, it has also 
been shown that COM and hydroxyapatite crystals share the same binding sites, and 
they are both endocytosed and induce cell proliferation [Khan, SR., 2004; Mandel, 
NS., 1994; Lieske, et al., 1992; Mandel, NS., & Riese, R., 1991]. Therefore, crystal 
cell interactions are based upon specific molecular contacts between the cell and 
crystal surfaces and upon the nature of the crystals and cell types [Mandel, NS., 1994; 
Mandel, NS., & Riese, R., 1991]. Recently it has been reported that when MDCK or 
LLC-PK1 cells were treated with brushite at a similar density to that used in this study
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(28.4 jag/cm2) and at the same time periods (4 hr), LDH release and H2O2 levels were 
increased [Aihara, K., et al, 2003]. However, MDCK cells showed less sensitivity to 
brushite crystals in terms of LDH release and H2O2 production. This study by Aihara 
reports oxidative stress mediated by brushite crystals in intact cells due to cytosolic 
sources, whereas in this current study, the effect of the same crystal was investigated 
in digitonin permeabilised cells and therefore principally in the mitochondrial 
compartment. Furthermore, a specific cell can respond differently to different types of 
crystal [Umekawa, T., et al, 2003], and also to different forms of the same type of 
crystal [Weisner, J., et al., 1988]. As other crystals have been reported to bind and be 
internalised by MDCK cells in a similar time frame to these experiments [Koka, R., et 
al, 2000; Aihara, K., et al, 2003], it is unlikely that an endocytotic/phagocytotic 
phenomenon is the sole trigger of mitochondrial superoxide production. A recent 
study [Koka, RM., et al, 2000] has also suggested that interaction between renal 
epithelial cells and COM or HA crystal differs from that of UA crystals. Specifically, 
COM and HA crystals behave as if they are positively charged which bind to 
negatively charged molecules that constitute the apical surface of the plasma
membrane. On the other hand UA crystals appear to be electrostatically neutral,
suggesting that charge does not play a major role in interaction between UA crystals
and cells. Specifically, Koka, RM., et al, [2000] have proposed that UA have a
perfect hydrogen bonding system and that the apical cell surface more likely has 
organic molecules organised according to a motif that satisfies a demand of the UA 
crystalline lattice for hydrogen bonding interaction. Therefore it is not surprising that 
hydrogen rather ionic bonding appears to play a role in UA crystal cell-interaction. 
Since COM and HA crystals share the same mechanistic interaction with the cell 
membrane and respond with similar levels of superoxide formation, this may suggest
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that there is a relationship between the manner of adhesion and oxidative stress. In 
addition, another study [Bigelow, MW., et al., 1997] has also provided evidence that 
lipid components from the plasma membrane may play a role during adhesion of 
different crystals to renal cells. In the present study, digitonin was used to 
permeabilise cells in order to monitor superoxide production. This membrane poration 
will have an effect on the cholesterol component of the plasma membrane and 
therefore affect the types or the quantity of cell surface anionic receptor molecules. 
This consequently may influence the adhesion capacity of different crystals to retain 
binding to the renal epithelial cells, therefore creating a favourable environment for 
COM binding in the plasma membrane.
To investigate the mechanism by which COM crystals contribute to mitochondrial 
superoxide formation, it is important to study the fate of COM crystals once engulfed 
in the plasma membrane. The hypothesis suggested in this work, was that COM once 
internalised dissociates to Ca 2+ and free oxalate. To explore this, experiments were 
carried out in the absence of EDTA and presence of other chelators in the respiration 
buffer. Interestingly, the COM-mediated rise in superoxide was lower in respiration
94-buffer containing EGTA compared with EDTA. This may be due to the fact that Ca
9 4-complex of EGTA, in contrast to EDTA, is 100,000 times more stable than its Mg 
complex [Bers, DM., et al, 1994]. Alternatively the EGTA difference may arise
9 .
because of Mg -mediated decrease in respiration [Sordahl, LA., & Silver, BB., 
1975]. Therefore, the ablated chemiluminescence signal in the absence of strong 
calcium chelators, indicates that dissociation of COM to free oxalate is a necessary 
and an important step in enhanced superoxide formation. This was further supported 
by the observation that at the level of free oxalate released from COM by EDTA in 
the respiration buffer calculated from the radioactive release from crystal to aqueous
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phase, although a significant rise in superoxide occurs, production is only « 30 % of 
that apparent with crystals. This again implies that the physical presence of crystals as 
well as free oxalate is important, and that a critical concentration of free oxalate is 
needed to trigger this synergy.
As it was shown in Chapter 3, the absence of lucigenin chemiluminescence signal 
when cells were not permeabilised with digitonin indicates no extracellular sources of 
superoxide were evident, when MDCK cells were treated with COM. Plasma 
membrane NAD(P)H oxidase is recognised as a major source of superoxide 
production in non-inflammatory cells. However, absence of lucigenin 
chemiluminescence signal, without cell permeabilisation, implies that superoxide 
formation resulting from COM exposure originates from intracellular sources. 
Therefore, further studies were performed to identify the intracellular origin of 
superoxide and possible consequences of this pathology.
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CHAPTER 5
Intracellular origins of MDCK cell superoxide production in 
response to exposure to calcium oxalate; mechanisms of free
oxalate transport into mitochondria
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5.1 INTRODUCTION
Generation of calcium oxalate monohydrate crystals results from a series of key 
events occurring in renal epithelial cells. These include supersaturation of tubular 
fluid with respect to calcium oxalate ions, crystal nucleation and crystal adherence to 
the surface of renal epithelial cells. Therefore, there is strong evidence that tubular 
dysfunction results from COM-cell interactions [Grases, F., et al., 1998; Selvam, R., 
& Devaraj, S., 1991].
It is now established that exposure of renal cells to CaOx results in a free radical 
mediated oxidative stress [Muthukumar, A., & Selvam, R., 1998]. This oxidative 
stress results from increased production of reactive oxygen species (ROS). These 
species initiate diverse cellular effects ranging from upregulation of key transcription 
factors, through gene induction, to cell proliferation or necrotic or apoptotic cell death 
[Hensley, K., et al, 2000]. ROS are also formed endogenously in resident non­
inflammatory cells. This may occur via two pathways: (i) either through dysregulation 
of oxidative enzymes, such as xanthine oxidase, cyclooxygenase, lipoxygenase, and 
plasma membrane CytbsssNADH oxidase [Griendling, KK., et al., 1994; Bayraktutan, 
U., et al., 1998], or (ii) due to continuous leakage from the mitochondrial electron 
transport chain [Chance, B., et al., 1979].
In previous chapters it was shown that calcium oxalate is the form of crystals that 
mediate the main oxidative insult in terms of superoxide formation. Previous work in 
this laboratory has showed that the origin of this insult originates mainly from the 
mitochondria [Khand, FD., et al., 2002]. Therefore, the aim of the work presented in 
this chapter focuses initially to confirm the above findings and to correlate them with 
subsequent mitochondria responses upon crystal deposition.
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5.2 Lucigenin-derived chemiluminescence monitors 
mitochondrial 0 2"  production
In order to demonstrate that the lucigenin CL signal is derived primarily from 
mitochondrial O2*", superoxide dismutase (SOD) or Mn(III)tetrakis(l-methyl-4- 
pyridyl) porphyrin (MnTMPyP), a SOD mimetic, were used. In digitonin 
permeabilised COM treated cells, CL was inhibited 27 % by SOD (300 mU/ml) and 
95 % by the cell permeable SOD mimetic MnTMPyP [Figure 5.1]. Exogenous SOD 
in plasma membrane permeabilised cells is unable to access the mitochondrial matrix, 
but may have limited access to the cytoplasmic compartment and to the inner 
membrane space of the mitochondria. Therefore, lucigenin CL signal was monitored 
at high and non-significant levels when compared with that of COM treated cells and 
in the absence of SOD. By contrast, the membrane-permeable SOD mimetic 
MnTMPyP that penetrates the mitochondrial compartment effectively inhibited the 
CL signal. Furthermore, it was observed that superoxide formation in the presence of 
MnTMPyP was lower than that resulting from control cells, confirming MnTMPyP’s 
permeability property, and its ability to inhibit endogenous basal levels of O2*’ 
production. This provides strong evidence that (i) lucigenin CL signal arises due to 
O2*' and, (ii) a membrane enclosed subcellular compartment is responsible for the O2*’ 
production.
152
Chapter 5 -  Results
1400
1200
c
2  1000 
I
g 800
u
O
600 -
c5o>
O 400
200  -
-COM
MnTMPyP
SOD
control
2 3 4 5 6 7 8
min
Figure 5. 1 Lucigenin signal derived from intracellular 02*'. Lucigenin-enhanced 
chemiluminescence counts after permeabilisation of COM treated MDCK cells. SOD 
and MnTMPyP were used at 300 U/ml and 2 pM, respectively and lucigenin- 
enhanced chemiluminescence counts were monitored for 7 minutes at 1 minute 
intervals.
5.3 Mitochondrial origin of 0 2~
As suggested in section 5.2, O2*" formation in this model originates from the 
mitochondria. To further support this finding, a range of mitochondrial and non- 
mitochondrial inhibitors were employed to establish the intra-cellular origin of 
enhanced O2*' formation in renal epithelial cells mediated by COM crystals. Inhibitors 
that targeted known non-mitochondrial O2*' producing enzyme systems failed to 
abrogate lucigenin CL. Nordihydroguaiaretic acid (NDGA) [Figure 5.2], a
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lipoxygenase inhibitor, and indomethacin [Figure 5.4], a potent inhibitor of 
prostaglandin-forming cyclooxygenase showed no effect on COM-enhanced O2*" 
production. Furthermore, hydralazine, and oxypurinol, a NADH oxidase and a 
xanthine oxidase inhibitor respectively showed no inhibition of superoxide production 
upon COM treatment. In contrast, to this nominal effect on CL, employing 
mitochondrial inhibitors resulted in dramatic changes in O2*" formation. Rotenone, a 
complex I inhibitor which blocks the flow of electrons towards complex III, inhibited 
02*’ production [Figure 5.3].
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Figure 5. 2 NDGA effect on lucigenin CL. MDCK cells treated with 250 pg/ml 
COM for 4 h. 250 pM NDGA was added in the respiration buffer prior to superoxide 
assay. Lucigenin-enhanced chemiluminescence counts were taken every 1 minute. 
Data are mean ± SD for n=20; ** p < 0.01 vs untreated MDCK cells (control) without 
NDGA and t  p  < 0.01 vs untreated MDCK cells in the presence of NDGA.
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Figure 5. 3 Effect of rotenone on COM induced lucigenin CL. MDCK cells were 
treated with 250 pg/ml COM for 4 h. Rotenone (20 pM) was added in the respiration 
buffer to untreated and treated cells, and lucigenin-enhanced chemiluminescence 
counts were taken every 1 minute. Data are mean ± SD for n=20; ** p  < 0.01 vs 
control without rotenone and t  P < 0.05 vs COM treated cells with rotenone.
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In addition, of particular interest was the protonophore carbonylcyanide m- 
chlorophenylhydrazone (CCCP), which dissipates the mitochondrial proton gradient 
and therefore, as would be expected severely inhibits the O2*' formation. Furthermore, 
in the presence of succinate (complex II substrate), thenoyl trifluoracetone (TTFA) 
which inhibits succinate dehydrogenase together with 4-hydroxyccinamic acid which 
blocks pyruvate entry from the cytoplasm, prevented COM mediated O2*’ formation. 
Antimycin A, an inhibitor that blocks the respiratory chain at complex III between 
cytochrome b and cytochrome ci did not inhibit lucigenin chemiluminescence signal. 
However, oligomycin, a mitochondrial inhibitor of phosphorylation that blocks ATP 
synthesis (and degradation) by the F0/F 1 ATPase did not inhibit superoxide production 
when cells were treated with COM. Figure 5.4 summarises the cytosolic and 
mitochondrial inhibitors used to confirm the mitochondrial intracellular O2 
production.
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Figure 5. 4 Effect of cytosolic and mitochondrial inhibitors on COM enhanced
CL. MDCK cells were treated with 250 pg/ml COM for 4 h (control). Cytosolic and 
mitochondrial inhibitors were added in the respiration buffer to COM treated cells, 
and lucigenin-enhanced chemiluminescence counts were taken every 1 minute. 
Values are expressed as a percentage of CL counts in respect to control. Data are 
mean ± SD for n=20; ** p < 0.01 and * p < 0.05 vs control.
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Having confirmed the mitochondrial origin of superoxide upon crystal deposition 
combined with the data shown in chapter 4 showing that oxalate is released in the 
presence of EDTA when MDCK cells were treated with COM, further experiments 
were performed to investigate possible mechanisms by which oxalate may be 
transported to mitochondria and initiate oxidative stress in terms of superoxide 
production.
5.4 Mechanisms of oxalate transport to mitochondria
Oxalate ( jj°° ) is a small dicarboxylic ion that is freely filtered at the glomerulus.
C O O ’
Studies have shown when renal epithelial cells are exposed to free oxalate they 
undergo oxidative injury, following free radical formation [Scheid, et al., 1996]. As 
previously shown (Chapter 4) COM crystals attached to the renal epithelial cells, and 
over time were internalised. In this model, when treated cells were permeabilised in 
the presence of EDTA, free oxalate was released in the cells. Interest in this 
dicarboxylic transport arose from data in this study demonstrating that the 
mitochondrial electron transport chain is the most probable origin of free radicals. 
Therefore, the initial question was to identify the mechanism of the oxalate transport 
into the mitochondria, and investigate whether it is associated with free radical 
production that could lead to renal cellular injury.
It has been suggested that oxalate can be transported by the dicarboxylic carrier in 
kidney mitochondria by three mediator systems [Liu, G., et al., 1996]. These include 
electron-neutral transport, the dicarboxylate carrier and the Inner Membrane Anion 
Channel (IMAC). Firstly, electrophoretic transport via IMAC was examined. To 
investigate this, N ,N ’ dicyclohexylcarbodiimide (DCCD), a selective IMAC inhibitor 
was employed and 0 2 was monitored [Figure 5.5].
158
Chapter 5 -  Results
3200
2800
c 2400
£  2000
_i 1600
g 1200
o>
400
COM COM/DCCDcontrol NaOx NaOx/DCCD
Figure 5. 5 Effect of IMAC inhibition by DCCD on lucigenin CL. Lucigenin 
chemiluminescence was performed in MDCK cells treated with COM or NaOx in the 
presence and absence of 50 pM DCCD. Data are mean ± SD for n=20; ** p  < 0.01 vs 
control.
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This data demonstrates that in COM treated cells, DCCD did not have an inhibitory 
effect on superoxide formation. This indicates that free oxalate originating from COM 
crystals was not transported into the mitochondria via IMAC. On the contrary to the 
COM effect, in NaOx treated cells, DCCD inhibited the formation of superoxide.
Further experiments were carried out to investigate other forms of dicarboxylic 
transport. Energised mitochondria generate a high membrane potential that drives the 
electrophoretic influx of K+. In the steady state this flux is compensated by 
electroneutral efflux of K+ by nigericin.
Nigericin, a K+/H+ antiporter was used to investigate whether dicarboxylates were 
transported via this electroneutral mechanism involving the co-transport of protons. 
The figure shown below [Figure 5.6] indicates that nigericin inhibited superoxide 
formation only when cells were treated with NaOx. Therefore, electroneutral anion 
flux may be partially involved in the transport of free oxalate in the mitochondria. 
Hence, the data collected using DCCD and nigericin implies that COM and NaOx act 
differently once they are found in the intracellular matrix milieu.
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Figure 5. 6 Effect of nigericin on lucigenin CL. Chemiluminescence was performed 
in MDCK cells treated with COM or NaOx in the presence and absence of 10 pM 
nigericin. Data are mean ± SD for n=20; ** p  < 0.01 vs control.
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Finally, mitochondrial transport via the dicarboxylate carrier was investigated. This 
carrier mediates electroneutral exchange of dicarboxylates for inorganic phosphate 
(Pi). When phosphate was omitted, the dicarboxylic acid transport was disrupted, 
leading to inhibited formation of O2’" [Figure 5.7]. In order to avoid pH alterations by 
omitting phosphate in the buffer, 5 mM MOPS, 3 mM HEPES or 3 mM Tris-HCl 
were included in the RB.
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Figure 5. 7 Superoxide production in the absence of phosphate. Lucigenin 
chemiluminescence was performed when MDCK cells were treated with COM or 
NaOx and omitting phosphate from the respiration buffer (RB). Phosphate was 
replaced with 5 mM MOPS, 3 mM HEPES, or 3 mM Tris-HCl. Data are mean ± SD 
for n=20; ** p  <0.05 and * p  < 0.01 vs control, t  p  < 0.01 vs COM and NaOx treated 
cells in phosphate containing RB.
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To confirm the above finding, further experiments were performed by employing 
mersalyl which, is commonly used as a specific inhibitor of dicarboxylate-phosphate 
transport. Therefore, by including 150 pM mersalyl in the respiration buffer, there 
was a significant decrease (50 %) in superoxide production evoked by COM 
treatment. The same effect was also observed when MDCK cells treated with NaOx 
(30 % decrease) [Figure 5.8]. Furthermore, this abrogation in superoxide signal 
observed in COM and NaOx treated cells by omission of phosphate, was not observed 
in control cell superoxide formation.
Therefore, this data illustrates that the disruption of the dicarboxylic transport when Pi 
is absent, abrogated COM and NaOx treated cells to produce 02*'. This indicates the 
importance of this transporter for oxalate uptake in the mitochondria of MDCK cells.
Thus, it was shown here that intracellular dissociation of internalised COM, as well as 
mitochondrial oxalate uptake on the dicarboxylate transporter, are important factors in 
enhancing O2*' formation. Subsequent studies were carried out to investigate the 
mitochondria responses mediated by crystal toxicity.
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Figure 5. 8 Superoxide production in the presence and absence of mersalyl.
Lucigenin chemiluminescence was performed when MDCK cells were treated with 
COM or NaOx and using 150 pM mersalyl as a phosphate inhibitor. Data are mean ± 
SD for n=20; ** p  and * p  < 0.01 vs control, + p < 0.01 vs COM and NaOx treated 
cells in mersalyl included conditions.
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mediated by changes in Av|/m. In order to investigate whether COM exposure is 
accompanied by similar changes in Avj/m, a membrane potential-sensitive dye TMRM 
together with confocal microscopy, were employed.
When concentrated, TMRM exhibits auto-quenching, such that the fluorescence 
signal becomes a non-linear function of dye concentration [Dutchen, MR., & Biscoe, 
TJ., 1992; Bunting, JR., et al., 1989]. Mitochondrial depolarisation causes loss of 
mitochondrial dye, and dilution into the cytosol where the signal therefore increases. 
Untreated MDCK cell monolayers contained only weakly polarised mitochondria 
[Figure 5.9]. However, some cells differentiated into tubular zones forming rings, 
containing mitochondria in which the A\j/m was much greater [Figure 5.10]. 
Furthermore, in confluent COM treated MDCK cells, Avj/m was increased dramatically 
[Figure 5.11].
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Figure 5. 9 Fluorescence imaging of mitochondrial membrane potential in 
untreated confluent MDCK cells. Cells were loaded with TMRM (20nM in HEPES- 
buffered salt solution). Illumination intensity was 0.1 % of total laser output and the 
pinhole was set to give an optical slice of ~ 2 pm.
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Figure 5. 10 Fluorescence imaging of mitochondrial membrane potential in 
untreated non-confluent MDCK cells. Cells were loaded with TMRM (20nM in 
HEPES-buffered salt solution). Illumination intensity was 0.1 % of total laser output 
and the pinhole was set to give an optical slice of ~ 2 pm.
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Figure 5. 11 Fluorescence imaging of mitochondrial membrane potential in 
COM-treated MDCK cells. Cells were treated with COM and loaded with 20 nM 
TMRM. Illumination intensity was 0.1 % of total laser output and the pinhole was set 
to give an optical slice of ~ 2 pm.
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Moreover, Figure 5.12 A and B show TMRM fluorescence and light images, 
respectively, which when superimposed [Figure 5.12 C] show a clear association 
between crystal attachment and increased TMRM signal localised to mitochondria. In 
contrast, when crystals did not attach to MDCK cells the mitochondrial fluorescence 
signal was minimal.
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Figure 5. 12 Fluorescence imaging of mitochondrial membrane potential in 
COM-treated MDCK cells. Cells were loaded with TMRM (20 nM in Hepes- 
buffered salt solution). Illumination intensity was 0.1% of total laser output and the 
pinhole was set to give an optical slice of ~ 2 pm. (A) Increased TMRM fluorescence 
and distinct mitochondria in the cells on the left of the field, where COM crystals 
have attached (see transmitted light image, B). In contrast, cells to the upper right of 
the field, where crystals are absent, display much lower TMRM signal. (C) 
Superimposition of the fluorescence and transmitted light images. (D) Increased 
TMRM fluorescence where COM crystals have attached. (E) Transmitted light image 
showing crystal presence. Arrows indicate presence of crystals and the line represents 
10 pm.
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Therefore, significant changes in mitochondrial potential after COM treatment was 
observed when compared to untreated MDCK cells in 4 different cell populations (n = 
4), including 200 cells in each group [Figure 5.13].
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Figure 5. 13 Effects of COM treatment on mitochondrial membrane potential.
Confocal microscopy performed on control and COM treated MDCK cells. Mean ± 
SEM (n ~ 200 individual cells) of TMRM fluorescence over single cells.
An increase in intracellular TMRM fluorescence can either be derived from changes 
in mitochondria A\|/m or from plasma membrane hyperpolarisation [Duchen, MR., et 
al., 2003]. However, accumulation of intracellular dye in response to a hyperpolarized 
plasma membrane results in a more homogenous dye distribution than that caused by 
mitochondrial hyperpolarisation, and hence the ratio of the standard deviation (SD) of 
the fluorescence signal across the whole cell to the mean whole cell signal can be 
used to distinguish between the two phenomena [Duchen, MR., et al., 2003]. In the 
MDCK cells images observed here this SD/mean ratio was significantly increased
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indicating that with COM treatment a mitochondrial hyperpolarisation occurs [Figure 
5.14].
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Figure 5. 14 Effects of COM treatment on mitochondrial membrane potential.
Confocal microscopy performed on control and COM treated MDCK cells. Increased 
SD TMRM signal/mean TMRM ratio of every cell upon COM application.
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Furthermore, a linear increase in A\\im was observed during continuous monitoring by 
a CCD camera when COM crystals were applied by micropipetting, [Figure 5.15]. In 
contrast to this mitochondrial response derived within minutes of crystal attachment, 
untreated cells manifested a steady significant decrease in TMRM fluorescence, 
which may be due to photobleaching [Figure 5.16].
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Figure 5. 15 Changes in A\|/m mediated by COM treatment. Each trace represents 
the TMRM fluorescence over single COM treated cell as recorded by a CCD camera.
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Figure 5. 16 Changes in A\j/m mediated by untreated MDCK cells. Each trace 
represents the TMRM fluorescence over single untreated cell as recorded by a CCD 
camera.
5.6 Ca2+ signalling upon COM binding
Mitochondria are key modulators of intracellular [Ca2+] and it is well established that 
regulation of intracellular [Ca2+] is disrupted in oxidative stress [Jacobson, J., & 
Duchen, MR., 2002]. Consequently, further experiments were performed to examine 
whether Ca2+ signalling is altered due to oxidative stress caused by COM treatment.
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Changes in intracellular Ca in MDCK cells exposed to COM were investigated by 
employing the Ca2-sensitive dye Fura-2 AM and the ratio of fluorescence excited at 
340 nm and emission at 380 nm was measured. When COM was applied to MDCK 
cells, Ca pulse signals were rapidly induced after 2-3 min [Figure 5.17].
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Figure 5. 17 Changes in [Ca2+] transients mediated by COM treatment. Each 
trace represents the ratios of excitation of Fura-2 at 340 and 380 nm over single COM 
treated cell.
These Ca oscillations derived from COM treatment were cyclical, and were 
observed rising and falling over individual cells for up to 45 min after the addition of 
the COM. Untreated MDCK cells, however, did not respond to any rise in signal of 
Fura-2 ratio signal [Figure 5.18].
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Figure 5. 18 Changes in [Ca2+] transients observed in untreated MDCK cells.
Each trace represents the ratios of excitation of Fura-2 at 340 and 380 nm over single 
untreated cell.
Moreover, it should be noted here that the above measurements were made in HEPES 
buffer containing calcium without EDTA, thus dissociation of calcium and oxalate 
from the COM treatment would not occur. This indicates that crystal mediated 
changes of mitochondrial membrane potential and [Ca2+] rises could contribute to 
formation of superoxide. In addition, these are dependent on COM crystal adherence.
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5.7 DISSCUSSION
It is now well established that cell injury is central to the process of urolithiasis 
[Wiessner, JH., et al., 2001]. An injury to the epithelial cells results in membrane 
damage and shedding, which play a critical role in crystal formation as well as crystal 
retention. Oxidative stress is a recognised source of cell injury and results from 
increased production of ROS. Although there is evidence that free oxalate ions can 
mediate oxidative insult, the origin of the ROS in oxalate crystal interactions with 
renal epithelial cells, is still unknown. This study was conducted to examine and 
confirm the findings that ROS mainly originates from the mitochondrial 
compartment.
In order to demonstrate that in this model the lucigenin chemiluminescence signal is 
derived from the mitochondria, superoxide dismutase (SOD), and MnTMPyP, a small 
molecular weight cell permeable SOD mimetic were used. Data presented here, 
showed that the lucigenin chemiluminescence signal was reduced greatly by the 
membrane permeable SOD mimetic, whereas SOD resulted in a non-significant 
decrease of the chemiluminescence signal. This non-inhibitory effect of SOD is due to 
its ability to penetrate only the porated plasma but not the intact mitochondrial
' s
membrane. Thus, this confirms that the cytosol is not the primary site of superoxide 
formation in this model. In contrast to SOD, MnTMPyP can penetrate the 
mitochondrial membrane and therefore dismutate the superoxide formed in the 
mitochondria. In addition, incubation of COM treated MDCK cells with MnTMPyP 
resulted in less superoxide detection than those observed in untreated (control) 
MDCK cells, implying that MnTMPyP was able to inhibit superoxide derived from
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mitochondria under control conditions. Thus, it is now evident that lucigenin- 
chemiluminescence signal arises due to mitochondrial superoxide.
To further support this finding, selective mitochondrial and cytosolic inhibitors were 
employed. Results presented here, show that by using cytosolic inhibitors, such as 
indomethacin, hydrazaline, NDGA, DPI, and oxypurinol, this resulted in increased 
superoxide formation. This indicates that the lucigenin chemiluminescence signal, 
derived from COM exposure on MDCK cells, was not due to cytosolic sources of 
superoxide. On the contrary, employment of mitochondrial inhibitors diminished the 
chemiluminescence signal, indicating the mitochondrial source of superoxide. It is 
now established that, in non-inflammatory cells, electron leakage at NADH- 
ubiquinone reductase (complex I), and ubiquinone-cytochrome c reductase (complex 
III) during electron transport contribute to superoxide generation [Turrens, JF., et al., 
1985; Liu, SS., 1997]. Therefore, when rotenone, a complex I inhibitor, was 
employed, superoxide production was decreased. In addition, pyruvate diminished 
chemiluminescence signal by decreasing NADH, and when COM treated MDCK 
cells were incubated with 4-OHCA that inhibits pyruvate transport into mitochondria, 
the levels of superoxide formation were further decreased. Furthermore, to investigate 
whether COM activated superoxide, CCCP, a mitochondrial uncoupler, was used and 
resulted in abrogated chemiluminescence signal. This indicates a coupled electron 
transport chain is a requirement for the superoxide production. Similar results were 
also obtained when TFA, a succinate dehydrogenase inhibitor was used. When 
oligomycin was employed in the same study, superoxide formation was increased. 
Oligomycin inhibits ATP synthesis and therefore backs-up electron flow from 
complex III. In addition, when antimycin A was employed levels of superoxide 
production were still increased. Antimycin A is a complex III inhibitor, blocks
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electron transport from cytochrome b to ubiquinone which is behind the site of 
superoxide formation in complex III. The presence of antimycin A therefore would 
cause the electrons to build up, leading to increased superoxide production. This data 
presented here combined with a previous report by Khand, FD., et al., 2002, confirms 
and establishes the mitochondrial origin of superoxide under COM exposure on 
MDCK cells.
In addition, it has been shown in Chapter 4 that COM crystals once internalised into 
the cells undergo dissociation to free calcium and free oxalate. This part of the study 
also examined the fate of oxalate once it dissociates from COM and transported into 
the mitochondria. Further evidence that free oxalate is transported into mitochondria 
and initiate superoxide formation was provided by the studies with different 
dicarboxylate transport inhibitors. DCCD, an IMAC inhibitor, and nigericin, a K+/H+ 
antiporter inhibitor, both were able to inhibit oxalate transport into mitochondria 
resulting in no effect on superoxide production mediated by COM. However, both of 
these inhibitors showed to decrease the levels of superoxide production when MDCK 
cells were treated with NaOx. However, when these studies were repeated in the same 
laboratory these findings were not reproducible with DCCD and nigericin showing no 
distinguishable effect on superoxide formation when MDCK cells were treated with 
either COM or NaOx. Omitting phosphate from the medium or using mersalyl to 
inhibit the mitochondrial phosphate-dependent dicarboxylate transporter caused a 
significant decrease in the superoxide production evoked by COM or NaOx treatment. 
Mechanisms for the transport of dicarboxylic acids into mitochondria isolated from a 
wide range of tissues have been demonstrated [Kamiski, LP., 1998; Kakhniashvilli, 
D., et al, 1997; LaNoue, KF., & Schoolwerth, AC., 1979]. In mammalian 
mitochondria, dicarboxylate transport is mediated by a phosphate-dicarboxylate
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exchange [Robinson, BH., & Williams, GR., 1970]. Further evidence for the 
importance of phosphate-dicarboxylate exchange resulting from the mersalyl 
experiments, may arise from the sensitivity of dicarboxylate accumulation to 
uncouplers (CCCP). This type of inhibitor can directly affect internal phosphate 
uptake, and thus lower the amount of internal phosphate available for exchange with 
external dicarboxylates such as oxalate.
It has been suggested earlier in this chapter and in other reports from this laboratory 
[Khand, FD., et al., 2002] that mitochondria are a significant source of the superoxide 
that is produced in renal cells following exposure to oxalate or to COM crystals. Since 
perturbations in mitochondrial function, in particular a loss of mitochondrial 
membrane potential (Ai|/m,) are a common occurrence in cell death [Lemaster, JJ., et 
al, 1999; Kim, JS., et al, 2003], further experimental work was performed to 
investigate whether COM treatment of renal epithelial cells could trigger a change in 
Avym. A recent study by Cao et al, 2004, has shown that when MDCK cells were 
exposed to oxalate there was a reproducible decrease in A\j/m. This was assessed by 
shifts in JC-1 (l,l',3,3'-tetraethylbenzimidazolylcarbocyanine iodide) fluorescence 
ratios, suggesting that mitochondria are targets for oxalate-induced toxicity [Cao, LC., 
et al, 2004]. JC-1 is a green fluorescent probe which exists as a monomer at low 
membrane potentials and forms aggregates at higher potentials. Even though JC-1 has 
been widely used to estimate qualitative changes in Ai|Jm it has been noted [Reers, M., 
et al, 200] that the equilibrium between monomers, dimmers and polymers may not 
be solely influenced by changes in Atpm, since JC-1 is pH-sensitive and its absorption 
spectrum may be affected by the osmolarity of its environment or by the presence of a 
dissociated acid. This disadvantage of JC-1 may result in underestimation of the 
actual changes in Av|/m. Furthermore, in the same study the authors did not account
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for any crystals that might have been formed due to the calcium, oxalate and 
hydrogen ion concentrations in the media. Microcrystals may well have formed and 
potentially influence cellular processes [Cao, LC., et al., 2004]. It has been shown 
here for the first time an increase caused by COM crystals on renal mitochondrial 
polarisation. By employing TMRM, a specific intramitochondrial dye, it was shown 
that COM causes a marked change in the A\|/m of cells onto which COM has been 
attached. It has been known that A\j/m is a component of the overall proton force that 
drives the ATP generation in mitochondria [Polyak, K., et al., 1997]. Therefore, this 
increase in proton gradient is a significant finding as it is known to result in increased 
electron leakage from the electron transport chain especially during State 4 respiration 
[Jacobson, J., & Duchen, MR., 2002]. The reasons for this increase in AvjJm are 
currently unknown but any inhibition of steps downstream of complex III are 
potential candidates. In addition, this increase in A\\tm could be due to disruption of 
mitochondrial functions on the inner membrane, including the reduction of 
mitochondrial electron transport flow rate and the instability of FoFl-ATPase to 
effectively pump protons to the mitochondrial matrix [Gottlob, K., et a l, 2001]. An 
alternative mechanism that could cause the increase in Av|/m could be due to a defect 
in adenine nucleotide translocator (ANT) on the inner mitochondria membrane or in 
the voltage-dependent anion channel (VDAC) on the mitochondrial outer membrane 
[Vender Heinden, MG., et al., 2000]. A defect in the properties of ANT or VDAC 
permeabilities may result in the disruption of mitochondrial ATP/ADP exchange with 
the cytosol [Vender Heinden, MG., et al., 2000]. The inhibition of cytochrome c 
oxidase by oxalate [Muthukumar, A., & Selvam, R., 1998] may account for the 
increased electron leakage at ubiquinone oxidoreductase in the inner mitochondrial 
membrane.
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• • 2 +Mitochondrial ROS have previously been shown to induce perturbations m Ca 
signalling [Jacobson, J., & Duchen, MR., 2002]. ROS and mitochondrial Ca2+ 
overload in combination can induce cell death by both apoptotic and necrotic routes.
• 94-As ROS derived from mitochondria have been shown to induce Ca release from 
intracellular stores, possibly by thiol group modulation [Richter, C., et al., 1995],
• • 2 *b  • •experiments to investigate whether COM treatment induced cytosolic Ca signalling 
were carried out. Calcium movements of intracellular origin were apparent in cells 
pre-treated with COM for 4 h and within minutes of applying COM. It should be 
noted that these measurements were made in HEPES-buffered salts containing 
calcium without EDTA, and therefore dissociation to oxalate would have not 
occurred. The absence of EDTA and digitonin in this series of experiments is of great 
importance, since these conditions mimic physiological ones encountered in human 
renal tubular cells. In addition, absence of EDTA supports the findings that 
depolarised mitochondria and changes in Ca2+ transients are phenomena observed 
upon crystal exposure. In contrast, work from this laboratory (data not shown) 
demonstrated that addition of NaOx (750 pM) induced much smaller [Ca ]c signals 
in a subpopulation of the cells, which were cyclical in some cells but more sustained 
in others. Furthermore, as the signals were still apparent in the presence of the 
mitochondrial protonophore FCCP, in which ROS production ceases [Scheid C et al, 
1996], the increased production of superoxide is not the cause of large amplitude
9 1
[Ca ]c oscillations. However, it is known that FCCP results in a rapid rise in
9-4-cytosolic Ca originating from the decrease in the proton gradient [Friel, DD., &
9 1
Tsien, RW., 1994], which could block any potential diminution of the [Ca ]c signals 
resulting from lowered superoxide release. Mitochondria seem to play a role in 
modulating the COM-induced Ca2+ fluctuations, as the [Ca2+]c rises were more
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• • 9+ • •sustained in the FCCP-treated cells, with fewer repetitive Ca oscillations. Previous 
work [Rizzuto, R., et al., 1998] suggested a privilege access of ER Ca2+ to 
mitochondria. More recent data [Jacobson, J., & Dunchen, MR., 2002] has also shown
 ^ I
that oxidative stress increases the probability of Ca release from ER. These authors
• • • 2 “b  *showed that the very close proximity of ER and mitochondria means that Ca is 
accumulated by nearby mitochondria and further sensitises the mitochondria to ROS. 
Therefore, to investigate whether this also applies in the current study, additional 
experiments were performed. Specifically, to investigate whether the changes in 
[Ca2+]c were due to Ca2+ influx from the plasma membrane or were a result of 
intracellular signalling events resulting in Ca2+ release from intracellular Ca2+ stores, 
cells were treated with sarcoplasmic/endoplasmic reticulum calcium ATPase inhibitor
2 “F  •thapsigagrin. Thapsigargin induces emptying of intracellular Ca stores by blocking 
reuptake of cytosolic Ca2+. Thapsigargin completely prevented COM-induced Ca2+ 
fluctuations in MDCK cells and produced a profile identical to that of control cells 
(data not shown). This confirms that the [Ca2+]c signals derived from intracellular 
stores rather than through extracellular influx or Ca2+ derived directly from the COM 
crystal itself. Dissipation of the mitochondrial proton gradient with FCCP had no 
effect in the amplitude of these transients. However, their rises were sustained for 
longer periods, indicating that polarised mitochondria are not necessary for the release 
of stored Ca2+ (data not shown). This observation together with the fact that the fura-2 
ratio was initially higher over the FCCP treated cells, implies that MDCK
9+mitochondria take up cytosolic Ca , modulating the cell signalling cascade induced 
by COM crystal adherence.
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CHAPTER 6
Oxalate -  mediated stress from renal epithelial cells of
different origin and morphology
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6.1 Introduction
The most widely used cell type to conduct experiments to identify the pathology of 
the kidney stone disease is the Madin Darby Canine Kidney (MDCK) cells. This cell 
line forms tight junctions, has the morphological properties of distal tubular epithelial 
cells and lacks several proximal tubular enzyme markers [Rindler, MG., et al., 1979]. 
When the cells are cultured on filter membranes, the MDCK cells obtain a 
morphology that resembles more the in vivo situation, and form confluent 
monolayers, composed of morphologically and functionally polarised cells, with 
apical and basolateral domains [Barker, G., & Simmons, NL., 1981]. Therefore, this 
cell line has been used frequently for studies of cellular processes in epithelial cells, 
and is so far the best characterised epithelial cell line [Simons, K., & Fuller, SD., 
1985].
In addition to MDCK cells, Lewis Lung Carcinoma Pig Kidney cells (LLCPK-1), a 
cell line of renal proximal tubule epithelial cells, is also widely employed to study cell 
injury when exposed to free oxalate or CaOx crystals. It is thus important to 
determine the differences in oxidative stress response by epithelial cells lining along 
various sections of nephron.
The aim of the study presented in this chapter is to demonstrate whether the observed 
superoxide production is influenced by cell culture on solid plastic culture dishes or 
on polycarbonate membranes. In addition, this study was conducted to show whether 
COM and free oxalate treatment on MDCK and human renal epithelial (HK2) cells 
result in the same degree of oxidative stress in terms of superoxide production.
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6.2 Oxalate toxicity in MDCK and HK2 cells
Previous work in this laboratory [Khand, FD., et al., 2002], has shown that 250 pg/ml 
of COM and 1.5 mM of NaOx treatment on MDCK cells cultured on 35 mm dishes, 
responded to a three-fold increase of superoxide production when compared to 
untreated cells. To investigate and compare the effect of COM and NaOx treatment 
between MDCK and HK2 cells, lucigenin-dependent chemiluminescence was used to 
monitor superoxide production. Specifically, HK2 and MDCK cells were cultured in 
35 mm dishes and were pre-incubated with 250 pg/ml COM or 1.5 mM NaOx for 4 h 
or 15 min, respectively. As indicated in Figure 6.1, superoxide production was 
significantly increased in COM or NaOx pre-treated HK2 cells. It was also observed 
that in these human kidney proximal originating cells, free oxalate resulted in a 
higher, however not significant, production of superoxide than that monitored with 
COM crystals. Higher levels of superoxide formation were also observed in NaOx 
treated HK2 cells when compared with NaOx treated MDCK cells.
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Figure 6. 1 Superoxide production after COM or NaOx pre-treatment of MDCK 
and HK2 cells cultured on 35mm dishes. Percentage of lucigenin chemiluminesence 
counts after MDCK and HK2 cells were treated with 250 pg/ml COM or 1.5 mM 
NaOx for 4 h and 15 min respectively. Data are mean ± SD for n=5. *p<0.05 and 
fp<0.05 compared with corresponding values for untreated MDCK and HK2 cells, 
respectively.
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In addition, as shown in Figure 6.1, when both MDCK and HK2 cells were treated 
with COM this resulted in similar levels of superoxide production. This indicates that 
both cell lines, despite their different origins, resulted in the same response of 
oxidative damage in terms of levels of superoxide formation detected by lucigenin- 
dependent chemiluminescence.
6.3 Oxalate toxicity in polarised cells
Further experiments were performed to investigate the effect that COM crystals and 
NaOx have on MDCK and HK2 cells, when these are cultured on porous membrane 
supports to provide conditions of polarisation. MDCK and HK2 cells were cultured 
on polycarbonate membrane supports and treated with normal media on the 
basolateral side and with COM or NaOx at the luminal side. As it can be seen in 
Figure 6.2, growing MDCK cells on membrane supports did not interfere with the 
oxidative stress caused by COM crystals or free oxalate. HK2 cells grown on 
membrane supports responded in similar levels of superoxide formation when 
exposed to COM crystals, however when treated with free oxalate, superoxide levels 
were not significantly different compared to the untreated cells.
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Figure 6. 2 Superoxide production after COM or NaOx pre-treatment of MDCK 
and HK2 cells cultured on a polycarbonate membrane. MDCK and HK2 cells 
were cultured on a polycarbonate membrane support and were pre-incubated with 
COM or NaOx for 4 h or 15 min respectively. Data are mean ± SD for n=5 *p<0.05 
and tp<0.05 compared with corresponding values for untreated MDCK and HK2 
cells respectively.
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In addition, a comparison was made [Figure 6.3] between MDCK cells cultured on a 
plastic surface or on a polycarbonate membrane support. There was no apparent 
difference in the levels of superoxide formation between polarised and non-polarised 
MDCK cells. It was therefore concluded that cell polarisation did not affect the 
process by which oxalate mediated the mitochondrial superoxide production.
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Figure 6. 3 Superoxide production after COM or NaOx pre-treatment of MDCK 
cells cultured on a 35 mm dish or on a polycarbonate membrane. MDCK cells 
were cultured on a 35 mm dish or on a polycarbonate membrane support and were 
pre-incubated with 250 p-g/ml COM or 1.5 mM NaOx for 4 h or 15 min, respectively. 
Data are mean ± SD for n=5 *p<0.05 and tp<0.05 compared with corresponding 
values for untreated MDCK cells.
190
Chapter 6 -  Results
The same comparison was performed for HK2 cells. The results [Figure 6.4] 
demonstrated that oxidative stress manifest by elevated levels of superoxide, was 
diminished when HK2 cells were cultured on a porous membrane surface and exposed 
with free oxalate. This indicates that changes of HK2 cell polarity may result in 
altered oxalate transport mechanism into the cells and subsequently into the 
mitochondria.
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Figure 6. 4 Superoxide production after COM or NaOx pre-treatment of HK2 
cells cultured on a 35mm dish or on a polycarbonate membrane. HK2 cells were 
cultured on a 35 mm dish or on a polycarbonate membrane support and were pre­
incubated with 250 pg/ml COM or 1.5 mM NaOx for 4 h or 15 min, respectively. 
Data are mean ± SD for n=5. *p<0.05 compared with corresponding values for 
untreated HK2 cells and tp<0.05 compared with oxalate treated cells in 35 mm dish.
1.5 mM NaOx250 Mg/ml COM
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6.4 DISCUSSION
During the past 100 years, stone formation in the urinary tract has become an 
increasing problem in most countries of the world [Coe, FL., et al., 2005]. Calcium 
oxalate monohydrate crystals are the commonest component of kidney stones and 
their presence in renal cells are known to contribute to the pathology of the disease. 
The use of renal epithelial cells in tissue culture is an accepted powerful tool used to 
study physiological and biological cell functions. A number of cell lines with distinct 
nephron segmental characteristics have been used in the past to study the pathology of 
kidney stones. For example, LLC-PK1 cells of proximal tubular origin have been used 
to study oxalate transport mechanisms [Koul, H., et al, 1994; Verkoelen, CF., et al.,
1993]. In addition, MDCK cells derived from a normal adult male cocker spaniel 
kidney have been widely used as a model for the distal collecting duct [Gausch, CR., 
et al., 1966]. Crystal-cell interactions have also been studied in primary cultures of rat 
renal inner medullary collecting duct cells (IMCD) [Mandel, N., 1995; Riese, RJ., et 
al., 1988]. It is therefore important, when selecting the model culture system, to 
mimic as closely as possible, both morphologically and functionally, the cell 
phenotype found in vivo.
Previous studies from this laboratory on two cell types of different origin had been 
employed to investigate the effect of crystal-cell interaction in terms of oxidative 
stress [Khand, FD., et al., 2002]. These authors showed that when MDCK and LLC- 
PK1 cells were treated with 250 pg/ml COM or 1.5 mM NaOx, a three-fold increase 
of superoxide formation was observed. Increased levels of superoxide indicate that at 
this concentration of COM or NaOx, renal cells even of different origin, could 
undergo oxidative stress mediated cellular injury. Thamilselvan et al., [1999] have
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reported cellular injury by demonstrating increased levels of LDH release when both 
LLC-PK1 and MDCK cells were exposed to COM and NaOx. Furthermore, they have 
shown that treatment of COM and NaOx together resulted in a more pronounced LDH 
release from LLC-PK1 cells than that of MDCK cells. Data from this laboratory 
[Khand, FD., et al, 2002], have also demonstrated that at the lowest and patho­
physiological relevant levels of COM (25 pg/ml COM), LLC-PK1 cells loose their 
sensitivity in terms of oxidative stress and superoxide levels are monitored at basal 
levels. This indicates that cells of proximal tubule origin are less susceptible to COM 
initiated oxidative stress at low crystal deposition, implying that in the proximal 
tubule region of the kidney, patho-physiological levels of calcium oxalate crystals are 
unlikely to cause damage.
Both of the cell model systems employed in these studies originate from animal cell 
lines. In order to confirm the above findings and validate the model system used to 
study oxidative stress in cultured renal epithelial cells mediated by crystal-cell 
interaction, it is important to examine if a cell line originating from human epithelial 
(HK2) cells, elicits the same response. Data shown in this chapter, demonstrated that 
when HK2 and MDCK cells were treated with 250 pg/ml COM or 1.5 mM NaOx, a 
response with similar significantly increased superoxide levels when compared to 
untreated cells was observed. In addition, there was no significant difference in 
oxalate mediated oxidative stress in terms of superoxide production, between COM 
treated MDCK and HK2 cells. Therefore, the MDCK cell line can be considered as a 
valid system of study since it performs comparably to that of a human cell phenotype. 
Furthermore, the distal tubule is the most likely location within the nephron for COM 
crystal exposure to arise. Supersaturation of tubular fluid with respect to calcium 
oxalate, at the end of the descending limb of the Loop of Henle indicates that calcium
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oxalate may nucleate in this region [Asplin, JR., et al., 1996; Kok, DJ., & Khan, SR.,
1994].
The experimental studies carried out in this work, have been performed in cell culture 
on 35 mm plastic culture dishes. It has been shown that cells cultured on a permeable 
substrate obtain higher levels of differentiation than cells cultured on solid plastic 
dishes [Handler, JS., 1989]. This cell polarisation has been shown to lead to alteration 
of binding properties of crystals [Verkoelen, CF., et al., 1997]. In order to examine 
whether different culture conditions may lead to different experimental behaviour, 
both MDCK and HK2 cells were cultured on polycarbonate membrane supports. 
Treatments were performed in an identical way as mentioned above and superoxide 
formation was monitored. Results shown here, demonstrated a two-fold increase of 
superoxide production when COM treated cells were grown on membrane supports 
compared to untreated cells. In addition, there was no significant difference when 
superoxide levels were compared between COM treated cells cultured on 35 mm 
dishes and COM treated cells grown on membrane supports. This indicates that in this 
study, binding of crystals did not depend on the polarity of the surface on which 
crystals attach. This finding contrasts with that reported by Verkoelen, CF., et al., 
[1997], were they showed that the ability of crystals to adhere to the cells, varied 
according to culture protocols used. This difference in observations may be due to 
different cell density and culture duration. In particular, in the work of Verkoelen 
[1997] cells were seeded at 1 x 106 density and cultured from 0-10 days and this 
author showed that after 4 days in culture, crystal binding was different between cell 
growth conditions. In this study, cells were seeded at twice the cell density and were 
cultured for only two days prior to treatment. At this time-point where MDCK cells 
were grown to form confluent monolayers, Verkoelen et al., [1997] had also reported
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the same crystal binding ability on different growth substrates. However, in the same 
study these authors suggested that when MDCK cells continued to proliferate and 
form multilayers, crystal binding was decreased. This crystal adherence property 
exhibited by intact monolayers did not differ between cells cultured on permeable or 
impermeable growth substrates. This indicates that surface differences on which cells 
were grown did not contribute to COM-cell interactions. This includes changes to 
intercellular junctions as well as polarisation associated with dome cell-formation 
[Rothen-Rutishauser, et al, 1998]. Therefore, the present study demonstrated that 
these changes in cellular differentiation had no quantitative or qualitative effects on 
COM -  mediated superoxide production.
From the above findings it was concluded that MDCK, LLC-PK1 and HK2 cell lines 
provide a suitable model system to study cellular processes involved in renal stone 
pathology. In addition, having shown how a cell line of human origin responds in the 
tissue culture environment, it is important to examine how this is related to the in vivo 
studies.
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CHAPTER 7
Changes in mitochondrial glutathione and energy 
homeostasis in a rat model of calcium oxalate urolithiasis
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7.1 INTRODUCTION
Kidney stone formation is a complex process and involves a cascade of events, 
including crystal nucleation, growth and aggregation, retention within the renal 
tubules, and migration to the renal papillary surfaces [Khan, SR., 1995]. 
Hyperoxaluria is a major risk factor of human idiopathic calcium oxalate disease and 
leads to increased calcium oxalate supersaturation and calcium oxalate stone 
formation [Asplin, JR., 2002]. In addition, hyperoxaluria can provoke calcium oxalate 
nephrolithiasis in both humans and rats. Oxalate metabolism is considered to be 
almost identical between rats and humans. Thus, there are many similarities between 
experimental nephrolithiasis induced in rats and human kidney stone formation. A rat 
model of calcium oxalate nephrolithiasis has been used to investigate the mechanisms 
involved in human CaOx kidney stone formation.
Previous reports have shown that CaOx kidney stones in rats can be produced by the 
induction of acute or chronic hyperoxaluria using a variety of agents such as sodium 
oxalate, ethylene glycol (EG), and glycolic acid [Khan, SR., 1991; Khan, SR., & 
Hacket, RL., 1987]. Furthermore, other studies have shown that hyperoxaluria 
together with hypercalciuria can also contribute to the pathogenesis of kidney stones 
[Halabe, A., 2003; de Water, R., et al., 1996]. Specifically, administering rats with 
vitamin D3 which plays an important role in calcium homeostasis, can induce 
hypercalciuria. Hence, in a chronic rat model based on EG and vitamin D3 diet, 
crystal deposition was observed.
As it has been shown in a previous chapter (Chapter 3), using MDCK cells exposed to 
COM as a model, an increased oxidative stress in terms of superoxide production was 
observed. In addition, it has been shown that increased levels of superoxide in
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response to injury, originates from the mitochondria, which consequently results in 
depletion of mitochondrial glutathione.
According to the above findings, the aim of the current study was to examine whether 
oxidative stress, which occurs as a result of the interaction between calcium oxalate 
crystals and tubular epithelial cells in culture, also occurs in an animal model of 
hyperoxaluria and hypercalciuria.
7.2 Urinary oxalate and calcium concentrations
Early urine crystal formation was checked by light microscopy. Freshly passed urine 
collected 24 h after the start of EG feeding was clear of crystals and throughout the 
study urine remained either free of crystals or exhibited only slight crystal presence. 
Three hours after administration of DHC in EG-fed animals, crystal formation was 
observed (data not shown), whereas in animals treated only with DHC, crystal 
formation was either not detected or slight crystal nucleation was observed. This 
situation maintained throughout the 3 weeks of treatment.
The concentration of urinary free oxalate [Table 7.1] was also measured by 
conductivity after ion chromatography, ionised calcium concentrations, and urine pH 
as shown in Table 7.2, and Table 7.3. The crystalluria group (EG + DHC) had 
significantly lower oxalate levels than the EG alone group. This is a result of a 
proportion of the free oxalate being excreted as crystals, which are removed from the 
urine before analysis.
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Table 7. 1 Urinary oxalate (mM) in hyperoxaluric, calciuric and crystalluric 
animals. Values are means ± SD. EG, ethylene glycol; DHC, 1,25 -  
dihydroxycholecalciferol.
Weekl Week2 Week3 
Control 0.91±0.11 1.12±0.16 140±23
EG 6.3±0.75 7.03±0.66 158±19
DHC 1.1±0.19 0.89±0.14 411±56
EG+DHC 4.2±0.60 4.6±0.78 345±60
Table 7. 2 Urinary ionised Calcium (pM) in hyperoxaluric, calciuric and 
crystalluric animals. Values are means ± SD. EG, ethylene glycol; DHC, 1,25 -  
dihydroxycholecalciferol.
Weekl Week2 Week3
Control 185±31 156±29 0.95±0.12
EG 144±19 165±23 7.11±0.86
DHC 475±32 466±55 1.25±1.9
EG + DHC 401±58 396±61 4.71±0.54
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Table 7. 3 Urinary pH in hyperoxaluric, calciuric and crystalluric animals.
Values are means ± SD. EG, ethylene glycol; DHC, 1,25 - dihydroxycholecalciferol
Weekl Week2 Week3
Control 7.1±0.4 7.4±0.5 6.9±0.4
EG 7.6±0.5 8.2±0.5 8.4±0.6
DHC 6.4±0.4 6.9±0.6 6.8±0.6
EG + DHC 7.3±0.3 7.2±0.3 7.8±0.6
7.3 Kidney hypertrophy in nephroiithic rats
As shown in biodata [Table 7.4], animal body weight did not differ between 
experimental groups and throughout treatment. On the contrary, kidney hypertrophy 
was observed by the end of the treatment course [Figure 7.1] in the crystalluric (EG + 
DHC) experimental group. Kidney weight was significantly increased by the end of 
week 1 in hyperoxaluric (EG), hypercalciuric (DHC), and crystalluric groups when 
compared with the untreated group (control) [Figure 7.2]. In the following weeks 2 
and 3 this increase was only observed in the EG + DHC group whereas in EG and 
DHC groups, kidney weight maintained at the control levels. Fluid intake was also 
significantly increased in the EG + DHC group but not with the EG or DHC treatment 
alone [Table 7.4].
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Table 7. 4 Changes observed in animal weight (g), kidney weight (g), and water 
intake per ml per rat per day, throughout the 3 week course treatment.
Control EG EG+DHC DHC
week 1 Rat weight
(g)
262 ± 9.07 250 ± 14.98 227 ±23.67 253 ±5.29
Kidney 
weight (g)
0.66± 0.03 1.00± 0.12 1.43 ±0.01 0.87 ±0.09
week 2 Rat weight 
(g)
293 ± 4.73 299 ± 15.87 221 ± 17.52 281 ±9.07
Kidney 
weight (g)
0.86 ±0.13 1.00 ± 0.13 1.70 ±0.1 0.97 ± 0.07
week 3 Rat weight 
<g)
264 ±60.81 301 ± 4 257 ± 11.02 296 ±3.4
Kidney 
weight (g)
1.03 ±0.04 1.04 ±0.07 1.71 ±0.04 0.95 ±0.11
Water 
intake (over 
3 weeks) 
(ml/rat/day)
32.8 ± 8 40 ± 9 56 ± 13 39 ± 7
Control
I
Figure 7. 1 Kidney hypertrophy in the crystalluric group. Photographic images of 
the kidneys from control, ethyl glycol fed (EG), ethyl glycol + DHC (EG ± DHC), 
and 1, 25-dihydroxycholecalciferol (DHC) groups excised at the end of experimental 
week 3.
EG+ DHC DHC
t
201
Chapter 7 -  Results
□  W eek 1
□  W eek 2 
■  W eek 3
control EG EG+DHC DHC
Figure 7. 2 Changes in kidney weight during the 3 weeks treatment. Kidneys from 
control, ethyl glycol fed (EG), ethyl glycol + DHC (EG + DHC), and DHC groups, 
excised at the end of experimental weeks 1, 2, and 3 and their weight (g) was 
determined. Mean ± SD for n=3; * p  < 0.05 vs untreated animals (control) at week 1, 
t  p  < 0.05 vs control at week 2, and J p  < 0.05 vs control at week 3.
To investigate kidney hypertrophy formation, protein concentration in kidney 
homogenates was measured. As shown in Figure 7.3, protein concentration in the 
kidney did not change between the experimental groups and throughout the 3 week 
treatment course. Therefore, total kidney protein does not account for kidney 
hypertrophy. On the contrary, fluid intake was significantly increased by 70 % in the 
EG + DHC treated rats but not in the groups treated with EG and DHC alone. 
Therefore, increase in weight of the nephrolithic (EG + DHC) kidney may be due to 
water retention [Table 7.4]. This is in line with reports showing that hypercalciuria is 
known to lead to tubular fluid retention [Lieske, JC., & Toback, FG., 2000].
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Figure 7. 3 Total kidney protein in hyperoxaluric, calciuric and crystalluric 
animals. Kidneys from control, ethyl glycol fed (EG), ethyl glycol + DHC (EG + 
DHC), and DHC groups, homogenised and protein concentration (mg / ml) was 
determined using the BCA protein assay. Mean ± SD for n=3.
7.4 Kidney m orphology and pathology
To examine renal histopathology, H & E stained sections of kidney were examined by 
polarisation and light microscopy (all data are summarised in Table 7.5). Histological 
examination revealed that kidney tubules from EG + DHC treated animals after week 
1 treatment, were distended when compared with the compact and higher density of 
distal tubules from untreated animals [Figure 7.4 A]. In addition, crystal formation 
was observed in the lumen and within tubular cells even after week 1 in EG + DHC 
treatment [Figure 7.4 B]. Renal crystal formation was increased at 2 weeks after EG + 
DHC as was the tubular distension. Interstitial inflammation with focal infiltrates of
□  Week 2 
■  Week 3
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inflammatory cells consisting largely of polymorphic granulocytes and lymphocytes 
was also observed after 2 weeks EG + DHC treatment [Figure 7.4 C and Figure 7.4 
D]. These changes were even more prominent by week 3 of treatment with the kidney 
containing larger crystals and widely distended tubules. Furthermore, loss of renal 
epithelial cells was observed by the end of week 3 EG + DHC treatment [Figure 7.5 A 
and Figure 7.5. B]. Histology of kidney tissue of the EG or DHC treated animals 
showed an absence of crystals and no morphological differences when compared with 
controls [Figure 7.5 C and Figure 7.5 D].
Table 7.5 Renal crystal occurrence in hyperoxaluric, calciuric and crystalluric 
animals. —,Absent; +, small and infrequent crystals; + +, medium-sized and 
moderate crystal occurrence; + + +, large and frequent crystal occurrence
Control 0.5% EG DHC EG + DHC
Week 1 — — +  +
Week 2 + + +  +  +
Week 3 + + +  +  +
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Figure 7. 4 Haematoxylin staining of kidney tissue from hyperoxaluric, calciuric, 
and crystalluric animals. (A) Histological examination of control kidney with 
compact distal tubules (B) kidney sections of EG + DHC treated group at week 1 with 
white arrows showing crystal deposition and black arrows distended distal tubules (C) 
kidney sections of EG + DHC treated group at week 2 with white arrows showing 
increased crystal formation and black arrows pronounced tubular distension (D) 
kidney sections of EG + DHC treated group at week 2 with black arrows showing 
inflammatory cells. Scale bars represent 100 pm.
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Figure 7. 5 Haematoxylin staining of kidney tissue from hyperoxaluric, calciuric, 
and crystalluric animals at week 3. (A) kidney sections of EG + DHC treated group 
at week 3 with white arrows showing increased crystal formation and black arrows 
pronounced tubular distension and (B) loss of epithelial cells indicated by black 
arrows. Histology of kidney tissues of the EG (C) and DHC (D) treated groups at 
week 3 treatment. Scale bars represent 100 pm.
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Having observed these morphological changes and differences between the 
nephrolithic and non-nephrolithic groups, further studies were performed to assess 
changes occurring at the cellular and biochemical level under the oxidative insult 
initiated by the deposition of calcium oxalate crystals in the renal tubules.
7.6 Glutathione in nephrolithic rats
Total cell and mitochondrial glutathione levels, over the 3 weeks treatment were 
monitored to investigate any changes occurring in the kidneys of rats with crystalluria 
during the process of stone formation. There was a decrease in total mitochondrial 
glutathione by week 1 in all of the experimental groups [Figure 7.6], but it was most 
severely depleted in the EG + DHC group. After weeks 2 and 3, the EG + DHC 
treated group had retained these markedly low levels of glutathione, indicating an 
excessive oxidative stress. In the EG or DHC fed groups, total glutathione was 
restored back to the control levels, implying that they were able to recover from the 
initial hyperoxaluric and calciuric shock.
In addition, glutathione in the whole homogenate [Figure 7.7] and cytosolic fractions 
[Figure 7.8] were also measured and showed a similar pattern of decrease throughout 
the three-week course treatment in the EG + DHC group.
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Figure 7. 6  Total mitochondrial GSH levels in hyperoxaluric, calciuric, and 
crystalluric kidneys. Total glutathione measured in the mitochondrial fractions of 
experimental groups (control, EG, EG + DHC, and DHC) at the end of week 1, 2, 3. 
Values presented as a percentage relative to the controls. Mean ± SD for n=3; * p < 
0.05 vs control at weeks 1, |  p  and %p < 0.01 vs control at weeks 2, 3 respectively.
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Figure 7. 7 Total whole homogenate GSH levels in hyperoxaluric, calciuric, and 
crystalluric kidneys. Total glutathione measured in the whole homogenate fractions 
of experimental groups (control, EG, EG + DHC, and DHC) at the end of week 1, 2, 
3. Values presented as pmoles / mg of tissue. Mean ± SD for n=3; * p  < 0.05 vs 
control at weeks 1, t  p  and J p < 0.01 vs control at weeks 1, 2, 3.
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Figure 7. 8  Total cytosolic GSH levels in hyperoxaluric, calciuric, and 
crystalluric kidneys. Total glutathione measured in the whole cytosolic fractions of 
experimental groups (control, EG, EG + DHC, and DHC) at the end of week 1, 2, 3. 
Values presented as pmoles / mg of tissue. Mean ± SD for n=3; * p  < 0.05 vs control 
at weeks 1, f  p  and $ p  < 0.05 vs control at weeks 2, 3.
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7.7 Antioxidant enzym es in nephrolithic rats
To further confirm that crystal deposits and crystalluria initiate an oxidative insult, 
experiments were carried out to examine the levels of antioxidant enzymes 
responding to this insult. Specifically, glutathione peroxidase [Figure 7.9] and 
glutathione reductase [Figure 7.10] were measured in the mitochondrial fraction and 
showed similar profiles.
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Figure 7. 9 Glutathione peroxidase levels in hyperoxaluric, calciuric, and 
crystalluric kidneys. Glutathione peroxidase was measured in the mitochondrial 
fractions of experimental groups (control, EG, EG + DHC, and DHC) at the end of 
week 1, 2, 3. Values presented as pmoles / mg of tissue. Mean ± SD for n=3; * p  < 
0.05 vs control at weeks 1.
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Figure 7. 10 Glutathione reductase levels in hyperoxaluric, calciuric, and 
crystalluric kidneys. Glutathione peroxidase was measured in the mitochondrial 
fractions of experimental groups (control, EG, EG + DHC, and DHC) at the end of 
week 1, 2, 3. Values presented as pmoles / mg of tissue. Mean ± SD for n=3* p  < 0.05 
vs control at week 1 .
Both of these antioxidant enzymes were significantly increased in the EG + DHC 
group after week 1 of treatment, indicating that the kidney initially increased 
antioxidant activity to cope with increased oxidative stress. However, in the following 
weeks glutathione peroxidase and reductase were restored to control levels. G-6 PDH 
levels were markedly increased in the EG + DHC group throughout the whole 3 
weeks treatment [Figure 7.11], hence maintaining reduced glutathione and a supply of 
reducing equivalents in the form of NADPH.
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Figure 7. 11 Glucose-6 -phosphate dehydrogenase (G-6 PDH) levels in
hyperoxaluric, calciuric, and crystalluric kidney. G-6 PDH measured in the 
cytosolic fractions of experimental groups (control, EG, EG + DHC, and DHC) at the 
end of week 1, 2, 3. Values presented as pmoles / mg of tissue. Mean ± SD for n=3; * 
p  < 0.05 vs control at weeks 1, 2, 3.
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7.7 Superoxide Monitoring
In order to provide further evidence of oxidative stress in this nephrolithic animal 
model, superoxide production was also monitored in the kidney mitochondria. 
Mitochondrial superoxide production from the EG + DHC group was markedly 
decreased (> 90 %) throughout the whole course of treatment [Figure 7.12]. This 
phenomenon implies that EG + DHC causes severe kidney mitochondrial damage. At 
week 1 both the hyperoxaluria and the hypercalciuria groups also showed decreased 
levels of superoxide production, however this was lower (< 40 %) than the crystalluria 
animals and was reversed by week 2  and 3 of treatment.
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Figure 7. 12 Superoxide production in hyperoxaluric, calciuric, and crystalluric 
kidneys. Superoxide formation as measured by lucigenin chemiluminescence in the 
mitochondrial fractions of experimental groups (control, EG, EG + DHC, and DHC) 
at the end of week 1, 2, 3. Mean ± SD for n=3; * p,  fp , and % p  < 0.01 vs control at 
weeks 1, 2, 3.
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7.9 Oxygen consumption rates
Mitochondrial oxygen consumption was measured to investigate if the electron 
transport chain was a potential source of the observed changes in superoxide 
production. Oxygen consumption in kidney mitochondria of EG or DHC groups and 
in the presence of malate and pyruvate, complex I substrates, was not significantly 
changed compared to the control [Figure 7.13 and Figure 7.14]. However, in the 
nephrolithic kidney (EG + DHC) group, the rate that oxygen was consumed in the 
presence of complex I substrates, was reduced to 80 % after weeks 2 and 3. Using 
succinate, a complex II substrate, [Figure 7.15 and Figure 7.16] the same level of 
diminution of oxygen rates was observed. The oxygen consumption data combined 
with monitoring of superoxide production provide strong evidence that nephrolithic 
kidneys undergo a severe mitochondrial dysfunction in this animal model.
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Figure 7. 13 Oxygen consumption rates in hyperoxaluric, calciuric, and 
crystalluric kidneys at week 1 using complex I substrates. Representative plot of 
oxygen consumption by mitochondria from control, EG or DHC treated animals using 
malate/pyruvate; lower line and EG + DHC; upper line. Addition of ADP (state III 
respiration) denoted by arrow.
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Figure 7. 14 Oxygen consumption in kidney mitochondria of hyperoxaluric, 
calciuric, and crystalluric animals using complex I substrates. Rates of oxygen 
consumption during state III respiration using malate/pyruvate. Values are means ± 
SD for n=3 expressed as a percentage of oxygen consumption rate in respective 
control kidney. Open bars week 1, closed bars week 2 and shaded bars week 3. *, 
fand J p<0.01 v control at week 1, 2 and 3 respectively.
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Figure 7. 15 Oxygen consumption rates in kidney mitochondria at week 1 using 
complex II substrates. Representative plot of oxygen consumption by mitochondrial 
from control, EG or DHC treated animals using succinate; lower line and EG + DHC; 
upper line. Addition of ADP (state III respiration) denoted by arrow.
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Figure 7. 16 Oxygen consumption in kidney mitochondria using complex II
substrates. Rate of oxygen consumption during state III respiration using succinate.
Values are means ± SD for n=3 expressed as a percentage of oxygen consumption
rate in respective control kidney. Open bars week 1, closed bars week 2 and shaded
bars week 3. *, fand J p<0.01 v control at week 1, 2 and 3, respectively.
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7.10 DISCUSSION
This study examined whether this oxidative stress, which occurs as a result of the 
interaction between COM and tubular epithelial cells in culture, also occurs in an 
animal model of crystalluria arising from hyperoxaluria and hypercalciuria. To 
achieve this, a rat COM crystalluria model was used, comprising a low (0.5 %) 
ethylene glycol feeding which raises urinary oxalate [Lee, YH., et al., 1996] and 1,25- 
dihydroxycholecalciferol the active form of Vitamin D3, to raise calcium levels in 
tubular fluid [Horst, R., et al, 2000]. In this model of hyperoxaluria (EG - treatment), 
hypercalciuria (DHC - treatment), and crystalluria (EG + DHC, hyperoxaluria and 
hypercalciuria), calcium oxalate kidney stone formation occurred after week 1 and 
only in the crystalluria group. Crystal formation became more pronounced in 
subsequent weeks. None of the control groups exhibited renal pathology comparable 
to the EG + DHC treated animals whose kidneys showed signs of hypertrophy, renal 
tubular damage consisting of tubular obstruction due to crystal formation, dilatation, 
atrophy, interstitial inflammation and loss of tubular epithelial cells. The observed 
hypertrophy of the crystalluria animals was a result of fluid retention as there was no 
change in kidney protein content. This is despite an increase in renal workload 
demonstrated by the increased fluid intake and distended bladders.
The appearance of calcium oxalate crystals in the kidney by the end of week 1 is rapid 
relative to other reported studies of rat nephrolithiasis, where higher ethylene glycol 
treatments (0.75 %) were used without simultaneous raising the urinary calcium 
(without any forms of Vitamin D). Under these circumstances intra-renal crystal 
appearance was slower and appeared later than week 1 [Huang, HS., 2002]. In the 
current study, calcium oxalate crystals began to aggregate in the tubular lumen
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causing widening of the interstitial space. However, histological studies of kidneys 
from animals fed with only 0.5 % ethylene glycol did not show any morphological 
differences. Findings from this study also differ from those of de Water et al, [de 
Water, R., et al, 1996] who showed using \TtD3 and 0.5 % EG that only some of the 
rats showed calcium oxalate deposits in the renal cortex or medulla after 4 weeks. 
When 0.75 % EG was used, the amount of kidney-associated crystals was 
proportionally higher. This disparity is most probably a result of differences in the 
potential of different forms of \TtD3 used, to raise urinary calcium. In addition, in 
another study where rats were fed with 0.75 % EG and 2 % NH4CL, these animals 
showed poor renal function even as early as day 10 of treatment [Huang, HS., et al, 
2002]. Furthermore, Lee YH et al, [1996] have shown the presence of kidney stones 
in animals fed with 0.5 % EG alone. However, this study was conducted over a longer 
period of 4 weeks. This demonstrates the ability to achieve crystalluria and kidney 
stones formation at lower and potential sub-cytotoxic doses of EG, making this 
animal model appropriate to investigate the mechanisms involved in human kidney 
stone formation.
Changes in total glutathione levels in both mitochondria and the cytosol indicate a 
considerable oxidative stress imposed in the kidneys of animals exhibiting 
crystalluria, which is absent from the other treatment groups. This indicates the 
importance of crystalline oxalate rather than the free ion in the pathological process. 
The smaller decrease apparent at week 1 in the EG treated group may result either 
from the initial hyperoxaluric stress or from circulating levels of EG and/or its 
subsequent metabolites (including oxalate). The reversal of this phenomenon at weeks 
2 and 3 indicate that this is a transient event, and is certainly not related to 
crystalluria, which is absent from this group. Antioxidant enzyme activity can be
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increased when damage of oxidative modification occurs. Glutathione peroxidase 
(GPx), glutathione reductase (GR) and glucose-6 -phosphate dehydrogenase (G- 
6 PDH) were used as specific indicators of responses to oxidative stress in renal 
tubular injury induced by EG + DHC treatment in this nephrolithiasis rat model. In 
this study, kidney mitochondrial GPx and GR were elevated by the end of week 1 in 
the crystalluria group, where in the rest of experimental groups (EG or DHC) 
antioxidant activities remained the same as those in the control group indicating no 
forms of oxidative stress. However, by the end of weeks 2 and 3 the nephrolithic rat 
group showed gradual attenuation of antioxidant enzyme activities indicating 
impairment of the defence mechanism of the kidney in response to persistent 
oxidative stress. On the contrary to GPx and GR, cytosolic G-6 PDH levels were 
significantly increased in the crystalluria group throughout the whole course 
treatment. G-6 PDH is important in supplying redox equivalents, in the form of 
NADPH, for thiol maintenance and is a marker routinely observed to be induced 
under oxidative stress conditions [Salvemini, F., et al., 1999]. Previous literature 
usually describes this enzyme as unchanged or decreased. However, this is the first 
time this enzyme has been investigated in a model employing DHC. Vitamin D3 and 
its analogues have been shown to both upregulate and activate (via a calcium 
dependent-mechanism) G-6 PDH and at the doses used in this study, no changes were 
observed in animals treated with DHC alone. Although, it is possible that the 
combination of DHC with oxidative stress in the form of kidney crystals, may 
contribute to the increased activity of G-6 PDH.
It has previously been observed that mitochondrial derived superoxide was the source 
of oxidative stress in renal epithelial cells treated with COM in vitro. Mitochondrial 
oxygen consumption and superoxide formation were investigated in this model to
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determine whether the electron transport chain was compromised, and if mitochondria 
were also the source of oxidative stress in vivo. Oxygen consumption in kidney 
mitochondria of EG or DHC groups in the presence of malate/pyruvate (complex I 
substrates) and succinate (complex II substrate), was not significantly changed 
compared to the control, indicating that hyperoxaluria or hypercalciuria alone were 
ineffective in changing mitochondrial function. By contrast, in the nephrolithic kidney 
(EG + DHC) group, the rate at which oxygen was consumed in the presence of 
complex I and complex II substrates, was severely decreased. The restriction in 
electron flow, which was apparent mainly during state III respiration with complex I 
substrates, is normally associated with an increased incidence of electron leakage, 
therefore superoxide formation. This is a consequence of the decreased flow of 
electrons and results from an increased concentration of ubisemiquinone of complex 
II during the Q cycle [Turrens, JF., & Boveris, 1980]. However this did not appear to 
be the case in this model as superoxide formation was decreased to a greater extent 
than oxygen consumption. This indicates that the redox state of ubiquinone (ratio of 
oxidised ubiquinone to ubisemiquinone to reduced ubiquinol) remained oxidised due 
to impaired mitochondrial reductive capacity (complex I and/or II). A study by Huang 
et al., [2000] has shown elevated luminol chemiluminescence levels of renal venous 
samples, in the 7-day 0.75 % EG treated rats. They have also suggested that free 
radicals induced by hyperoxaluria in the early stages in this animal model. This, along 
with the observation of mitochondrial impairment at week 1, may suggest that in the 
current accelerated nephrolithic model, superoxide measurements should have been 
taken earlier than the end of week 1 treatment. Furthermore, no other studies in my 
knowledge have reported attempts of measurement of superoxide in kidney tissues.
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Finally, this data indicates that electron leakage from the electron transport chain did 
not result from impaired electron flow. Thus, mitochondrial dysfunction caused by 
crystal formation may contribute to pathological events during clinical conditions 
where tubular crystal-cell interactions are uncontrolled, as in renal stones disease.
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8.1 Summary
Cultured renal tubular cells serve as tools in experimental studies to further explore 
the mechanisms of urolithiasis. In this work, it is confirmed and established that 
MDCK cells could be used as a model system for the distal/collecting duct studies. 
Initially, in the attempt to provide a link between kidney stone disease and oxidative 
stress, this work confirmed and further optimised technical conditions to study 
oxidative damage under crystal deposition. Detection and measurement of fluxes of 
reactive oxygen species within the cells are of critical importance for investigating the 
patho-physiological consequences resulting from altered cellular reactive oxygen 
homeostasis. Due to their sensitivity, both lucigenin and luminol chemiluminescence 
techniques have extensively been used to assess ROS generation by various cellular 
systems. In this study particularly, lucigenin-chemiluminescence was employed to 
show that COM crystals, free oxalate and to a lesser extent hydroxyapatite crystals 
initiate oxidative damage in terms of superoxide production. Lucigenin has been 
questioned by many due its autoxidation ability above certain concentrations however 
it is now characterised as the most appropriate probe for measuring superoxide 
production. In contrast, it has been reported that luminol-derived CL reflects the H2O2 
released from the mitochondria and should not be used to assess biological derived 
O2*’ generation [Li, Yi., et ai, 1999]. In addition, it has been reported that uptake of 
lucigenin by mitochondria appears to depend on the membrane potential [Li, Y., 
1999]. Based on these observations and the immediate connection of lucigenin and 
mitochondria employing lucigenin was of critical importance since one of the aims of 
the current work was to identify the main origin of oxidative damage occurring upon 
crystal deposition. Furthermore, the involvement of the mitochondrial electron 
transport chain in the generation of the lucigenin derived chemiluminescence was
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further confirmed by employing a number of agents that modulate mitochondrial 
respiration at selective sites of the mitochondrial electron transport chain. In 
particularly it was shown that in the presence of rotenone, a complex I inhibitor, the 
electron flow from NADH/iron-sulphur clusters to ubiquinone is blocked, leading to 
reduction of both membrane potential and O2*’ production by the electron transport 
components, particularly complex III. In contrast to the effects of rotenone, antimycin 
A blocks the electron transport from cytochrome bs62 to ubiquinone, which is 
downstream the site of O2 ’ formation in complex III. The presence of antimycin A 
therefore would cause the electrons to build up, leading to the increased univalent 
reduction of O2 to O2*'. In summary, these data demonstrate that lucigenin uptake and 
accumulation by mitochondria appear to occur via an ionic attraction between the 
positively charged lucigenin molecule and the negatively charged mitochondrial inner 
membrane. Once inside the mitochondria, lucigenin undergoes a one electron 
reduction catalysed by components of the mitochondria electron transport chain, 
yielding the lucigenin cation radical. The lucigenin cation radical then reacts 
specifically with the O2 *" derived from the mitochondria electron chain, leading to 
lucigenin-derived chemiluminescence. Therefore, besides O2 " production by the 
mitochondria, the lucigenin-derived chemiluminescence appears to be determined by 
two other factors: the mitochondrial membrane potential and the one electron 
reduction of lucigenin.
Even though, lucigenin has been proven to be a good chemilumigenic probe to assess 
mitochondria derived ROS, uptake of lucigenin by mitochondria in intact cells was 
uncomplicated. Data from the current work showed that intact cells were not able to 
uptake lucigenin and therefore monitor superoxide production. Other studies however, 
have shown that intact mitochondria can take up lucigenin and therefore give rise to a
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chemiluminescence signal [Li, Y., et al., 1999]. This indicates that lucigenin is unable 
to penetrate the plasma membrane and therefore to achieve the mitochondria- 
lucigenin charge attraction. To facilitate such an action to occur, digitonin, a 
solubilisation agent, was employed in the current work. Digitonin is able to cause cell 
permeabilisation by creating pores of the plasma membrane, and allowing entry of 
lucigenin into the cytosolic compartment and in close proximity with the 
mitochondria. This extensive membrane poration was also confirmed by the scanning 
electron micrographs of COM treated MDCK cells. However, permeabilising the cells 
with digitonin may have two consequences. Firstly, the concentration of digitonin can 
be crucial in the monitoring of O2* formation and therefore in the interpretation of the 
results. Specifically, digitonin at high (< 100 pg/ml) concentrations could cause 
mitochondrial perturbations and disturb the mitochondrial membrane potential 
therefore lowering the levels of O2 *" formation. A recent study however has shown 
that by measuring O2 consumption in a Clark oxygen electrode digitonin up to 100 
pg/ml did not cause mitochondria uncoupling [Khand, FD., et al., 2002]. The integrity 
of the mitochondria has also been shown by the effect of mitochondrial inhibitors in 
the formation of 02*’. In the case where mitochondria were uncoupled due to the 
digitonin effect, mitochondria transport chain would have also been compromised and 
an effect of mitochondrial inhibitors would not have been shown.
Another important consequence that digitonin may have on the cells, could be that of 
a structural change of the cell membrane. Results obtained from the present study 
showed that COM crystals are the most potent constituents of kidney stone to initiate 
oxidative stress in terms of significantly higher levels of O2’’ formation. Free oxalate 
and hydroxyapatite crystals were also shown to induce high levels of O2*’, whereas 
other micro-particles such as uric acid crystals, brushite, zymosan and latex beads had
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no effect. This difference in effect may arise from the fact that digitonin contributes to 
the alteration of the lipid composition of the MDCK cells and therefore affects the 
manner of adhesion. The effect of cell surface molecules on the affinity of crystals has 
been studied by many. Mandel’s group [Weissner, JH., et al., 2001; Bigelow, MW., et 
al, 1997] have reported that the plasma membrane phospholipids have an important 
role in the attachment of COM crystals. In particular they revealed that the expression 
of phosphatidylserine at the cell surface greatly enhanced crystal binding. The same 
authors also proposed that under pathological conditions, the appearance of 
phosphatidylserine at the surface of the epithelial cells occurs and this contributes to 
crystal retention. Recently, the group of Scheid demonstrated that the same effects of 
phosphatidylserine exposure and crystal binding were observed after exposing MDCK 
cells to toxic oxalate concentrations [Cao, LC., et al., 2001]. Furthermore, other 
reports by Lieske et al, [1996] have shown the effect of charged compounds on the 
adherence of COM crystals to MDCK cells. These authors proposed two populations 
of anions; one anchored to the apical plasma membrane and the other free in tubular 
fluid, can be viewed as competitors for the crystal surface. Alteration in the quality 
and quantity of either population of anions could alter this competitive balance and 
thereby determine whether or not crystals bind to the cell surface. This may also 
explain the effect of digitonin in this balance. Incubation of MDCK cells with 
digitonin can cause changes in the phospholipid membrane composition and favour 
COM crystal adhesion. On the contrary digitonin could also affect the quantity of 
anionic presented molecules of the cell surface and therefore inhibit adhesion of 
crystals or other micro-particles such as brushite or zymosan.
In addition to digitonin, the culture conditions in which cells were grown could also 
affect crystal binding and its consequences. In particular, epithelial cells cultured on
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porous supports in a two-compartment system tend to form highly polarised and 
differentiated monolayers. Results presented in this work showed that MDCK and 
HK2 cells when cultured on membrane supports, O2’" production levels were at 
similar levels with those resulted from MDCK and HK2 cells cultured in plastic 
dishes. This indicates that COM binding was not affected by the different cell growth 
methodology. In contrast, different culture substrates seemed to interfere with the 
NaOx effect observed in MDCK and HK2 cells. In particular, results from this work 
showed that NaOx treated MDCK cells grown on both different substrates initiate 
similar levels of O2’" production, whereas the NaOx effects on HK2 cells grown on 
porous supports were lost. This indicates that different culture substrates may interfere 
with oxalate transport. Oxalate transport to the tubular fluid requires its crossing of 
the basolateral plasma membrane and the apical plasma membrane which faces the 
tubular fluid. The transport of oxalate across these membranes is mediated by anion- 
exchange mechanisms. Therefore, when HK2 cells of proximal origin are cultured on 
membrane supports the anion exchange transport mechanisms are functional and 
under external NaOx stimuli, this would facilitate cellular exit of the oxalate at the 
apical membrane. This may indicate that oxalate levels passing through the epithelial 
cells were not high enough to initiate mitochondrial oxidative stress due to continuous 
oxalate outflow.
Even though the effect of COM on MDCK and HK2 cells grown on different culture 
substrates was not lost it could be of great importance to investigate how other 
crystalline forms such as brushite, or hydroxyapatite, respond under these conditions. 
This could lead to important observations since important surface molecules would be 
different, critically altering the crystal binding sites therefore promoting or inhibiting 
binding of such micro-particles. Furthermore, cell culture on membrane supports
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could also be used in studies on oxalate transport into the mitochondria. In the current 
work it was shown that oxalate transport into the mitochondria is mediated via the 
dicarboxylate-phosphate transport mechanism when cells are grown on plastic 
surfaces. Therefore, by introducing anion exchange mechanisms between the 
basolateral and apical membrane, this could lead to an oxalate competition for oxalate 
transport between the mitochondria and oxalate outflow in the tubular fluid. This 
potentially could result in a different cell pathology.
In addition, in the present work, an overall scheme in which COM crystals, as 
opposed to other endocytic particles bind to and are internalised in renal epithelial 
cells is proposed. Under circumstances during which free oxalate is released via 
dissociation, COM enters the mitochondrion via the phosphate-dependent 
dicarboxylate transporter. This leads to an increase in the mitochondrial membrane 
potential with a resultant rise in electron leakage and mostly mitochondrial matrix 
superoxide production. This together with a non-mitochondrial mechanism, which, 
because of its rapidity is crystal - attachment, initiates intracellular calcium transients. 
This has the potential to damage the renal epithelium.
Finally, to provide a link between in vitro and in vivo studies and to investigate 
whether the effects observed due to crystal-cells interactions in tissue culture also 
occur in an animal model, a rat crystalluria model was used. In this in vivo crystalluria 
model of kidney stones, it was observed that nephrolithic kidney underwent oxidative 
stress. Specifically, in the EG + DHC treated animals, this oxidative insult was 
manifest by a decrease in mitochondrial total GSH concentration, as well as an 
increased activity of G-6PDH, both important in maintaining cell redox. Severe 
kidney damage at the mitochondrial level was a key observation, indicated by the
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diminished oxygen consumption. Although the above observations do not share the 
same response as shown in vitro studies this indicates severe renal damage and the 
mitochondria being the primary site. Furthermore, the above findings observed only 
in animals of crystalluria, suggest that damage related events result directly from the 
occurrence of COM crystals in kidney distal tubules. This has clinical importance for 
whole cell and mitochondrial antioxidant therapies in conditions mimicked by this 
model and of particular significance to primary and enteric hyperoxaluria and the 
acute situations in idiopathic stone formers.
8.2 Future work
Post-translational modification of proteins (glycation, oxidation and nitration), are 
common events during patho-physiological age related disease. The elevation of 
products derived during oxalate metabolism and increased oxidative stress, both 
events associated with calcium oxalate crystalluria, mimic conditions associated with 
these modifications, and the onset of such diseases. Therefore, by employing the 
animal model studied in this work, it would be important to investigate whether 
specific proteins undergo post-translational modification. Specifically, the level of 
expression of heat shock protein (Hsp)-25 from kidney tissue, which is the kidney 
form of a protein known to be a powerful protectant against stress events, could be 
examined. In addition, the level of expression of Hsp-25 would be compared with 
other Hsps such as Hsp70 and Hsp60, which have been reported not to change their 
expression under similar insult conditions [Muller, E., et al., 1996]. Since, 
mitochondria integrity has been shown to be impaired in the animal model employed 
in this work, it could be further tested by assessing the activity and expression of 
adenine nucleotide translocase 1 (ANTI), a mitochondrial protein, [Yan, LJ., &
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Sohal., RS, 1998]. Furthermore, levels of oxidation, nitration, and glycation of Hsp-25 
and ANTI, could be examined to identify post-translational modifications occurring 
during nephrolithiasis. These studies might explain why tubular damage is evident 
and would provide a suitable target for protection.
In addition, microarray technology is a now well established technique that enables 
the screening of thousands of genes simultaneously and could provide information on 
diseased mechanisms, and therefore enabling the development of effective 
therapeutics. Therefore, to obtain a more detailed insight into the pathogenesis of 
nephrolithiasis, it would be very informative to examine gene expression profiles in 
the kidney of the rat CaOx nephrolithiasis model developed in the current study, using 
cDNA microarrays. Specifically, generation of a list of genes that are upregulated or 
downregulated upon EG, or DHC and EG + DHC treatment would provide useful 
information. Cluster analysis of the differentially expressed genes may reveal changes 
in gene expression that could correlate with the biochemical and histopathological 
findings observed in the current study. Therefore, by employing a cDNA microarray 
approach, it would further enhance our understanding of specific gene functions in the 
progression of nephrolithiasis.
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